Inflammatory signalling pathways in cystic fibrosis airway epithelial cells by Lavelle, Michaela J.
        
University of Bath
PHD








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
INFLAMMATORY SIGNALLING PATHWAYS IN CYSTIC 
FIBROSIS AIRWAY EPITHELIAL CELLS
Submitted by Michaela J. Lavelle 
for the degree of PhD 
of the University of Bath 
2002
COPYRIGHT
Attention is drawn to the fact that the copyright of this thesis rests with its author. 
This copy of the thesis has been supplied on condition that anyone who consults it is 
understood to recognise that its copyright rests with its author and that no quotation 
from the thesis and no information derived from it may be published without the prior
written consent of the author.
This thesis may be made available for consultation within the University library and may 
be photocopied or lent to other libraries for the purposes of consultation.
 J L . .
UMI Number: U602103
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U602103
Published by ProQuest LLC 2014. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
jjasttsTO.'-m-,
I rvr,£i






List of Figures viii
List of Tables xiv
Abbreviations xv
1. INTRODUCTION 1
1.1 An Overview of Cystic Fibrosis 1
1.1.1 The Discovery of the CF Gene 2
1.1.2 Structure and Function of the Cystic Fibrosis Transmembrane 
Conductance Regulator 3
1.1.3 The CF Gene Defect 6
1.1.4 The Role of CFTR in CF Lung Disease 7
1.1.5 Airway Host Defence and CF 11
1.2 Nitric Oxide 13
1.2.1 Nitric Oxide and Airway Epithelium 18
1.2.2 Nitric Oxide and CF Airway Disease 20
1.3 Chemokines 22
1.3.1 lnterleukin-8 and CF Airway Disease 25
1.4 Epithelial Transcription Factors and Inflammation 29
1.5 Cell Signalling and CF 37
1.5.1 The Role of Mitogen-Activated Protein Kinases in NF-kB Regulation 37
1.5.2 The Role of Phosphatidylinositol 3-Kinase in NF-kB Regulation 39
ii
1.6 Aim of the Study 50
2 MATERIALS AND METHODS 51
2.1 Materials 51
2.2 Cell Culture Conditions 52
2.2.1 9HTEo' and ZCFTE29o' Airway Epithelial Cell Lines 52
2.2.2 9HTEo'/pCEPRF and 9HTEo'/pCEP#2 Airway Epithelial Cell Lines 52
2.2.3 A549 Airway Epithelial Cell Line 53
2.2.2 Cell Culture Vessels 53
2.2.3 Cell Culture 53
2.3 Experimental Protocol 55
2.4 Fluorometric Nitrite Assay 55
2.5 lnterleukin-8 Enzyme-Linked Immunosorbant Assay 56
2.6 Immunoblot Analysis 57
2.6.1 Preparation of Whole Cell Extracts 57
2.6.2 Quantification of Protein 58
2.6.3 Separation of Cellular Proteins 58
2.6.4 Electrophoretic Transfer of Proteins to Nitro-cellulose 59
2.6.5 Immunoblotting of Nitro-Cellulose-Bound Protein 60
2.7 In Vitro Lipid Kinase Assay 61
2.7.1 Cell Stimulation 61
2.7.2 Immunoprecipitation of Phosphatidylinositol 3-Kinase 61
2.7.3 Phosphatidylinositol 3-Kinase Assay 62
2.8 In Vitro Lipid Phosphatase Assay 63
2.8.1 Preparation of Whole Cell Extracts 63
2.8.2 Immunoprecipitation of PTEN 63
iii
2.8.3 Phosphatase Assay





3 NITRIC OXIDE PRODUCTION BY AIRWAY EPITHELIAL CELLS 66
3.1 Introduction 66
3.2 Nitrite Generation by A549 Cells 67
3.3 Nitrite Generation by 9HTEo' and ICFTE290' Cells 69
3.4 Nitrite Generation by 9HTEo'/pCEP#2 and 9HTEo'/pCEPRF Cells 86
3.5 Discussion 96
3.6 Summary of Results 104
4 INTERLEUKIN-8 PRODUCTION BY AIRWAY EPITHELIAL CELLS 105
4.1 Introduction 105
4.2 lnterleukin-8 Generation by 9HTEo' and ICFTE290' Cells 105
4.3 lnterleukin-8 Generation by 9HTEo'/pCEP#2 and 9HTEo'/pCEPRF Cells 118
4.4 Discussion 128
4.5 Summary of Results 135
5 PHOSPHATIDYLINOSITOL 3-KINASE SIGNALLING IN AIRWAY 
EPITHELIAL CELLS 136
5.1 Introduction 136
5.2 The Regulation of Protein Kinase B and Glycogen Synthase Kinase-3 
Phosphorylation in 9HTEo' and £CFTE29o' Cells 136
5.3 Phosphatidylinositol 3-Kinase Activity in 9HTEo' and £CFTE29o' Cells 161
IV
5.4 Activity of the Lipid Phosphatase PTEN in 9HTEo' and £CFTE29o' Cells 163
5.5 Discussion 166







Firstly I would like to thank my two supervisors, Dr. Malcolm Watson and Dr. Anthony 
Smith for all their supervision, help and guidance throughout the course of this study. I 
will always be very grateful to them for giving me the opportunity to get back into 
research.
Many people have given me their support to help finish this work, but I would 
particularly like to thank Dr. Helen Brown for her advice and help with cell culture and 
immunoblot analysis, Jane Leithead for her instructions in ELISA techniques and Dr. 
Stephen Ward for his invaluable guidance with the cell signalling aspects of this project. 
I would also like to give a special mention to Victoria Reidy, Stephanie Williams, Mona 
Bustami, Gillian Whittaker and Clare Baker who have helped to make my time at Bath 
very special and who have provided continued support and encouragement along the 
way. Thank you for your friendship and I hope we will remain in contact.
Most importantly I would like to thank my husband Sean, as I could not have completed 
this thesis without his love, patience and understanding. He has been a huge motivator 
for me and has always believed that I could do this, even when I did not! Thanks must 
also go to my mum and the rest of my family and friends who have always provided 
encouragement and had to put up with me ensconcing myself in my study for weeks on 
end during the last few months.
Finally, I would also like to thank the Medical Research Council and Novartis for their 
generous financial support.
ABSTRACT
It has been reported that CF airway epithelium is deficient in inducible nitric oxide 
synthase (iNOS) activity. It has also been proposed that CF airway epithelial cells are 
primed to produce high levels of the neutrophil attracting chemokine interleukin-8 (IL-8) 
in response to infection. Recently, activation of phosphatidylinositol 3-kinase (PI3K) 
has been linked to the inhibition of iNOS transcription in epithelial cells. In this study the 
potential of human CF and non-CF airway epithelial cells to produce NO and IL-8 was 
examined and the possible role of the PI3K signalling pathway in the regulation of these 
inflammatory mediators was investigated.
The airway epithelial cell lines 9HTEo', XCFTE29o', 9HTEo'/pCEP#2 and 
9HTEo'/pCEPRF were found to produce basal levels of NO but these were not 
increased by proinflammatory cytokine stimulation. This lack of response was not a 
consequence of substrate limitation or competition. Proinflammatory cytokines were 
found to induce IL-8 expression in all four cell lines. The levels of IL-8 produced by the 
CF phenotype cell line, 9HTEo'/pCEPRF in response to proinflammatory stimuli were 
significantly higher than those produced by the 9HTEo-/pCEP#2 cell line, a non-CF 
genetically matched control. This difference may be a consequence of impaired cAMP- 
dependent chloride ion transport. No link was found between the regulation of IL-8 
synthesis and the PI3K signalling pathway.
Interleukin-13 (IL-13) was shown to activate PI3K and lead to the phosphorylation of 
protein kinase B (PKB) and glycogen synthase kinase-3 (GSK3) in human airway 
epithelial cells. The ERK1/2 and JNK MAP kinase pathways and the PKC pathway 
were shown to play a larger role in GSK3 phosphorylation in the CF phenotype 
ECFTE29o' cell line than the non-CF 9HTEo' cell line. These findings could have 
implications for the control of the many cellular processes that are regulated by GSK3, 
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1.1 AN OVERVIEW OF CYSTIC FIBROSIS
Cystic fibrosis (CF) is an autosomal recessive genetic disorder affecting children and 
young adults (Boat et al., 1989). It is the most common life-threatening genetic trait in 
the Caucasian population. In Northern Europe the heterozygote frequency is about 
1:25 and the disease frequency is approximately 1:2500 live births. The dominant 
clinical feature of CF is the obstruction of airways by thick, sticky mucus and 
subsequent infection, primarily by Pseudomonas aeruginosa. As the disease 
progresses some patients may also become infected with Burkholderia cepacia 
(Armstrong et al., 1995; Bauernfeind et al., 1997). Once these pathogens are 
established it is extremely difficult to eradicate them and they cause rapid deterioration 
of lung function. Although relatively uncommon, B. cepacia is particularly difficult to 
control as it is resistant to most antimicrobial agents. Chronic inflammation results from 
the presence of persistent infection and this contributes to the obstructive lung disease 
and tissue destruction. The final consequence is often respiratory failure. As a result, 
lung infection is the major cause of mortality for cystic fibrosis patients.
The gastro-intestinal tract is also affected in CF. Approximately 85% of patients show 
pancreatic insufficiency as a result of mucus obstruction of the pancreatic ducts and 
destruction of exocrine function. In addition, 5-10% of newborns with CF suffer from an 
intestinal obstruction termed meconium ileus. This obstruction is caused by incomplete 
digestion of intraluminal contents in utero and is generally ascribed to failure of 
pancreatic enzyme secretion and a decrease in fluid secretion. In adults with CF, 
infertility is almost universal in males and common in females (Boat etal., 1989).
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At present the management of CF includes chest percussion to clear mucus from the 
airways and improve lung function, the use of antimicrobials to deal with lung infection, 
pancreatic enzyme replacement to aid digestion and close attention to diet (Boat et al., 
1989). As a result of these combined therapies survival has improved steadily over the 
last four decades, with the median survival of patients born in 1990 now being 
approximately 40 years of age (Jaffe, 2001)
1.1.1 The Discovery of the CF Gene
CF was first described as a distinct clinical entity in the late 1930s. In 1983 Paul 
Quinton showed that chloride uptake by absorptive sweat duct epithelium was 
abolished in CF. This characteristic is now used as a diagnostic tool for the disease. 
Shortly afterwards cyclic AMP-dependent transport of chloride ions across airway 
epithelia was also shown to be greatly reduced in CF and the defect was localised to 
the apical membrane (Stutts et al., 1985; Widdicombe et al., 1985; Yankaskas et al., 
1985[b]). Studies suggested that this defect was probably due to the failure of an 
outwardly rectifying anion channel to respond to phosphorylation by a cyclic AMP- 
dependent protein kinase (Welsh, 1986; Frizzell et al., 1986; Schoumacher et al., 1987; 
Li et al., 1988). However, this information alone was not sufficient to identify directly the 
protein product of the gene that is defective in this disease.
In 1989 researchers successfully identified the defective gene responsible for CF; it was 
found to be on chromosome 7 (Kerem et al., 1989; Riordan et al., 1989). Analysis of 
the predicted gene product revealed a transmembrane protein that had the structure of 
a regulated ion channel. The protein was termed the cystic fibrosis transmembrane
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conductance regulator (CFTR) because of the link between abnormal chloride ion 
transport and the CF defect.
1.1.2 Structure and Function of the Cystic Fibrosis Transmembrane Conductance 
Regulator
Functional CFTR is expressed on the apical surface of secretory epithelial cells. It is a 
member of the ATP-binding cassette (ABC) family. Members of this family exhibit a 
range of functions, including ATP-dependent transmembrane transport of large 
molecules, regulation of other membrane transporters and ion conductance (Wine,
1999). CFTR shows at least two of these properties, being a chloride ion channel and a 
regulator of other membrane proteins. For example, CFTR negatively regulates the 
amiloride-sensitive epithelial sodium channel (ENaC) (Knowles et al., 1993). Many 
regulatory roles have been proposed for CFTR, however it is its role in ion transport that 
has influenced most current hypotheses of CF disease.
CFTR is a 1480 amino acid glycosylated membrane glycoprotein. It is composed of two 
homologous halves which each have six membrane spanning segments and one 
nucleotide binding domain (NBD) (Fig 1). A cytoplasmic regulatory domain (R), 
containing a number of consensus phosphorylation sites, links the two homologous 
halves. Residues from the twelve membrane spanning segments form the channel 
lining (reviewed in Akabas, 2000).
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Abbreviations: M1-M12, membrane spanning segments; NH2, N-terminal domain;
COOH, C-terminal domain; NBD-1, nucleotide binding domain-1; NBD-2, nucleotide 
binding domain-2; R, cytoplasmic regulatory domain
Two separate processes control the gating of CFTR. Firstly, serine residues in the 
regulatory domain are phosphorylated by a cAMP-dependent protein kinase (PKA). 
The more extensive this phosphorylation, the greater the probability that the channel will 
open. Secondly, the nucleotide binding domains bind and hydrolyse ATP (Cheng et 
al., 1991). Researchers have traditionally proposed that unphosphorylated R domain 
inhibits the channel by physically blocking the pore and that phosphorylation relieves 
this inhibition (Collins, 1992; Rich et al., 1993). However more recently it has been 
demonstrated that unphosphorylated R domain does not ‘act like a plug’ but that 
phosphorylation of R stimulates interaction between the NBDs and ATP (Winter et 
al., 1997). The hydrolysis of ATP by the NBDs causes the channel to open and anions 
flow through it along an electrochemical gradient. The R domain can be
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dephosphorylated by the protein phosphatases PP2C and PP2A and this closes the 
channel (Vankeerberghen etal., 2001).
CFTR also directly interacts with other proteins. Its cytoplasmic N-terminal domain has 
a direct interaction with syntaxin 1 A. This protein is known to inhibit channel activity. At 
its C-terminus it interacts with a family of PDZ domain containing proteins (Akabas,
2000). The term PDZ derives from the first three proteins in which these domains were 
identified: PSD-95 (a 95 kDa protein involved in signalling at the post-synaptic density), 
DLG (the Drosophila melanogaster Discs Large protein) and ZO-1 (the zonula 
occludens 1 protein involved in the maintenance of epithelial polarity) (reviewed in 
Harris & Lim, 2001). In vivo these domains are thought to be involved primarily in the 
organization of multiprotein complexes that function in signalling, as well as in the 
establishment and maintenance of cell polarity. They particularly recognise specific 
C-terminal motifs called PDZ interacting domains, in the cytoplasmic tails of 
transmembrane receptors and channels (Kornau et al., 1995; Niethammer etal., 1996). 
It has been demonstrated that a C-terminal PDZ interacting domain is required for the 
polarization of CFTR to the apical plasma membrane in airway and kidney epithelial 
cells, although the mechanism behind this directed polarized expression is not known 
(Moyer et al., 1999; Moyer et al., 2000; Milewski et al., 2001). Recent evidence 
suggests that PDZ domain containing proteins may also have direct affects on CFTR 
activity as well as on membrane localization. Two studies have shown that the Na7H+ 
exchanger regulatory factor, or ezrin-radixin-moesin binding phosphoprotein of 50 kDa 
(NHERF/EBP50) can directly increase conductance through the CFTR channel via 
binding of its PDZ domains to the C-terminal tail of CFTR (Wang et al., 2000; Raghuram 
et al., 2001). However, it is not clear exactly how this interaction with NHERF/EBP50 
causes a change in conductance.
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1.1.3 The CF Gene Defect
There are a range of mutations which may lead to CF (reviewed by Zeitlin, 1999).
1. Class I mutations - These lead to the synthesis of unstable/truncated CFTR 
mRNA, usually due to premature stop codons. The result is a total absence of 
CFTR protein. The disease phenotype of this class is often severe.
2. Class II mutations -  These are responsible for CF in approximately 70% of 
patients. The most frequent mutation, AF508 is in this class. The AF508 
mutation corresponds to a specific deletion of three base pairs, which results in 
the omission of a phenylalanine residue at amino acid position 508 in the centre 
of the first NBD of the CF gene product (Kerem et al., 1989; Riordan et 
al., 1989). The established view is that the protein is translated but fails to 
escape the endoplasmic reticulum. It is thought that misfolding of the protein 
targets it for early proteolysis and as a result little or no CFTR reaches the 
plasma membrane. However, work by Kalin et al. (1999) on epithelial tissue 
from AF508 homozygous CF patients, demonstrated an absence of CFTR in 
sweat duct epithelium, but the presence of CFTR in respiratory and intestinal 
epithelium. This suggests that expression of AF508 CFTR shows tissue specific 
variation. The disease phenotype of this class is often severe.
3. Class III mutations -  These disrupt activation of CFTR at the plasma 
membrane (biosynthesis, trafficking and processing are undisturbed). The 
channel is probably defective with respect to ATP binding and hydrolysis or R 
domain phosphorylation. This can also result in a severe disease phenotype.
4. Class IV mutations -  The mutations are in the membrane spanning regions 
which form the chloride ion channel. These mutations may affect the rate of
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chloride ion flow or channel open time. This class confers a mild disease 
phenotype.
5. Class V mutations -  These lead to a decrease in the level of normal CFTR by 
alterations to the promoter. If the reduction of CFTR is greater than 10% this will 
lead to disease.
The mutations can act in combination. For example the deletion of the codon for 
phenylalanine 508 can act alongside a reduced channel opening time. A small set of 
these mutations may confer residual pancreatic exocrine function in a subgroup of 
patients who are pancreatic sufficient.
1.1.4 The Role of CFTR in CF lung Disease
Two main hypotheses exist to explain the effect of mutated CFTR on the function of 
lung epithelia. They both consider the role of CFTR in salt absorption to be of primary 
importance.
1. The high salt hypothesis. Smith et al., 1996 - This hypothesis emphasizes 
the function of CFTR as an anion channel. According to Smith and colleagues, 
missing or defective CFTR leads to a decrease in transepithelial chloride 
conductance. By analogy with CF sweat duct epithelium (Quinton, 1983) they 
propose the consequence of this is reduced movement of sodium through 
amiloride sensitive sodium channels (Fig. 2). The overall result is an increased 
salt concentration in the airway surface fluid (ASF) of the CF lung. This high 
salt concentration could interfere with natural antibiotics in the ASF such as 
defensins and lysozyme. Smith et al. suggest that normal airways, like sweat
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ducts, reabsorb salt in an excess of water from the ASF, therefore producing a 
low salt content in the ASF which does not affect the action of antimicrobial 
agents. Zabner et al. (1998), have provided evidence to support this hypothesis 
by demonstrating that apical fluid covering CF cells is approximately twice as 
salty as normal in their culture system. However, it is worth noting that in vitro 
defensin activity is negligible above 50 mM salt and one study has found a 
chloride salt concentration of 170 ± 79 mM in bronchial ASF from CF patients 
versus 85 ± 54 mM in control subjects (Gilljam et al., 1989). Findings such as 
these cast doubt on the importance of such changes in salt concentration and/or 
the accuracy of ASF salt measurements.









Abbreviations: ENaC, epithelial sodium channel; CFTR, cystic fibrosis transmembrane 
conductance regulator; TJ, tight junction; Na,K pump, sodium, potassium pump.
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Key features of this model are: the central importance of CFTRs channel role, the lack 
of alternative non-CFTR pathways for the transport of chloride ions and no specific role 
for the inhibition of ENaC by CFTR.
2. The low volume hypothesis. Matsui et al., 1998 -  This hypothesis is based 
on CFTR regulation of the amiloride sensitive epithelial sodium channel (ENaC). 
Matsui and colleagues found no difference in the salt concentration of the ASF 
from normal and CF airway cultures. However they did find differences in the 
volume of the ASF from these cultures; the liquid layer in CF epithelial cell 
cultures was reduced in volume compared with that from normal airway cultures. 
The researchers suggest that CFTR mutations eliminate the inhibition by CFTR 
on ENaC. This leads to increased sodium absorption, via ENaC, from the apical 
surface. Chloride ions follow via a non-CFTR shunt pathway. As a 
consequence water flows transcellularly from the apical fluid (Fig. 3). The 
overall result is ASF containing a decreased volume of water (i.e. more viscous 
mucus). This would compromise mucociliary clearance and promote infection.
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Figure 3 The low volume hypothesis (adapted from Wine, 1999).





Abbreviations: ENaC, epithelial sodium channel; CFTR, cystic fibrosis transmembrane 
conductance regulator; TJ, tight junction; Na,K pump, sodium, potassium pump.
Key features of this model are: the parallel pathway for chloride ion conductance and 
the inhibition of ENaC by CFTR.
These two hypotheses are different. It is possible that each group is accurately 
measuring the properties of their cell cultures, but that these properties differ (Wine, 
1999). Cultured epithelial cells exhibit different degrees of CFTR expression, water 
permeability and shunt resistance. These features can affect epithelial transport 
properties and the results of CFTR malfunction. In vivo experiments are needed to 
determine the composition of ASF in actual human airways. However, it is technically 
very challenging to perform such experiments.
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Whilst these theories may account for some of the symptoms of CF, they do not easily 
explain many of the lung manifestations that are responsible for approximately 90% of 
patient deaths. CF airway disease is characterised by long lasting bacterial infections 
with persistent local and systemic inflammation. How does the exaggerated 
inflammatory response relate to the CF defect?
1.1.5 Airway Host Defence and CF
The epithelium of the mammalian airway is in close contact with the outside world and 
this provides a vast opportunity for infection. However the incidence of infection in a 
normal, healthy lung is very low. It has become evident in recent years that the ciliated 
epithelium lining the airway prevents colonization by inhaled bacteria in three ways. 
Firstly, physical processes such as induced turbulent flow of inspired air, coughing, 
ciliary clearance and epithelial cell shedding act to remove much of the inhaled material. 
Secondly, constitutively expressed and inducible chemical defences serve to provide a 
broad-spectrum of antimicrobial agents. Finally, phagocytic cells are recruited to the 
site of infection and an inflammatory response is mobilised (reviewed by Bevins, 1999).
In the CF lung the presence of thick, sticky mucus has a detrimental effect on many of 
the physical processes forming the initial line of defence in the airway. Inhaled 
organisms therefore gain a foothold and infection is easily established. This problem is 
compounded by the failure of CF airway epithelial cells to ingest and subsequently 
inactivate bacteria and the apparent increased binding of certain bacteria to the surface 
of these cells. Both of these defects have been directly linked to mutated CFTR (Pier et 
al., 1996; Zar et al., 1995).
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Examinations of the constitutive antimicrobial agents found in the mucus layer covering 
healthy airway epithelium have identified a wide range of peptides, proteins and organic 
molecules. Two of the most important of these host defence molecules are lysozyme 
and lactoferrin, which are both broad-spectrum antibiotic proteins (Travis et al., 1999). 
They have different modes of action; whereas lysozyme causes lysis of bacterial cells, 
lactoferrin brings about their agglutination (Cole et al., 1999; Harbitz et al., 1984). Many 
other potential antimicrobial agents have also been described including secretory 
leukoprotease inhibitor, uric acid, peroxidase, aminopeptidase, statherin, secretory 
phospholipase A2 and a/p-defensins (Kaliner, 1991; Cole et al., 1999; Diamond & 
Bevins, 1998). These all have a wide and diverse range of actions. It is the activities of 
these antimicrobials, which may be affected if salt concentrations are elevated in the CF 
lung (Smith et al., 1996).
Two complementary inducible defence mechanisms have also been observed in the 
response of healthy airway epithelium to infection (reviewed by Diamond et al., 2000). 
The first mechanism is the increased production of antimicrobial agents and the second 
mechanism is the induction of a signaling network to recruit phagocytic cells to the 
infectious site. Airway epithelial cells will upregulate the expression of many 
antimicrobials in response to numerous infectious and inflammatory agents, including 
bacterial lipopolysaccharide (LPS) and the proinflammatory cytokines tumor necrosis 
factor alpha (TNFa), interleukin-1 beta (IL-1 (3) and interferon gamma (IFNy). Activated 
alveolar macrophages are a primary source of proinflammatory cytokines in the infected 
airway. Examples of antimicrobials that are induced in this manner include human 
p-defensin 2 (hBD2), mucins and reactive nitrogen species such as nitric oxide 
(Diamond et al., 2000). Together these antimicrobial agents act to prevent further
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colonization by infecting microbes. Alveolar macrophages are also capable of 
generating numerous other inflammatory mediators that orchestrate the recruitment of 
large numbers of polymorphonuclear leukocytes (PMNs) from the pulmonary 
vasculature into the alveolar space (Zhang et al., 2000). These recruited PMNs provide 
additional phagocytic capacities to support the alveolar macrophage and can also 
produce proinflammatory cytokines to help maintain high levels of inducible 
antimicrobial agents. Both these functions are crucial for the effective eradication of 
offending pathogens. The alveolar macrophage-derived substances capable of eliciting 
PMN migration into the airways include complement, chemokines such as interleukin-8 
(IL-8) and arachidonic acid metabolites such as leukotriene B4 (Zhang et al., 2000). 
Under normal circumstances the induction of antimicrobials and the generation of an 
inflammatory response should clear an infection relatively quickly, before the host 
tissues suffer any major damage. The chronic inflammatory response associated with 
CF airway disease may be caused by deficits in one or more of these inducible defence 
mechanisms. These deficits may or may not be linked directly to mutated CFTR.
1.2 NITRIC OXIDE
Nitric oxide (NO) is a highly reactive gaseous mediator involved in many physiological 
processes. It was first described in the body as a pharmacological effector of 
endothelium-derived relaxation, through the activation of guanylate cyclase in vascular 
smooth muscle (Muhl et al., 1995). NO is now recognized as a mediator of host 
defense, immune regulation, neurotransmission and inflammation (Moncada et 
al., 1993). It is derived from the amino acid L-arginine by a family of enzymes known as 
the nitric oxide synthases (NOS). The oxidation of a terminal nitrogen of L-arginine by 
these enzymes produces citrulline and NO (Fig. 4). There are three isoforms of NOS:
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endothelial (eNOS), neuronal (nNOS) and inducible (iNOS), which are products of 
different genes and show different localization, regulation, catalytic properties and 
inhibitor sensitivity. eNOS and nNOS are constitutively expressed and are collectively 
termed constitutive NOS (eNOS), whereas in most tissues iNOS is expressed only after 
induction by proinflammatory cytokines, microbes and/or bacterial products (Knowles & 
Moncada, 1994). All forms of NOS require reduced nicotinamide adenine dinucleotide 
phosphate (NADPH), flavine dinucleotide (FAD), flavine mononucleotide (FMN) and 
tetrahydrobiopterin (BH4) as cofactors. In addition, cNOSs are calcium and
calmodulin-dependent (Green et al., 1993). Regulation of iNOS activity shows no 
dependency on calcium.






Electrons (e) are donated by NADPH to the reductase domain of the enzyme and 
proceed via FAD and FMN redox carriers to the oxygenase domain. There they interact 
with the haem iron and BH4 at the active site to catalyse the reaction of oxygen with L- 
arginine, generating citrulline and NO as products. Electron flow through the reductase 






Constitutive NOS produce small amounts of NO (nM range) and are involved in 
homeostatic processes (Moncada et al., 1991). Inducible NOS is responsible for the 
main production of NO in tissues (pM amounts) and is regulated at the transcriptional 
level (Morris & Billiar, 1994). Activation of eNOS can also be distinguished from that of 
iNOS on the basis of the length of time required to observe a significant increase in the 
levels of NO released and the length of time these levels can be maintained. eNOS 
requires no induction and increased NO is observed within seconds of a significant 
increase in intracellular Ca2+ accumulation. This increase is transient and fully inhibited 
by calmodulin antagonists (Stuehr & Griffith, 1992). Generation of NO by iNOS is highly 
regulated by the action of proinflammatory cytokines (Moncada & Higgs, 1993). The 
induction of iNOS can be measured at the RNA level within 30 minutes to 2 hours and 
increased NO release can be measured as soon as 3-4 hours post induction (Stefano et 
al., 1998; Radomski et al., 1990). Maximal production of NO by iNOS is commonly 
observed 6-24 hours post induction and increased NO release can be observed for 
24-72 hours depending on cell type and species studied (Stefano & Magazine, 2001). 
iNOS is sensitive to inhibitors of DNA transcription and protein synthesis, such as 
actinomycin D and cycloheximide. Glucocorticoids (Radomski et al., 1990; Pfeilschifter, 
1991) and cytokines such as TGF(3, PDGF, IL-4 and IL-10 (Oswald et al., 1992; McCall 
et al., 1992; Ding et al., 1990; Cunha et al., 1992) have been found to inhibit iNOS 
expression, without affecting eNOS. The differences in the activities and regulation of 
the various forms of NOS suggest that the level of NO production can be regulated 
rapidly or slowly, depending on the needs of the organism.
NO produced by eNOS is associated with numerous physiological effects. In mammals, 
the activation of eNOS is linked to blood vessel relaxation, which helps to maintain
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normal blood pressure (Welch etal., 1995) and vascular integrity (Cosentino & Luscher,
1995). NO produced by nNOS acts as a non-conventional neurotransmitter and is an 
important regulator of cerebral vascular tone (Brian et al., 1996). Induced NO can have 
a variety of effects, which may be beneficial or detrimental, depending on the amount 
produced, duration of activity and site of synthesis. It is believed to play a role in 
various pulmonary physiological processes, such as bronchodilation (Jorens et al., 
1993,) as well as being responsible for mediation of macrophage cytotoxicity and a part 
of the host response to sepsis and inflammation. A high level of NO production has 
also been associated with tissue damage, septic shock and airway inflammation of 
asthma (Lyons, 1995; Titheradge, 1999; Guo et al., 1995). Increased iNOS expression 
and NO production have been demonstrated at sites of infection in animal models such 
as toxoplasmosis and leishmaniasis (Stenger et al., 1996) and in human infections such 
as tuberculosis (Nicholson et al., 1996). It seems that the induction of NO in many 
animal models is directly associated with the ability of the host to contain microbial 
proliferation, as abrogation of iNOS activity produces dramatic increases in microbial 
burden (Stenger et al., 1996; MacMicking et al., 1997). In support of this, in vitro 
studies of phagocytic cells and a variety of microbial targets have demonstrated 
cytokine-inducible microbiostatic or microbicidal activity which is L-arginine-dependent 
and inhibitible by competitive NO synthase inhibitors such as NG-monomethyl-L-arginine 
(Adams etal., 1990).
Induced NO can combine with reactive oxygen intermediates to generate a variety of 
antimicrobial molecular species, such as peroxynitrite (OONO ), S-nitrosothiols (RSNO), 
nitrogen dioxide (N02#), dinitrogen trioxide (N20 3), dinitrogen tetroxide (N20 4), and 
dinitrosyl-iron complexes (DNIC) (Fang, 1997). Such interactions between reactive 
oxygen and nitrogen intermediates provide a molecular basis for synergy between the
Introduction 17
respiratory burst and synthesis of NO. Interestingly, reaction products such as 
peroxynitrite, formed from the rapid interaction of NO and superoxide (02* ), can have 
greater cytotoxic potential than NO or 0 2"  alone. It is likely that different NO species 
have different affects on target microbial pathogens. For example NO itself does not 
possess antimicrobial activity for S. typhimurium or E. coli but S-nitrosothiols are 
bacteriostatic and peroxynitrite bactericidal for these organisms (Pacelli et 
al., 1995; DeGroote et al., 1995). In contrast, S-nitrosothiols and NO are microbicidal 
for S. aureus (Kaplan et al., 1996), L. major (Assreuy et al., 1994) and G. lamblia 
(Fernandes et al., 1997), under conditions where peroxynitrite does not exert any 
antimicrobial effect.
DNA appears to be an important target of reactive nitrogen intermediates. N02* and 
peroxynitrite can oxidatively damage DNA, resulting in abasic sites, strand breaks and a 
variety of other DNA alterations (Juedes et al., 1996). There is also evidence that 
reactive nitrogen intermediates may interact with DNA repair systems and directly 
modify deoxyribonucleotides (Fang, 1997). These observations may explain the 
anti-proliferative effects of various NO species. NO and its intermediates have also 
been shown to inhibit key microbial enzymes by nitrosylation of reactive groups, such 
as iron-sulphur centres (Fe-S) and thiol groups (-SH), which are essential for enzyme 
catalytic function (Molina Y Vedia et al., 1992; Cattel & Cook, 1993). This may account 
for the cytotoxic and cytostatic effects of NO on microorganisms. The cytotoxic activity 
of NO may play a role in tissue injury during inflammatory diseases and the generation 
of toxic radicals during its reaction with superoxide could contribute to this considerably. 
In particular, peroxynitrite has been shown to impair mitochondrial respiration and 
activate the poly-ADP ribose synthase (PARS) enzyme. This results in reduced NAD
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and a decrease in the rate of glycolysis, electron transport and ATP generation, which 
ultimately leads to cell necrosis or apoptosis (Szabo et al., 1997). To help to counteract 
these affects the body can protect against NO-mediated tissue damage by producing 
corticosteroids, growth factors and cytokines that are potent inhibitors of nitric oxide 
synthase expression (Laskin etal., 1994; Liew, 1995).
1.2.1 Nitric Oxide and Airway Epithelium
NO has been detected in the exhaled air of normal patient volunteers and is increased 
in several inflammatory lung disorders, including asthma and bronchiectasis (Kharitonov 
et al., 1994; Lundberg et al., 1996). The various effects of NO on smooth muscle, 
neutrophils, lymphocytes, platelets and epithelial cells suggest that it may be a mediator 
of major importance in human airways, particularly in association with inflammatory 
airway disease (Barnes & Liew, 1995). In the context of infection it has been 
established that tissue macrophages from rodents use NO, along with other reactive 
nitrogen intermediates, to combat disease-causing agents such as Mycobacterium 
tuberculosis (MacMicking et al., 1997) and Leishmania mayor (Wei et al., 1995). These 
findings suggest that alveolar macrophages could be a potential source of exhaled NO 
in the human airway. However, iNOS has been very difficult to demonstrate in human 
macrophages derived from normal donors monocytes (Nathan, 1997). Conversely, in 
macrophages from patients with a wide variety of inflammatory diseases, iNOS has 
been more readily detected or induced (MacMicking et al., 1997). It would seem that 
the macrophage priming environments that arise in infected or inflamed human hosts 
are difficult to recreate in vitro and further work is required to determine what 
contribution iNOS makes in human alveolar macrophages when it is fully expressed.
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It is well established that airway epithelial cells are one of the major cell types involved 
in the defence of the lung against invading bacteria and other pathogens (Quie, 1986; 
Diamond et al., 1996; Russell et al., 1996) and several studies have demonstrated that 
iNOS is basally expressed at low levels in airway epithelial cells from rats and humans 
(Felley-Bosco et al., 1994; Guo et al., 1995; Rosbe etal., 1996). The proinflammatory 
cytokines TNFa, IL-1(3 and IFNy have been shown to increase significantly the level of 
iNOS expression in human primary epithelial cell cultures and in A549 cells, a type II 
alveolar carcinoma cell line (Asano et al., 1994; Robbins et al., 1994). Levels of nitrite, 
the stable end product of NO breakdown, were maximal 24 hours after cytokine 
stimulation and this increase in nitrite was consistent with an observed increase in iNOS 
protein and mRNA. These results suggest that increased airway epithelial cell 
expression of iNOS may well contribute to the increase in exhaled NO observed with 
inflammatory lung disease. The studies do not exclude the production of NO by 
activated human macrophages within the lung, but suggest that these cells may also 
play a role by releasing cytokines which stimulate NO release by lung epithelial cells. 
Consistent with this concept, alveolar macrophages are known to release increased 
amounts of TNFa and IL-1(3 in asthma (Gosset etal., 1991; Borish etal., 1992).
In support of the reports by Asano and Robbins in 1994, a study carried out on the SV- 
40 immortalized human bronchial epithelial (BEAS-2B) cell line demonstrated that 
cultures treated with TNFa, IFNy and lipopolysaccharide (LPS) in combination, 
expressed iNOS mRNA which was associated with increases in supernatant nitrite 
concentration over 24 hours (Watkins et al., 1997). However, this response diminished 
rapidly as the cells were successively passaged, with the response to cytokine 
stimulation becoming less predictable after only 4 passages. This latter finding is
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consistent with work published by Guo and colleagues (1995) demonstrating that 
freshly isolated human bronchial epithelial cells lose their ability to synthesize iNOS 
mRNA within 72 hours. In a separate study on the bronchial epithelial cell line BET-1 A, 
Guo and colleagues (1997) were unable to demonstrate any expression of iNOS in 
response to cytokines. These studies raise an interesting question as to the most 
suitable cell culture model for the study of NO biology in human airway epithelium.
1.2.2 Nitric Oxide and CF Airway Disease
It has been established that high NO levels correlate with chronically inflamed airways 
(Kharitonov et al., 1994; Lundberg et al., 1996). CF airway disease is associated with 
long lasting bacterial infections alongside chronic inflammation and it might be expected 
that CF lungs should also show elevated levels of NO. However, studies examining 
NO production in CF patients have proved inconclusive. Two studies demonstrate that 
exhaled NO levels are actually reduced in CF patients compared with normal subjects 
and patients with bronchiectasis or emphysema (Light et al., 1989; Grasemann et 
al., 1997). This is despite evidence that increased levels of the proinflammatory 
cytokines TNFa, IL-1(3 and IFNy are present in the sputum from CF lungs (Bonfield et 
al., 1995). In contrast, two different studies have suggested that there is increased 
nitrite in CF sputum (Linnane et al., 1998; Francoeur & Dennis, 1995) and a further two 
report no differences in exhaled NO between CF patients and controls (Lundberg et 
al., 1996; Balfour-Lynn etal., 1996). Recently, it has been shown that iNOS expression 
is reduced in airway epithelium from CF mice (Kelley & Drumm, 1998) and the human 
CF bronchial epithelial cell line CFBE41o' (Meng et al., 1998). These latest data lend 
support to the studies suggesting decreased levels of NO in CF airways.
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The resulting effects of reduced levels of iNOS in the airway epithelium could underlie 
several aspects of the lung dysfunction which characterises CF airway disease. One of 
the most important is a compromised epithelial defence system. Epithelial cells appear 
to play a major role in the prevention of infection in the lung via generation of NO and its 
reactive nitrogen intermediates. Therefore, a lack of NO production could help to 
explain the persistence of microbial infections in CF. Smith et al. (1999), have 
demonstrated that NO can potentiate the toxicity of hydrogen peroxide, a major 
neutrophil-derived reactive oxygen species. If CF lungs do exhibit decreased levels of 
NO this could explain why some pathogens, particularly Burkholderia cepacia survive 
despite a vigorous neutrophil dominated inflammatory response.
The reasons behind the lack of iNOS expression in CF bronchial epithelium are unclear, 
but it is most likely a defect in signalling events leading to transcription. This could be at 
the level of cytokine receptors, their intracellular signalling pathways or transcription 
factors responsible for iNOS promotion (Meng etal., 1997). It is unlikely to be a genetic 
defect as other cells in the CF lung are capable of expressing iNOS, such as alveolar 
macrophages and submucosal inflammatory cells (Meng et al., 1997).
In addition to diminished antibacterial defences, a loss of iNOS expression in airway 
epithelial cells has also been linked to altered transepithelial transport of both sodium 
and chloride ions (Elmer et al., 1999; Kamosinska et al., 1997). Alongside chronic 
bacterial infection, sodium hyperabsorption is a common CF-associated airway 
abnormality (Kelley & Drumm, 1998). It is thought that in the healthy lung NO may act 
as a signalling agent to down-regulate sodium absorption via the amiloride sensitive 
epithelial sodium channel (ENaC) (Elmer et al., 1999). NO is known to act through the 
activation of guanylate cyclases, thus stimulating the production of cGMP (Moncada et
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al., 1991). The ability of cGMP to down-regulate amiloride sensitive sodium absorption 
has been demonstrated in several systems (Light et al., 1989; Rozenweig & Seidman, 
1991). Using murine airway epithelial cells Kelley and Drumm (1998) have 
demonstrated increased sodium absorption in response to the NOS inhibitor 
aminoguanidine. This study suggests that the loss of NO production in CF airways 
results in the subsequent loss of a cGMP signalling cascade and represents a potential 
mechanism for initiating the process of sodium hyperabsorption.
Since NO production has been shown to influence effectively both transepithelial 
chloride and sodium transport, it is plausible that CFTR conveys some regulation to 
iNOS production to further regulate basal ion transport properties. Using an in vivo 
mouse model Steagall et al. (2000), have demonstrated that iNOS expression is 
influenced at some level by the presence of active CFTR. Their study used cftr-I- mice 
where human CFTR had been introduced into the intestinal epithelium, but not the 
nasal epithelium. iNOS specific immunostaining of excised mouse tissue revealed 
strong iNOS expression in the epithelial cells of the ileum, but reduced staining in the 
nasal epithelium. This suggests a CFTR-related influence in the regulation of iNOS 
expression in epithelial cells. It is possible that in the absence of functional CFTR a 
change in cell signalling events occurs which alters the expression of iNOS in airway 
epithelium. Determining the mechanism of how a loss in CFTR function leads to 
reduced iNOS expression will hopefully lead to more effective therapeutic interventions.
1.3 CHEMOKINES
The term chemokine describes a family of closely related chemotactic cytokines, which 
are involved in attracting effector cells to inflammatory sites and also participate in the
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activation of specific leukocytes (Lindley et al., 1993). A wide range of cell types have 
been shown to produce chemokines, including lymphocytes, neutrophils, fibroblasts, 
endothelial cells and epithelial cells (Baggiolini et al., 1994). They are released in 
response to appropriate stimulation, for example by bacterial LPS and the cytokines 
TNFa, IFNy, and IL-1|3. Members of the chemokine family are small, with molecular 
weights in the range of 8-12 kDa. They are structurally related in that they possess 
highly conserved cysteine residues that form disulphide bonds and establish the tertiary 
structure of the protein. Chemokines are divided into four subfamilies based on the 
arrangement of these conserved cysteine residues in the molecule (Oppenheim et 
al., 1991).
The CXC subfamily has the first two NH2-terminal cysteines separated by one 
nonconserved amino acid residue. In contrast, members of the CC subfamily exhibit 
two adjacent cysteine amino acid residues. The C subfamily has one lone NH2-terminal 
cysteine residue, while the CX3C subfamily has these cysteines separated by three 
intervening amino acids. There may be as many as forty to fifty human chemokines and 
most fall into the CXC and CC groups (Rollins, 1997). IL-8 is a prominent member of 
the CXC subfamily of chemokines whereas two important CC family members are 
monocyte chemoattractant protein-1 (MCP-1) and regulated on activation, normal T cell 
expressed and secreted (RANTES). The chemokine subfamilies exhibit cell selectivity 
with respect to chemoattraction. Members of the CXC subfamily primarily target 
neutrophils, whereas various members of the CC subfamily target monocytes, 
eosinophils and basophils. In particular IL-8 mediates neutrophil chemotaxis (Baggiolini 
et al., 1989), MCP-1 mediates monocyte and basophil chemotaxis and activation 
(Leonard & Yoshimura, 1990), while RANTES induces chemotaxis of eosinophils, 
monocytes and CD45 RO+ memory T lymphocytes (Schall et al., 1990).
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Chemokines induce cell migration and activation by binding to specific G-protein- 
coupled cell surface receptors on target cells (Premack & Schall, 1996; Murphy, 1994). 
The ligation of these receptors activates multiple intracellular signalling pathways that 
regulate the intracellular machinery necessary to propel the cell in its chosen direction. 
To date at least six human CXC chemokine receptors (CXCR1 through to CXCR6) and 
eleven human CC chemokine receptors (CCR1 to CCR11) have been described 
(reviewed by Watson, 2002). CXC chemokine receptors are found predominantly on 
neutrophils, hence the selectivity of CXC chemokines for this cell type. In contrast, CC 
chemokine receptors are expressed on a much wider range of cells, including 
lymphocytes, monocytes, macrophages, eosinophils and basophils (Wells etal., 1998).
The migration of leukocytes from blood vessels to an inflammatory site is a highly 
regulated multi-step process, involving a series of coordinated interactions between 
leukocytes and endothelial cells. Four sequential steps can essentially define the 
process: rolling, triggering, adhesion and migration. Chemokines have been shown to 
participate at several stages in this process (Adams & Shaw, 1994). Initially, the 
expression of selectins by both endothelium and leukocytes facilitates the movement of 
leukocytes along the surface of endothelial cells. Chemokines trigger these leukocytes 
to express integrins on their cell surface. The integrins interact with adhesion 
molecules, which are expressed on the surface of activated endothelial cells. This 
interaction promotes strong adhesion of the leukocytes to the vessel wall. Finally, the 
leukocytes migrate into the underlying tissue along a chemotactic gradient. Different 
subsets of leukocytes express particular integrins on their cell surface, which interact 
with specific adhesion molecules. This results in the selective recruitment of leukocytes 
into inflamed tissue.
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The increased secretion of chemokines has been detected in a wide variety of 
inflammatory diseases, such as acute respiratory distress syndrome (Chollet-Martin et 
al., 1993), asthma (Bousquet et al., 1990) and Crohn’s disease (Garcia-Zepeda et al., 
1996; Reinecker et al., 1995; Grimm & Doe 1996). The type of inflammatory infiltrate 
that characterises each particular disease is controlled, in part, by the subgroup of 
chemokines expressed in the diseased tissue. This suggests that various chemokines 
and their receptors might provide novel targets for future therapeutic intervention in 
inflammatory conditions.
1.3.1 lnterleukin-8 and CF Airway Disease
The origin of airway inflammation in CF has been the subject of much debate following 
the finding of neutrophil dominated inflammation in the absence of bacterial infection in 
the bronchoalveolar lavage (BAL) fluid of CF infants (Wilmott et al., 1990; Ramsey et 
al., 1991; Birrer et al., 1994; Balough et al., 1995; Khan et al., 1995). These 
observations lead to the proposal that an inability to downregulate inflammation is 
intrinsic in CF (Cantin, 1995). Several pieces of data support this concept. Inhibition of 
inflammation by high dose ibuprofen or steroids is actually beneficial to patients with CF 
(Eigen et al., 1995; Konstan et al., 1995). Secondly, increased IL-8 has been found in 
the airways of young children with CF compared with the airways of other young 
children without CF but with a comparable airway burden of bacteria (Muhlebach et 
al., 1999). Finally CF mice die earlier from chronic Pseudomonas infection than their 
non-CF littermates. This increased death rate is accompanied by increased 
proinflammatory cytokines in BAL fluid, but not by an increased bacterial burden (Van 
Heeckeren etal., 1997).
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However, Armstrong and coworkers (1997), argue against this proposal. They carried 
out a longitudinal BAL study of infants with CF and found that in the absence of 
infection, the CF children had no increase in neutrophils or IL-8 compared with controls. 
This suggests that at a very early age, little excess IL-8 or inflammation is present in 
children with CF without an infectious stimulus. The authors suggested that the 
methods used in previous studies might have been insufficiently sensitive to detect 
infection. In particular, the usual practice of sampling only one or two segments of the 
lung during BAL was thought to be inadequate. Dakin et al. (2002), sampled three lung 
lobes when collecting BAL fluid, in order to maximize the potential of detection of 
infection and inflammation. Their findings did not exclude the possibility of a degree of 
intrinsic inflammation in CF, but did describe a very significant relationship between 
infection and inflammation, with the level of pathogens cultured from the BAL fluid 
explaining most of the variation in inflammatory cells and a third of the variation in IL-8 
levels.
One potential link between the tendency towards infection and excessive inflammation 
is the response of airway epithelial cells to contact with Pseudomonas aeruginosa, an 
organism that shows increased binding to CF cells in culture compared with non-CF 
cells (Imundo et al., 1995). This response may arise from the interaction of pilin on the 
surface of Pseudomonas with asialo-GIVL receptors, which are increased on the surface 
of CF airway epithelial cells (Saiman & Prince, 1993). The main product from 
Pseudomonas responsible for increasing IL-8 expression in airway epithelial cells has 
been identified and was initially described as a low molecular weight, heat stable, non­
protein, non-LPS molecule (Massion et al., 1994). More recently this molecule was 
further characterised as N-3-oxododecanoyl homoserine lactone (3-0-C12-HSL), a 
Pseudomonas aeruginosa autoinducer (Smith et al., 2001). Pseudomonas
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autoinducers are known to induce the transcription of genes that lead to the production 
of bacterial virulence factors (Van Delden & Iglewski, 1998). The effects of these 
virulence factors are known to contribute directly to the persistence and proliferation of 
the bacteria in the airway, which leads to induction of intense inflammation during 
infection. There is also evidence that when Pseudomonas is grown as a biofilm, the 
ratio of autoinducers produced is different to that of planktonic bacteria and the 
concentration of 3-0-C12-HSL is significantly higher (Smith et al., 2001). Biofilms are 
initiated by the attachment of individual planktonic bacteria to a membranous surface, 
such as the lung epithelium. As a result of cell-cell interactions, a matrix of hydrated 
polymers is produced and this eventually develops into an elaborate three-dimensional 
structure (Costerton etal., 1995; Watnick & Kolter, 2000). Bacteria growing as a biofilm 
are able to withstand host immune responses and exhibit increased resistance to 
antibiotics and biocides when compared with the same cells growing in liquid culture 
(Xu et al., 2000). Recent work has demonstrated that Pseudomonas aeruginosa exists 
as a biofilm in the CF lung (Singh et al., 2000). The concentration of autoinducers, such 
as N-3-oxododecanoyl homoserine lactone, may therefore by very high in 
Pseudomonas infected CF airways. If this were the case, it would have the effect of 
exacerbating any inflammatory response.
Using both matched and corrected airway epithelial cell lines, it has been consistently 
demonstrated that expression of IL-8 after Pseudomonas stimulation is increased in 
cells with CFTR dysfunction (DiMango et al., 1995; Bryan et al., 1998; Tabary et 
al., 1999). A recent study has shown that this increase in IL-8 production is attenuated 
when the cells are incubated with a mutant strain of Pseudomonas that lacks pili and 
therefore cannot bind to the asialo-GIVL receptors (Kube et al., 2001). However, even 
with the mutant strain the CF-phenotype cells still showed a significant increase over
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control cells, suggesting that factors other than Pseudomonas binding to the epithelial 
cell affect production of IL-8. The authors also demonstrated that the time course 
response differed between the normal and CF-phenotype cells used in this study, with 
the latter continuing increased IL-8 production long after it had ceased or slowed in the 
normal cells. This suggests that the mechanisms limiting IL-8 production in normal 
cells may be absent or altered in CF.
Studies examining the effects of proinflammatory cytokines on IL-8 production by CF 
and normal airway epithelial cells have produced results that contradict those from the 
bacterial experiments. Black et al. (1998), found that primary cultures of nasal epithelial 
cells from young children released increased amounts of IL-8 soon after a short 
exposure to TNFa. However, comparison of cultures from children with CF and similar 
cultures from children without CF showed no differences in the magnitude or duration of 
this IL-8 response. A further finding was that immortalised CF cells did not show 
increased IL-8 responses compared with retrovirally corrected cells derived from the 
same line. In fact the trend was actually towards lower IL-8 production in the cell lines 
with CFTR dysfunction. Other studies using a range of CF and non-CF primary and 
immortalised airway epithelial cell lines stimulated with a range of proinflammatory 
cytokines have found similar results (Schwiebert et al., 1999: Massengale et al., 1999). 
In contrast two studies have reported increased IL-8 expression by CF airway epithelial 
cells in the presence and absence of proinflammatory cytokines (Ruef et al., 1993; 
Stecenko et al., 1997). However, these authors examined only two epithelial cell lines, 
did not compare IL-8 expression between CF and non-CF primary airway epithelial cells 
and did not demonstrate that the corrected cell lines they used exhibited wildtype CFTR 
activity. A more recent study by Venkatakrishnan et al. (2000), demonstrated little IL-8 
production by CF airway epithelial cells in the absence of an inflammatory stimulus, but
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an augmented response compared to normal cells after TNFa stimulation. The authors 
suggest that differences in the duration of stimulation by TNFa may account for the 
differences between their findings and those of Black and colleagues (1998). In the 
Venkatakrishnan study, TNFa was continuously present in the cell culture medium, 
whereas in the study by Black et al. (1998), cell stimulation involved exposing the cells 
for one hour to cytokines.
Taken together the bacterial and cytokine studies suggest that different induction 
pathways may lead to IL-8 production depending upon the nature of the stimulus. It 
also appears that enhanced IL-8 expression by CF airway epithelial cells may not be 
the source of the increased IL-8 levels detected in CF patient BAL fluid. It has been 
demonstrated that large numbers of macrophages are present in the BAL fluid of 
infected CF patients (Khan et al., 1995). These macrophages could be the primary 
source of IL-8 in CF airways. Additional studies are needed to further investigate IL-8 
secretion in other airway epithelial cell lines and primary tissue and to determine directly 
whether defective CFTR production and surface expression alter the secretion of IL-8.
1.4 EPITHELIAL TRANSCRIPTION FACTORS AND INFLAMMATION
The binding of proinflammatory cytokines or microbial products to the surface of 
epithelial cells leads to the activation of transcription factors within the cells. This in 
turn leads to the transcription of genes involved in inflammation, cell growth control and 
apoptosis. Nuclear factor-kappaB (NF-kB) is one of the main transcription factors 
which regulates the inducible expression of genes encoding proteins involved in the
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modulation of inflammatory host defense processes in eucaryotic cells (Barnes & Karin, 
1997).
NF-kB was first identified as a regulator of the expression of the kappa light-chain gene 
in murine B-lymphocytes (Sen & Baltimore, 1986), but has since been found in many 
different cell types. In its active form it is a heterodimer usually consisting of a p50 
subunit and a p65 (relA) subunit. Other subunits, such as rel, relB, v-rel and p52 may 
also be part of activated NF-kB and it is likely that the different forms of NF-kB may 
activate different sets of target genes (Siebenlist et al., 1994; Baeuerle & Baltimore, 
1996). In unstimulated cells NF-kB is sequestered in the cytoplasm through interaction 
with inhibitory kappaB (IkB) proteins of which there are several forms, IkBoi, IkB[3, IkBe 
and Bcl-3 (May & Ghosh, 1997). This association with an inhibitory protein prevents NF- 
kB from entering the nucleus. Upon cell stimulation a kinase complex known as IkB 
kinase (IKK), phosphorylates IkB on specific serine residues, causing its subsequent 
ubiquitination and rapid degradation by proteosomes (DiDonato et al, 1996; Chen et al,
1996). Once NF-kB has been liberated, the complex translocates into the nucleus and 
transcriptionally activates target genes by binding to responsive elements in the DNA 
called kB motifs (Fig. 5).
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Figure 5 The activation of NF-kB by IkB kinases. Most work has focused on the 
predominant form of NF-kB, the p65/p50 heterodimer, and its association with kBa 
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It has been demonstrated that activated NF-kB can induce the synthesis of IkBcc by 
binding to kB motifs within its promoter (Arenzana-Seisdedos et al., 1995). Newly 
synthesised IkBoc enters the nucleus, binds to active NF-kB and the whole complex 
returns to the cytoplasm thus terminating the activation of gene expression. In contrast 
the synthesis of IkB(3 is not induced by NF-kB, which suggests that NF-kB is likely to be 
active for a more prolonged period in the types of cells where IkB(3 predominates 
(Thompson et al., 1995). Little is known about the regulation of the other IkB isoforms.
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NF-kB can be activated within minutes by a variety of stimuli, including proinflammatory 
cytokines, growth factors and stress inducers (Baldwin, 2001). Several signal- 
transduction pathways may be involved, but they all ultimately act by phosphorylating 
and therefore degrading IkB. Interestingly, products of the genes that are regulated by 
NF-kB can also cause its activation. For example IL-1 p and TNFa both activate and 
are activated by NF-kB (Barnes & Karin, 1997). This type of positive regulatory loop 
may amplify and perpetuate local inflammatory responses.
The activation of NF-kB leads to a coordinated increase in the expression of many 
genes whose products mediate inflammatory and immune responses. However it is not 
the only transcription factor involved in regulating these genes. It frequently functions 
together with other transcription factors such as activator protein-1 (AP-1). The AP-1 
transcription factor is a complex composed of proteins of the fos and jun 
proto-oncogene families. These proteins need to dimerize to promote binding of the 
complex to AP-1 recognition sites in target genes (Hunter & Karin, 1992). NF-kB and 
AP-1 act on genes for proinflammatory cytokines, chemokines, enzymes that generate 
mediators of inflammation, immune receptors and adhesion molecules (Barnes & Karin,
1997). Thus, they play a key part in the initial recruitment of leukocytes to sites of 
inflammation and in the induction of enzymes such as iNOS.
Most of our current understanding of the transcriptional regulation of iNOS has been 
derived from analysis of the 5’-flanking region of murine (and to a considerably lesser 
extent, human) iNOS promoter. Although iNOS isoforms are highly conserved between 
species, suggesting that they are all products of the same gene, there is less homology 
in the 5’-flanking region (Xie et al., 1992; Geller et al., 1993; Chartrain et al., 1994;
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Nunokawa et al., 1994). Moreover, iNOS gene transcription seems to be regulated 
differently between various human cell lines (Charles et al., 1993; Geller et al., 1993; 
Linn et al., 1997). This probably explains why cytokine combinations leading to iNOS 
induction seem to vary between species and between cell types in the same species 
(Charles et al., 1993; Geller et al., 1993; Lowenstein et al., 1993; Nunokawa et al., 
1994).
In the mouse two NF-kB binding sites have been identified in the 5’-flanking region of 
the iNOS promoter, with the more downstream site accounting for LPS induction of 
iNOS. An upstream site contains enhancer regions with binding sites for y-activated site 
element and interferon regulatory factor (IRF)-1 response element that account for the 
potentiation of LPS-stimulated promoter induction by IFNy (Lowenstein et al., 1993). 
Cytokine regulation of human iNOS promoter includes a considerably larger region of 
5’-flanking sequence compared with the mouse (DeVera et al., 1996; Taylor et 
al., 1998; Ganster et al., 2001; Mellott et al, 2001). Computer analysis of the 8296bp 5’ 
region of the human iNOS gene has identified multiple copies of IFNy response 
elements, two copies of AP-1 and two copies of NF-kB response elements. It should be 
noted that while NF-kB does have a role in the induction of human iNOS it appears to 
be less important than its role in the regulation of the murine gene (Chu et al., 1998). 
Recent studies have suggested that human iNOS regulation shows greater reliance on 
IRF-1 and the activation of the transcription factor signal transducers and activators of 
transcription (STAT)-1, both part of the IFNy signalling pathway (Bories et al., 1999; 
Guo et al., 1997). However, these requirements may differ considerably between cell 
types and cell lines. The differences in the regulation of human and murine iNOS call 
into question the suitability of using animal models in nitric oxide research. It would
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appear that data obtained from mouse studies do not accurately reflect signalling 
mechanisms in human cells.
IL-8 expression is regulated at both the transcriptional and the posttranscriptional levels. 
The former is primarily mediated by multiple elements in the 5’ promoter region of the 
IL-8 gene, including two IRF-1 elements, an AP-1 sequence, an AP-2 site, an AP-3 site, 
a CCAAT/enhancer binding protein (C/EBP) sequence and an NF-KB-nuclear factor of 
interleukin-6 (NF-IL-6) overlapping sequence (Mukaida et al., 1990; Kunsch & Rosen, 
1993; Matsusaka et al., 1993; Oliveira et al., 1994). Activation of NF-kB is the most 
crucial step for IL-8 gene transcription in most cells, however the transcription factors 
with which it cooperates may vary in a cell type specific manner (Mukaida et al., 1994). 
It also seems that the molecular mechanisms involved in IL-8 gene transcription differ, 
even in the same cell, depending on the employed stimuli. For example, it has been 
demonstrated that AP-2 and NF-kB are the most prominent activators of IL-8 when 
airway epithelial cells are stimulated with the Pseudomonas autoinducer 3-0-C12-HSL. 
However, when these same cells are stimulated with TNFa and IL-1(3only NF-kB is 
necessary for maximal IL-8 induction (Smith etal., 2001).
It has been suggested that the synergistic effect of different cytokines on iNOS and IL-8 
induction results from physical interactions between different transcription factors. 
These interactions were thought to lead to the formation of a highly stable multiprotein 
complex with enhanced DNA binding affinity (Taylor et al., 1998). However, a more 
recent study proposes that synergism may be secondary to structural alterations in DNA 
conformation that occur when transcription factors bind to their specific promoter
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regions. These alterations may lead to bending or looping of the DNA and thus 
enhanced transcription (Saura etal., 1999).
Not surprisingly, NF-kB has been found to be highly active in a wide range of 
inflammatory diseases, including airway diseases such as asthma (Hart et al., 1998). 
Recently it has been reported that NF-kB is constitutively' active in the CF airway 
epithelial cell line IB3 and in human CF bronchial gland (HBG) cells compared to normal 
cells (DiMango et al., 1998; Tabary et al., 1999). These data support the observations 
that cells with CFTR mutations are more readily stimulated to produce IL-8 (DiMango et 
al., 1995; Bryan et al., 1998; Tabary et al., 1999). DiMango and colleagues (1998), 
suggest that the aberrant trafficking of mutant CFTR and its accumulation in the 
endoplasmic reticulum (ER) could overwhelm normal cell degradation pathways 
provoking stress activation of NF-kB. They hypothesise that this endogenous 
activation, together with increased bacterial adherence to CF cells (Imundo et 
al., 1995), creates the inflammatory environment characteristic of CF airway disease. A 
more recent study (Weber et al., 2001) lends support to this theory. Weber and 
colleagues demonstrated that stable transfection of Chinese hamster ovary (CHO) cells 
with AF508 CFTR resulted in a significant increase in NF-kB activation compared with 
CHO cells stably transfected with wild-type CFTR. They also reported NF-kB activation 
in airway epithelial cell lines that lacked CFTR chloride channel function, but did not 
accumulate mutant protein in the ER. This activation of NF-kB correlated with elevated 
IL-8 expression. The authors concluded that mutated CFTR could activate NF-kB by 
two independent mechanisms: cell stress associated with mistrafficking or effects
directly due to lack of CFTR chloride channel function. However, there is an important 
caveat to these studies. Although it has been reported that AF508 CFTR accumulates
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in the ER due to abnormal maturation and folding (Cheng et al., 1990; Welsh & Smith, 
1993), other researchers have demonstrated AF508 CFTR expression levels in airway 
and intestinal epithelium that are comparable to wild-type (Kalin et al., 1999). This may 
impact on the relevance of the ER overload hypothesis in airway epithelial cells. In 
contrast to the studies outlined above, Venkatakrishnan et al. (2000), found little NF-kB 
activation in unstimulated CF airway epithelial cells compared to corrected control cell 
lines. However, they did demonstrate increased NF-kB activation in the CF cell lines 
compared to control after TNFa stimulation. They refute the ER overload hypothesis 
and instead suggest that these alterations in NF-kB activity are associated with 
changes in IkB[3 regulation. To date studies examining the relationship between mutant 
CFTR and NF-kB have only been carried out on a limited number of cell lines, so it 
remains to be determined whether these findings are applicable to other cell lines and 
primary tissue from CF patients.
The interactions between the various transcription factors involved in the induction of 
inflammatory genes are well on the way to being understood and blocking the activation 
of proteins such as NF-kB may help in certain inflammatory disorders. However, NF-kB 
does provide a useful role in cellular homeostasis and there could be serious side 
effects in blocking its activation in the long term. The intermediate events between 
cytokines binding to membrane receptors and the activation of transcription factors are 
incompletely defined and may involve numerous signalling pathways. Elucidation of 
these pathways will hopefully enable an approach to regulating inflammation, which 
aims to restore a balance of inflammatory mediators, rather than completely inhibiting 
their action.
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1.5 EPITHELIAL CELL SIGNALLING AND CF
Signal transduction involves the coupling of ligand-receptor interactions to intracellular 
events. These events include phosphorylation cascades that are regulated by tyrosine 
kinases, serine/threonine kinases and/or lipid kinases. The protein phosphorylations 
change enzyme activities and protein conformations, which in turn alter cellular activity 
and change the program of gene expression within a cell. It is possible that these 
pathways are intrinsically altered in CF airway epithelia.
1.5.1 The Role of Mitogen-Activated Protein Kinases in NF-kB Regulation
Among the signalling cascades involved in the response of cells to growth factors, 
cytokines or environmental stress are members of the mitogen-activated protein kinase 
(MAPK) family. Mitogen-activated protein kinases (MAPKs) are signalling proteins that 
are regulated by tyrosine and threonine phosphorylation mediated by distinct upstream 
MAPK kinases (MEKs). MEKs are themselves phosphorylated and activated by 
specific MEK kinases (Robinson & Cobb, 1997). These sequences of phosphorylation 
allow the amplification of external signals with each phosphorylating step. In 
mammalian cells, at least three different subfamilies of MAPKs have been described. 
They include the p42/p44 or extracellular signal-regulated kinases (ERK1/2), which are 
activated by growth factors and c-jun amino-terminal kinase (JNK) and p38, which are 
activated by cytokines and cellular stress. Each MAPK class responds to distinct stimuli 
and induces specific biological responses. This specificity is maintained throughout 
each cascade by selective enzyme-substrate interactions (Marshall, 1994). The 
activated MAPKs may then regulate the activity of transcription factors to control gene 
expression.
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To date only a limited amount of work has been carried out on the role of MAPKs in 
airway epithelial cell inflammatory responses. However, it has been shown in other 
systems that activation of the ERK1/2 MAPK pathway results in the phosphorylation of 
IkBoc and thus the activation of NF-kB (Blenis & Resh, 1993; Ghoda et al., 1997). Smith 
and colleagues (2001), suggest that the activation of NF-kB and the production of IL-8 
found in airway epithelial cells stimulated with the Pseudomonas autoinducer 
3-0-C12-HSL occur through a similar mechanism. They demonstrated that 
3-0-C12-HSL was able to up-regulate both ERK1 and 2 in the cytoplasm of 16HBEo' 
cells. When an inhibitor specific for the upstream kinase of ERK1/2 was added to the 
cultures, 3-0-C12-HSL stimulation of both IL-8 and NF-kB were inhibited. The authors 
did not show any involvement of JNK or p38 MAPK pathways in NF-kB activation in this 
cell line. Consistent with these results, Ratner et al. (2001), observed that ERK1/2 
inhibition caused a significant reduction in NF-kB activation and IL-8 production in 
1HAEo‘ airway epithelial cells in response to stimulation with Pseudomonas aeruginosa. 
However, in contrast with Smith et al. (2001), they also demonstrated a role for the p38 
MAPK pathway in this NF-kB activation and IL-8 induction.
Recently, Kristof et al. (2001), showed that the inhibition of p38 and ERK1/2 MAPKs 
caused a decrease in the activity of human iNOS promoter in A549 airway epithelial 
cells transiently transfected with luciferase reporter plasmids. Reduced cytokine and 
LPS/IFNy-stimulated AP-1 binding accompanied this decrease in activity, whereas 
binding to the upstream NF-kB (relA/relA) sequence was increased. These data are 
consistent with an essential role for MAPKs in AP-1, but not NF-kB, -dependent human 
iNOS activation. The mechanism by which binding to the NF-kB upstream site was
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augmented by the ERK1/2 and p38 inhibitors is not known, although one group have 
reported a reduction of NF-kB activity by activated MAPKs (Alpert et al., 1999).
It is unclear as to why microbial activation of NF-kB and induction of IL-8 should involve 
MAPKs, whereas cytokine and LPS/IFNy activation of NF-kB associated with iNOS 
induction do not. It is possible that these differences are the result of different NF-kB 
dimers binding to particular -kB motifs in the promoter regions of target genes in 
response to specific stimuli. However, more work into the involvement of MAPKs in 
NF-kB and AP-1 activation is needed if differences such as these are to be fully 
explained.
1.5.2 The Role of Phosphatidylinositol 3-kinase in NF-kB Activation
Phosphatidylinositol 3-kinases (PI3Ks) are a ubiquitously expressed enzyme family that 
participate in a wide range of cellular processes, including cell growth and 
transformation, differentiation, motility, insulin action and cell survival (Toker, 2000). 
They belong to a subfamily of lipid kinases and catalyse the addition of a phosphate 
molecule specifically to the 3’-OH position of the inositol ring of membrane-bound 
phosphoinositide (PI) lipids. The 3’-OH species found in mammalian cells include the 
single phosphorylated phosphatidylinositol-3-monophosphate (Ptdlns-3-P); the double 
phosphorylated forms phosphatidylinositol-3,4-bisphosphate (Ptdlns-3,4-P2) and 
phosphatidylinositol-3,5-bisphosphate (Ptdlns-3,5-P2) and finally the triple 
phosphorylated form phosphatidylinositol-3,4,5-trisphosphate (Ptdlns-3,4,5-P3). Inositol 
lipids phosphorylated at this position are termed D-3 lipids and they make up less than 
0.25% of the total inositol-containing lipids within the cell. This is consistent with the
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idea that these lipids have specific regulatory functions inside the cell as oppose to 
structural functions (Rameh & Cantley, 1999). Members of the PI3K family have been 
grouped into three classes according to their primary structure, their regulation and the 
molecules they utilise as substrates (reviewed in Vanhaesebroeck et al., 1997).
Class I PI3Ks are heterodimers consisting of a 110 kDa catalytic subunit (p110) and an 
85 kDa adaptor/regulatory subunit (p85). In vitro, this class of PI3K can utilise Ptdlns, 
Ptdlns-4-P and Ptdlns-4,5-P2. However, in cells their preferred substrate appears to be 
Ptdlns-4,5-P2 (Fig. 6). All class I PI3K members are also capable of binding to the 
monomeric G-protein Ras. The significance of this interaction in PI3K signalling is 
unclear, but it may be a way of tethering the enzyme to the membrane. Class I PI3Ks 
can be further subdivided into class lA and class lB enzymes. In class lA PI3Ks, the 
p110 subunit is complexed to an adaptor protein that has two Src-homology-2 (SH2) 
domains. These SH2 domains bind to phosphorylated tyrosine residues that are 
generated by activated tyrosine kinases in receptors and various adaptor proteins. This 
is believed to allow translocation of cytosolic PI3Ks to the membrane where their lipid 
substrates and Ras reside. All mammalian cell types so far investigated express at 
least one class lA PI3K isoform and stimulation of almost every receptor that induces 
tyrosine kinase activity also leads to class lA PI3K activation (Stephens et al., 1993; Fry, 
1994; Wymann & Pirola, 1998). The only class lB PI3K identified to date consists of a 
p110y catalytic subunit complexed with a 101 kDa regulatory protein (p101). 
P110y/p 101 heterodimers are activated by the (3y subunits of heterotrimeric G-proteins 
(Krugmann et al., 1999) and have only been found in any abundance in mammalian 
white blood cells.
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Class II PI3Ks are large molecules (> 170 kDa) that do not associate with an adaptor 
protein or bind to Ras. They are fairly ubiquitous and although little is known about their 
regulation, tyrosine kinase activity and heterotrimeric G-proteins may be involved 
(Arcaro et al., 1998). In vitro class II PI3Ks can utilise Ptdlns, Ptdlns-4-P and Ptdlns- 
4,5-P2 as substrates, although the preference is for Ptdlns and Ptdlns-4-P (MacDougall 
et al., 1995; Domin et al., 1997) (Fig. 6). It is not clear which lipids class II PI3Ks make 
in vivo.
Class III PI3Ks are the homologues of the yeast vesicular protein-sorting protein 
Vps34p. These PI3Ks can only use Ptdlns as a substrate in vitro (Fig. 6) and they are 
probably responsible for the generation of most of the Ptdlns-3-P found in cells. The 
cellular levels of Ptdlns-3-P remain fairly constant at all times, suggesting that the 
physiological processes in which class III PI3Ks are involved are not acutely triggered 
by cellular stimulation.
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Figure 6 Pathways outlining the synthesis of phosphoinositide 3-kinase lipids (adapted 
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Phosphoinositide 3-kinase lipids are generated in response to hormones, growth factors 
and other extracellular stimuli. They can lead to a wide range of cellular responses by 
interacting with effector proteins, which in turn modulate a large number of cellular 
targets (Corvera et al., 1998). The main products of PI3K activity, Ptdlns-3,4-P2 and 
Ptdlns-3,4,5-P3, are known to bind to proteins containing pleckstrin-homology (PH) 
domains (Vanhaesebroeck & Waterfield, 1999). The serine/threonine protein kinase B 
(PKB), also referred to as Akt, contains a PH domain and is the most well characterised 
target of Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3 (Rameh & Cantley, 1999). In addition to 
binding the phosphoinositide lipids, full in vivo activation of PKB also depends upon the
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phosphorylation of a threonine residue (Thr-308) in its kinase domain and a serine 
residue (Ser-473) in its C-terminal tail (Alessi et al., 1996). Phosphorylation of these 
residues is known to be dependent on PI3K. The Thr-308 kinase, phosphoinositide- 
dependent kinase 1 (PDK1), has recently been identified and like PKB it contains a PH 
domain and binds with high affinity to Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3 (Stephens et 
al., 1998). It has been proposed that PI3K lipid products are involved in recruitment of 
PKB and its upstream kinases to the membrane, via their PH domains and also in 
promoting conformational changes in PKB that expose Thr-308 and Ser 473 to 
phosphorylation by PDK1 and other such kinases (Franke et al., 1997; Downward, 
1998). Once activated PKB leaves the plasma membrane to phosphorylate a variety of 
intracellular substrates. The phosphorylation of these substrates triggers a wide range 
of cellular activities (Fig. 7).
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Many additional downstream targets of PI3K have been identified; those shown here 
have particularly well-defined roles in cell survival and proliferation.
Abbreviations: ( p)  phosphate; PIP3, Ptdlns-3,4,5-P3; PIP2, Ptdlns-4,5-P2; PI3K,
phosphatidylinositol 3-kinase; PDK1, phosphoinositide dependent kinase 1; PKB, 
protein kinase B; PH, pleckstrin-homology domain; GSK3, glycogen synthase kinase-3; 
BAD, Bcl-2 antagonist of cell death; FKHLR1, forkhead transcription factor, p70S6K, p70 
S6 kinase; IKK, IkB kinase; NF-kB, nuclear factor-kappaB; MAPK, mitogen-activated 
protein kinase; PTEN, phosphatase and tensin homologue deleted on chromosome ten.
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A great deal of evidence has emerged linking PI3K/PKB signalling to cell survival 
(reviewed by Coffer et al., 1998). Studies using primary human leucocytes have 
established that survival factors such as IL-3 can suppress apoptosis by activating PKB. 
Once activated, PKB phosphorylates and inactivates key components of apoptotic 
pathways such as the proapoptotic Bcl-2 family member, BAD and the protease 
caspase 9 (Datta et al., 1997; del Peso et al., 1997; Cardone et al., 1998). Recently it 
was demonstrated that activated PKB also inhibits apoptosis in a 
transcription-dependent manner in human B cells, by phosphorylating and inactivating 
the forkhead transcription factor family member, FKHRL1 (Brunet et al., 1999). Within 
the nucleus, FKHRL1 probably triggers apoptosis by inducing the expression of genes 
that are critical for cell death, such as the Fas ligand gene. Phosphorylation by PKB 
leads to the translocation of FKHRL1 from the nucleus into the cytoplasm away from its 
transcriptional targets.
Activated PKB has also been shown to activate the transcription factor NF-kB in human 
leucocytes and a range of cancer cell lines (Ozes et al., 1999; Romashkova & Makarov, 
1999; Kane et al., 1999; Madrid et al., 2000). Although the induced nuclear 
translocation of NF-kB has been highly regarded as the principal method to activate 
NF-KB-dependent gene expression, an alternative mechanism of NF-kB activation is 
emerging that involves the phosphorylation of the p65 subunit. For example, it has 
been shown that the proinflammatory cytokines IL-1 p and TNFa lead to the 
phosphorylation of p65 and the subsequent transactivation of NF-kB through pathways 
distinct from induced nuclear translocation (Bird et al., 1997; Wang & Baldwin, 1998). 
In 1999, Sizemore and colleagues established that this transactivation of NF-kB occurs 
in a PI3K/PKB-dependent manner. More recently Madrid et al. (2001), suggested that
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the ability of PKB to stimulate the transactivation potential of the p65 subunit of NF-kB 
in murine fibroblasts and human kidney cells requires IKK and the mitogen-activated 
protein kinase p38. They demonstrated that PKB signalling in response to IL-1(3 
exposure stimulates NF-kB by activating p38 in a manner dependent on IKK and that 
activated p38 indirectly stimulates the transactivation domain of the p65 subunit of 
NF-kB through a functional interaction with the transcriptional coactivator CREB-binding 
protein/p300 (CBP/p300). These findings are corroborated by other reports, which 
show that p38 modulates NF-kB by an indirect mechanism (Wesselborg et al., 1997; 
Norris & Baldwin, 1999).
One of the main physiological substrates of PKB is glycogen synthase kinase-3 (GSK3), 
which was discovered over twenty years ago as one of several protein kinases that 
phosphorylate and inactivate glycogen synthase, the final enzyme in glycogen 
biosynthesis (Embi et al., 1980). However, GSK3 has now been found to regulate the 
functions of many metabolic, signalling and structural proteins in a variety of tissues and 
could be involved in the coordinated regulation of a large number of cellular processes 
(Grimes & Jope, 2001). Mammalian GSK3 exists as two closely related isoforms 
termed a and (3, each encoded by a distinct gene (Woodgett, 1990, 1991). These 
proteins share 85% homology at the amino acid level. There is growing evidence that 
GSK3, particularly the (3 isoform, is involved in the regulation of gene transcription. An 
example of this is the phosphorylation of the transcription factor c-Jun, which is a 
component of the AP-1 transcription factor complex. c-Jun is phosphorylated in vitro by 
GSK3 on three sites that are highly phosphorylated in resting cells and are specifically 
dephosphorylated when cells are stimulated by growth factors. These sites lie close to 
the DNA-binding domain of c-Jun and phosphorylation results in a reduction in
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DNA-binding affinity (Woodgett, 1991; Plyte et al., 1992). Evidence that GSK3 plays an 
important role in transcriptional regulation in intact cells comes from observations that 
transactivation of AP-1 reporter genes is inhibited by coexpression of GSK3 (DeGroot et 
al., 1992). GSK3 has also been implicated in the control of the transcription factor 
cyclic-AMP response element binding protein (CREB) by cyclic-AMP and in vitro it 
phosphorylates sites in the transcription factor c-Myc that are phosphorylated in vivo 
(Fiol et al., 1994; DeGroot et al., 1992). More recently it has been reported that GSK3 
also plays a critical role in cell survival. Pap & Cooper (1998), demonstrated that 
overexpression of GSK3 was sufficient to induce apoptosis in Rat-1 and PC12 cells. 
They suggest that the phosphorylation of one or more targets of GSK3 serve to activate 
apoptotic cell death alongside other proapoptotic targets of PI3K/PKB signalling such as 
BAD.
It has been established that inhibition of GSK3 activity in vivo results from its 
phosphorylation at an N-terminal serine residue, Ser-21 in GSK3a and Ser-9 in GSK3(3, 
by PKB (Cross et al., 1995). In vitro these residues can also be phosphorylated by 
MAPK pathways (Sutherland et al., 1993). Given that phosphorylation by GSK3 
appears to inhibit the activities of proteins involved in a wide range of biosynthetic 
processes, inactivation of GSK3 via PI3K/PKB or MAPK may provide a coordinated 
mechanism for activating a spectrum of cellular activities. PI3K signalling, via PKB and 
GSK3, appears to trigger a diverse array of cellular responses. Of particular interest is 
the role of these pathways in transcription factor regulation. The fact that the 
downstream targets of PI3K can activate transcription factors such as AP-1 and NF-kB 
in a range of cell types suggests that PI3K signalling could be involved in the gene 
induction of inflammatory mediators such as iNOS and IL-8.
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Three separate lines of evidence implicate a role for PI3K signalling in the regulation of 
iNOS transcription, although the studies suggest that instead of PI3K activation leading 
to gene induction of iNOS it actually attenuates iNOS expression. For example, 
Donaldson and colleagues (1996), demonstrated that while IL-1(3 activated PI3K in 
renal mesangial cells, pharmacological inhibition of PI3K by wortmannin actually 
potentiated the IL-1|3-induced NO production. In addition, Wright et al. (1997), showed 
that stimulation of the colonic epithelial cell line HT-29 with IL-13 resulted in the 
inhibition of proinflammatory cytokine-induced iNOS expression and this was reversed 
upon PI3K inhibition. Finally Park et al. (1997), established that PI3K inhibitors 
enhanced LPS-induced iNOS expression and activity in murine macrophages. 
Together these data imply that inhibition of PI3K activity may be essential for iNOS 
induction. The mechanism by which PI3K might regulate expression of iNOS in these 
systems is not understood, although IL-13 has been shown to inhibit NF-kB activation in 
some cell models (Manna & Aggarwal, 1998) and this could contribute to the decrease 
in iNOS expression observed in colonic epithelial cells. However, given that the general 
consensus is that PI3K is required for NF-kB activation in most settings, it may be that 
the activation of PI3K in some cases results in the phosphorylation of an unknown 
protein that interferes with the transcriptional regulation of iNOS (Wright & Ward, 2000). 
Perhaps the interaction between iNOS and PI3K varies depending on the cell model 
used and exhibits tissue-specific regulation.
Interleukin-13 (IL-13) is the most recently identified cytokine to join the T helper 2 (Th2) 
family. It is distantly related to IL-4 and is produced by activated T-lymphocytes 
(especially Th2 cells), mast cells, basophils, dendritic cells and natural killer (NK) cells. 
IL-13 has been shown to induce a variety of immunomodulatory functions in a wide
Introduction 49
range of cell types, including macrophages, NK cells, fibroblasts, eosinophils, airway 
smooth muscle cells and endothelial cells, highlighting its pleiotropic activity (reviewed 
by Brombacher, 2000). It has recently been reported that the immune response to 
chronic Pseudomonas aeruginosa lung infection in CF patients is predominantly of the 
Th2 type (Moser et al., 2000). If this is the case there may be high levels of IL-13 in the 
CF infected lung, which could affect cytokine-induced iNOS expression.
IL-13 activation of a PI3K-dependent signalling cascade has also been linked to the 
inhibition of proinflammatory cytokine-induced apoptosis in the colonic epithelial cell line 
HT-29 (Wright et al., 1999). It has been suggested that antiapoptotic genes may be 
downstream targets of NF-kB (Hsu et al., 1996; Antwerp et al., 1996). If this is the 
case, PI3K may be involved in protecting cells from apoptosis via NF-KB-dependent 
mechanisms. However, Wright and colleagues (1999) demonstrated that cytokine- 
induced apoptosis in HT-29 cells was independent of NO formation. This seems to rule 
out a link with NF-kB. It is possible that cell survival in this case was a result of the 
phosphorylation of proapoptotic downstream targets of PKB, including BAD, caspase 9 
and FKHRL1 and/or the dephosphorylation of proapoptotic targets of GSK3.
As discussed earlier, there is evidence to suggest that CF airway epithelia show 
decreased levels of cytokine-induced NO production compared to non-CF airway 
epithelia (Light et al., 1989; Grasemann et al., 1997; Kelley & Drumm, 1998). It has 
also been suggested that apoptotic pathways may be altered in CF (Maiuri, 1997). By 
analogy with colonic epithelial cells it seems possible that PI3K activity could be 
aberrant in CF airway epithelium. An overactive PI3K system could account for some of 
the lung manifestations seen in CF.
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1.6 AIM OF THE STUDY
This study is based on the finding that activation of phosphatidylinositol 3-kinase (PI3K) 
leads to the inhibition of iNOS transcription in gut epithelial cells. CF airway epithelia 
show aberrant production of inflammatory mediators such as nitric oxide and IL-8, which 
may be a result of altered intracellular signalling. In this study the regulation of the PI3K 
signal transduction pathway was explored in well characterised airway epithelial cell 
lines and a possible link with nitric oxide and IL-8 production was investigated.
The objectives of the investigation were:
1. To explore the potential of human airway epithelial cells to produce nitric oxide 
and IL-8 in response to proinflammatory cytokines.
2. To investigate possible signalling mechanisms involved in the production and 
regulation of nitric oxide and IL-8 in human airway epithelial cells.
3. To characterise the regulation of the phosphatidylinositol 3-kinase signal 
transduction pathway in human airway epithelial cells.
The elucidation of the nature of the dysregulated inflammatory response in CF airway 
epithelia will help in the development of new therapeutic strategies for the effective 
treatment of this disease.
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2 MATERIALS AND METHODS
2.1 MATERIALS
Reagents were purchased from Sigma Chemical Co. (Poole, Dorset, UK), unless 
otherwise stated.
All cell culture plastics were purchased from Nunc (Nottingham, UK).
All cell culture reagents (media, PBS, HEPES, trypsin/EDTA, foetal calf serum, 
antibiotics, vitrogen) were purchased from Gibco BRL Life Technologies, Inc. 
(Paisley, Scotland).
Human recombinant IL-1 p was a generous gift from Glaxo Wellcome (Greenford, 
UK).
Human recombinant TNFa was a generous gift from Bayer (Slough, UK).
Human recombinant IFNy was purchased from Boehringer Mannheim (Mannheim, 
Germany).
Human recombinant IL-13 was kindly donated by Dr. A. Minty (Sanofi Elf Bio 
Recherches, Laberges, France).
All cytokines were diluted in sterile PBS + 0.1% bovine serum albumin (BSA, low 
endotoxin) and stored in aliquots at -20°C.
Hygromycin, L-arginine, SP600125 and Ro-32-0432 were purchased from 
Calbiochem (Darmstadt, Germany).
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2.2 CELL CULTURE CONDITIONS
2.2.1 9HTEo' and £CFTE29o~ Airway Epithelial Cell Lines
The human tracheal epithelial cell line 9HTEo' and the human CF tracheal epithelial 
cell line £CFTE29o' were generous gifts from D.C. Gruenert (University of San 
Francisco, California). The cell lines were created by transfecting human tracheal 
epithelial cells with a plasmid containing a replication-defective simian virus 40 
(SV40) genome. The process resulted in transformed human tracheal epithelial 
cells, which retained some aspects of the original phenotype. These include the 
presence of microvilli, responsiveness to agonists, Cl' ion transport and the ability to 
form tight junctions (Gruenert etal., 1988; Knuzelmann etal., 1993).
2.2.2 9HTEo'/pCEPRF and 9HTEo'/pCEP#2 Airway Epithelial Cell Lines
The human tracheal epithelial cell lines 9HTEo7pCEPRF and 9HTEo'/pCEP#2, were 
a kind gift from Pam Davis (Case Western, Cleveland, Ohio). The 9HTEo'/pCEPRF 
cell line was made by transfecting the SV40 transformed cell line 9HTEo' with a 
pCEP4 plasmid, containing genes that expressed the regulatory (R) domain of 
CFTR (Perez et al., 1996). Over expression of the R domain in these cells produced 
a CF phenotype. The 9HTEo"/pCEP#2 cell line was created in the same way as the 
9HTEoVpCEPRF cell line (Perez et al., 1996). However, in this case the 9HTEo' 
cells were transfected with an empty pCEP4 plasmid. The pCEP4 plasmid also 
contained genes conferring hygromycin B resistance to the pCEP cell lines. The 
inclusion of hygromycin B in the cell culture medium ensured that only cells 
containing the pCEP4 plasmid would survive and replicate.
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2.2.3 A549 Airway Epithelial Cell Line
The human type II alveolar carcinoma cell line A549 was obtained from the 
American Type Culture Collection (ATCC).
2.2.4 Cell Culture Vessels
All cell culture vessels used were coated with a solution of 6.6% collagen (1 ml 
vitrogen, 13 ml sterile Milli-Q water, 1 ml serum-free medium, 0.1 M NaOH). Once 
the collagen solution had been added to the vessels the excess was removed and 
the vessels were left to dry in the tissue culture hood overnight. Coated vessels 
were stored at 4°C until use.
2.2.5 Cell Culture
All solutions used for cell culture were prepared using sterile Milli-Q water obtained 
from a Milli-Q PF Plus system with ultrafiltration cartridge (Millipore UK Ltd).
9HTEo' cells and SCFTE29o’ cells were routinely cultured in 180 cm2 tissue culture 
flasks in Eagle’s minimum essential medium (MEM) supplemented with penicillin (10 
u/ml), streptomycin (10 ng/ml), fungizone (0.5 ng/ml) and 10% (v/v) foetal calf serum 
(FCS) (referred to as complete medium). Cultures were maintained at 37°C in a 
humidified air / 5% C 02 atmosphere. The medium was changed every 2-3 days.
9HTEo'/pCEP#2 cells and 9HTEo'/pCEPRF cells were routinely cultured in 180 cm2 
tissue culture flasks in Dulbecco’s modified Eagle’s medium with sodium pyruvate + 
L-glucose + pyridoxine (DMEM). This medium was supplemented with penicillin (10
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u/ml), streptomycin (10 pg/ml), fungizone (0.5 pg/ml), hygromycin (10 pg/ml) and 
10% (v/v) FCS (referred to as complete medium). Cultures were maintained at 37°C 
in a humidified air / 5% C 02 atmosphere. The medium was changed every 2-3 
days.
A549 cells were routinely cultured in 80cm2 tissue culture flasks in Dulbecco’s 
modified Eagle’s medium with sodium pyruvate + L-glucose + pyridoxine (DMEM). 
This medium was supplemented with penicillin (10 u/ml), streptomycin (10 pg/ml), 
fungizone (0.5 pg/ml) and 10% (v/v) FCS (referred to as complete medium). 
Cultures were maintained at 37°C in a humidified air / 5% C 02 atmosphere. The 
medium was changed every 2-3 days.
To subculture confluent monolayers, the medium was removed and the cells were 
washed. 9HTEo' cells, ZCFTE29o' cells and A549 cells were washed 3 times with 
PBS (w/o Ca2* and Mg2*). 9HTEoVpCEP#2 cells and 9HTEo'/pCEPRF cells were 
washed 3 times with PBS (w/o Ca2+ and Mg2+) + 20 mM HEPES. After washing 1.5 
ml of 0.05% (w/v) trypsin and 0.02% (w/v) EDTA were added to each flask and the 
cells were incubated for approximately 3 minutes at 37°C until the cells had 
detached from the flask. The action of trypsin/EDTA was inhibited by the addition of 
10 ml of complete medium and the cell suspension was centrifuged at 300 g for 10 
minutes. The cell pellet was resuspended in 1 ml of complete medium and cell 
number and viability were checked in a Neubauer haemocytometer after mixing 1:1 
with 0.4% Trypan Blue. Dead cells stained blue due to the uptake of Trypan blue. 
Cell viability was always greater than 90%. Cells were counted and then seeded at 
3-5 x 104 cells/ml of complete medium, into 180 cm2 tissue culture flasks (25 ml 
medium per flask) for further culture, or into 6-well plates (2 ml medium per well) or
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petri dishes (4 ml medium per dish) for experimental protocols. Flasks, plates and 
dishes reached confluency after approximately 5 days.
For storage, cells were resuspended at 1 x 106 cells/ml of freeze medium. The 
freeze medium contained 10% dimethylsulphoxide (DMSO), 40% FCS and 50% 
complete medium. The cell suspension was transferred to cryotubes at 1 ml/ tube. 
The cryotubes were gradually cooled in isopropyl alcohol at -70°C overnight and 
then stored in liquid nitrogen tanks. For resuscitation from liquid nitrogen, cells were 
rapidly defrosted at 37°C in a water bath, washed in complete medium and 
resuspended in 1 ml of complete medium. Cells from one cryotube were seeded 
into 180 cm2 tissue culture flasks in complete medium, continuing as above.
2.3 EXPERIMENTAL PROTOCOL
For experimental purposes cells were grown until they were approximately 90% 
confluent. Four to twelve hours prior to the experiment the monolayers were 
washed in PBS (w/o Ca2+ and Mg2+) or PBS (w/o Ca2+ and Mg2+) + 20 mM HEPES 
and cultured in FCS-free medium (MEM or DMEM). The growth arrested cultures 
were then stimulated with the appropriate doses of cytokines, drugs or vehicle 
controls for the times detailed in the results section. Supernatants were collected 
from the 6-well plates, centrifuged to remove cellular debris and either assayed for 
nitrite or stored at -20°C until assayed for IL-8. Cells were detached from the base 
of the wells by adding 1.5 ml of 0.05% (w/v) trypsin and 0.02% (w/v) EDTA and 
incubating for approximately 3 minutes at 37°C. Cell number was determined in a 
Neubauer haemocytometer after mixing 1:1 with 0.4% Trypan blue and the total 
amount of nitrite and IL-8 produced was expressed per 106 cells. Total cellular 
protein was extracted from the cells growing in petri dishes (see 2.6.1) for analysis 
via immunoblotting.
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2.4 FLUOROMETRIC NITRITE ASSAY
Nitric oxide (NO) concentrations in culture supernatants were determined by 
measuring nitrite, the stable end product of nitric oxide breakdown. All samples 
were measured in duplicate. Nitrite was measured using a fluorometric assay based 
upon the reaction of 2,3-diaminonaphthalene (DAN, Lancaster Synthesis Ltd, 
Morecombe, UK) with nitrite under acidic conditions to form the fluorescent product 
1-(H)-naphthotriazole. The assay was modified from the method of Misko and 
colleagues (1993), for use on a Photon Technology International (PTI) 
spectrofluorimeter. As specified by Misko et al. (1993), an excitation wavelength of 
365 nm and an emission wavelength of 405 nm were used. A standard curve of 
sodium nitrite in FCS-free medium ranging from 20 nM to 3.0 pM was prepared. 
The standards also contained the same percentage of vehicle as the culture 
supernatants. The reaction was initiated by mixing 1 ml of standard or culture 
supernatant with 100 pi of freshly prepared DAN reagent (50 pg/ml DAN in 0.62 M 
HCI) in disposable cuvettes. The mixtures were incubated at room temperature in 
the dark for 10 minutes and the reaction was stopped by the addition of 1 ml of 0.28 
M NaOH. The samples were read in the spectrofluorimeter and the nitrite 
concentration was calculated by reference to the standards. Phenol red present in 
both MEM and DMEM did not interfere with the assay. The sensitivity of the assay 
was 20 nM.
2.5 INTERLEUKIN-8 ENZYME-LINKED IMMUNOSORBENT ASSAY (IL-8 ELISA)
Extracellular IL-8 concentration of culture supernatants was measured by double 
ligand ELISA. All samples were measured in duplicate. 96 well microtitre plates 
(immuno maxisorb plates) were coated with 100 pi per well of mouse monoclonal
Materials and Methods 57
anti-human IL-8 antibody (1 pg/ml, a generous gift from Novartis, Vienna, Austria) in 
carbonate coating buffer (15 mM Na2C 03, 35 mM NaHC03, 3 mM NaN3), pH 9.6. 
Plates were covered, incubated overnight at 4°C and then washed three times in 
wash buffer (140 mM NaCI, 2.7 mM KCI, 1.5 mM KH2HP04, 8.1 mM Na2HP04, 
0.05% (v/v) Tween-20), pH 7.3. Plates were blocked by the addition of 100 pi per 
well of 5% foetal bovine serum (FBS) in coating buffer and left for 1 hour at room 
temperature. Three more washes followed. A range of IL-8 standards were 
prepared (0.1 -10ng/ml) in dilution buffer (wash buffer plus 2% FBS) from a 10 
pg/ml stock solution (R&D Systems Inc., Abingdon, UK) and the culture 
supernatants were appropriately diluted in the same buffer. Standards and samples 
(50 pi per well) were added in duplicate to the plates and incubated for 2 hours at 
37°C. Plates were washed 3 times and 50 pi per well of biotinylated goat polyclonal 
anti-human IL-8 detecting antibody (0.5 pg/ml, a generous gift from Novartis, 
Vienna, Austria) in dilution buffer was added to the plates for 1 hour at 37°C. Three 
more washes followed and 50 pi per well of streptavidin peroxidase (0.5 pg/ml, R&D 
Systems Inc., Abingdon, UK) in dilution buffer was added to the plates for 30 
minutes at 37°C. Plates were washed three times. One 10 mg tablet of 1,2 O- 
phenylene dihydrochloride (OPD) and 20 pi of 30% hydrogen peroxide were added 
to 50 ml of warmed substrate buffer (34 mM citric acid monohydrate, 66 mM 
Na2HP04), pH 5.0. This solution was added to the plates (100 pi per well), which 
were incubated for 30 minutes at room temperature in the dark. The reaction was 
terminated with 150 pi per well 1 M H2S 04and the OD measured at 490 nm.
2.6 IMMUNOBLOT ANALYSIS
Growth arrested cell monolayers were incubated with appropriate stimuli and 
proteins forming part of the PI3K signalling pathway were extracted for analysis.
Materials and Methods 58
2.6.1 Preparation of Whole Cell Extracts
After removal of culture supernatants, the cells were washed 3 times in PBS/PBS + 
20 mM HEPES and the cell culture vessels were placed on ice. Ice-cold lysis buffer 
including protease inhibitors (0.4 ml) (see appendix), was added to each sample and 
the samples were thoroughly homogenised. The whole cell extracts were then 
transferred to cold sterile 1.5 ml centrifuge tubes and rotated for 15 minutes at 4°C. 
The samples were centrifuged at 12,000 g for 2-3 minutes to pellet the debris. 
Twenty pi of cleared lysate was removed from each sample for protein quantification 
and150 pi of lysate was transferred to fresh sterile 1.5 ml centrifuge tubes along with 
30 pi of 5X sample buffer (see appendix). The samples were then placed in a 
heating block at 85-90°C for 15 minutes, cooled on ice and stored at -70°C.
2.6.2 Quantification of Protein
The protein assay was based on the Bradford procedure (Bradford et a l, 1976). A 
1 mg/ml solution of bovine serum albumin (BSA) was prepared in PBS (140 mM 
NaCI, 2.7 mM KCI, 1.5 mM KH2HP04, 8.1 mM Na2HP04), pH 7.4 and used to 
produce known concentrations of BSA in 1 ml of Bio-Rad protein Assay (Bio-Rad, 
Munchen, Germany). Equal volumes of each sample (20 pi) were added to 980 pi 
of Bio-Rad protein Assay and 200 pi of diluted sample or standard were transferred 
in duplicate to the wells of a 96-well microtitre plate. Protein concentration was 
measured with a microplate reader at 595 nm.
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2.6.3 Separation of Cellular Proteins
Proteins were analysed by one dimensional gel electrophoresis, which under 
reducing conditions separates proteins based on molecule size. Sodium dodecyl 
sulphate -  polyacrylamide gel electrophoresis (SDS-PAGE) was carried out as 
described by Laemmli et al. (1970), using the Protean II xi gel system (Bio-Rad, 
Munchen, Germany). Acrylamide running gels (7.5% w/v) were prepared (see 
appendix), poured into the gel equipment and overlaid with distilled water. After 1 
hour the water was removed and a 5% w/v acrylamide stacking gel (see appendix) 
was poured on top of each running gel and set with a 10-lane comb. Once set the 
gels were transferred to a tank filled with electrophoresis buffer (25 mM TRIS, 192 
mM glycine, 0.1% SDS) and the combs were removed. The gels were loaded with 
approximately 30 pg of sample per lane and a prestained, broad range, molecular 
weight marker (Bio-Rad, Munchen, Germany) was included on each gel. The gels 
were run at room temperature at 50 V until the bromophenol blue tracking dye 
entered the running gel. The voltage was then increased to 150 V. Gels were run 
until the bromophenol blue had reached the bottom of the resolving gel. The gels 
were then placed in transfer buffer (25 mM TRIS, 192 mM glycine, 20% methanol) in 
preparation for blotting.
2.6.4 Electrophoretic Transfer of Proteins to Nitro-cellulose
The separated proteins were transferred to nitro-cellulose membrane using a 
transblot electrophoretic apparatus (Bio-Rad, Munchen, Germany). Each 
polyacrylamide gel was soaked for 10 minutes in transfer buffer and the lanes of the 
stacking gel were removed. Four pieces of filter paper, a piece of nitro-cellulose 
membrane, just slightly larger than the gel and two nylon pads were also soaked in 
transfer buffer. A sandwich was constructed in which each gel was overlaid with a
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piece of wet nitro-cellulose membrane (Boehringer Mannheim, Mannheim, 
Germany), taking care to remove all air bubbles and these were surrounded on both 
sides by two layers of filter paper (Whatman, Maidstone, Kent, UK) and a nylon pad. 
This sandwich was enclosed in a cassette and placed in a transfer tank (Bio-Rad, 
Munchen, Germany) with the nitro-cellulose nearest the anode. The tank was filled 
with cold transfer buffer and electrophoretic transfer was carried out at 100 V for 1 
hour at 4°C. To check for successful protein transfer each piece of nitro-cellulose 
membrane was soaked in Ponceau. To remove the Ponceau, the membranes were 
washed with TBS/Tween (50 mM TRIS, 150 mM NaCI, 0.1% (v/v) Tween-20), pH
7.6 for a few minutes.
2.6.5 Immunoblotting of Nitro-Cellulose-Bound Protein
Immunoblot analyses of phospho-PKB/Akt, phospho-GSK3 and PTEN were 
performed as described in specific Cell Signalling Technology Anitbody Kits: 
PhosphoPlus Akt (Ser473), PhosphoPlus GSK3a/p (Ser21/9) and PTEN 
respectively (Cell Signalling Technology, Hertfordshire, UK). All the following steps 
were carried out with gentle shaking. Non-specific binding sites on the nitro­
cellulose were blocked by incubating the membranes for 1 hour in 5% non-fat dried 
milk protein reconstituted in TBS/Tween. The membranes had three 5 minute 
washes in TBS/Tween and were then incubated overnight with rabbit anti-human 
phospho-specific Akt (Ser473), rabbit anti-human phospho-specific 
GSK3a/p (Ser21/9) or rabbit anti-human PTEN diluted 1:1000 in TBS/Tween. The 
membranes had three further 5 minute washes in TBS/Tween before a 1 hour 
incubation with anti-rabbit secondary antibody conjugated to horseradish peroxidase 
(DAKO, Glostrup, Denmark), diluted 1:2000 in TBS/Tween. After further washing in 
TBS/Tween ( 3 x 5  min) phospho-Akt, phospho-GSK3cx/(3 or PTEN were detected by
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incubating each membrane with 10 ml LumiGLO (Amersham Pharmacia, 
Buckinghamshire, UK) for 1 minute at room temperature. The membranes were 
drained of excess developing solution, wrapped in cling film and exposed to Kodak 
omat AR5 X-ray film for an appropriate time. To verify equal loading of protein, 
additional gels were run using the same samples and the resulting nitro-cellulose 
membranes probed for non-phospho PKB/Akt, using the same conditions as 
previously described. In order to help analyse the immunoblot data, densitometry 
analysis was carried out. For each blot, the density of the darkest band was 
measured and normalised to 100%. The relative densities of the other bands were 
calculated accordingly.
2.7 IN VITRO LIPID KINASE ASSAY
2.7.1 Cell Stimulation
Growth arrested cultures were washed 3 times in PBS and 5 ml of Versene (1:5000, 
Invitrogen Ltd, California, USA) was added for 5 minutes at 37°C. FCS-free medium 
(10 ml) was then added and the cell suspension was centrifuged at 300 g for 10 
minutes. The cell pellet was resuspended in FCS-free medium at 1 x 107 cells/ml 
and aliquoted into 1.5 ml centrifuge tubes at 5 x 106 cells/sample. The samples 
were then equilibrated for 15 minutes at 37°C. If used, the cells were pre-incubated 
with wortmannin or vehicle control for 15 minutes. Cells were stimulated for 
appropriate times with agonist and the reactions were terminated by pulsing the cells 
for 6 seconds in a microcentrifuge, removing the supernatant and adding 500 pi of 
ice-cold lysis buffer (see appendix). The samples were incubated on a rotator for 10 
minutes at 4°C and any non-soluble material was removed by spinning in a 
microcentrifuge at 12,000 g for 10 minutes.
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2.7.2 Immunoprecipitation of Phosphatidylinositol 3-Kinase
Protein-A sepharose beads were prepared by mixing a known volume of beads with 
an equal volume of lysis buffer (minus protease inhibitors). After 30 minutes the 
beads were pulsed in a microcentrifuge for 15 seconds and the supernatant was 
removed. The beads were washed a further 3 times in lysis buffer (minus inhibitors) 
and finally resuspended in enough lysis buffer (minus inhibitors) to form a 50:50 
slurry. The cell lysates were incubated overnight with 4 pg of mouse monoclonal 
anti-PI3K p85 antibody (Upstate Biotechnology, Milton Keynes, UK) on a rotator at 
4°C. The immunocomplex was then captured by adding 50 pi of prepared Protein-A 
sepharose to each sample and incubating for a further 2 hours on a rotator at 4°C. 
Finally the samples were pulsed for 15 seconds in a microcentrifuge to pellet the 
beads and the supernatant was removed and discarded.
2.7.3 Phosphatidylinositol 3-Kinase Assay
PI3K assays were carried out following the procedure described by Gold et al. 
(1992), with some modifications. The immunoprecipitates were washed 3 times in 
wash buffer A (PBS, 1% NP-40, 100 pM Na3V 04), 3 times in wash buffer B (100 mM 
TRIS, pH 7.4; 5 mM LiCI, 100 pM Na3V 04) and 3 times in wash buffer C (10 mM 
TRIS, pH 7.4; 150 mM NaCI, 5 mM EDTA, 100 pM Na3V 04). Between each wash, 
the beads were pelleted by pulsing at 12,000 g for 5 seconds in a microcentrifuge. 
The final wash was removed as completely as possible and 50 pi of wash buffer C, 
20 pg of phosphatidylinositol and 10 pi of 100 mM MgCI2 was added to each pellet. 
The kinase reactions were started by adding 5 pi of ATP reaction buffer (0.88 mM 
ATP, 20 mM MgCI2, 30 pCi [y32P]-ATP [Amersham Pharmacia, Buckinghamshire, 
UK]) per sample. The reactions were allowed to proceed for 10 minutes at room
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temperature and were terminated by the addition of 20 pi of 5 M HCI and 160 pi of 
chloroform/methanol (1:1). The phases were mixed by vortexing and separated by 
centrifuging at 12,000 g for 10 minutes. Fifty pi of the lower, chloroform phase was 
removed and spotted onto oxalate-treated thin-layer chromatography (TLC) plates 
(BDH, Poole, Dorset). The lipids were resolved by thin-layer chromatography in a 
mixture of chloroform : methanol : water : ammonium hydroxide (60:47:11.3:2). 
Once resolved, the [32P]-labelled lipids were visualised by wrapping the TLC plate in 
cling film and exposing it to Kodak omat AR5 X-ray film at -70°C for an appropriate 
time.
2.8 IN VITRO LIPID PHOSPHATASE ASSAY
2.8.1 Preparation of Whole Cell Extracts
Growth arrested cultures were washed 3 times in PBS and cells were removed from 
the tissue culture flask using Versene (1:5000, Invitrogen Ltd, California, USA) and 
resuspended in FCS-free medium, as previously described. The cell pellet was 
resuspended in FCS-free medium at 1 x 107 cells/ml and aliquoted into 1.5 ml 
centrifuge tubes at 5 x 106 cells/sample. The cells were pulsed for 6 seconds in a 
microcentrifuge and the supernatant removed. Ice-cold lysis buffer (500 pi) (see 
appendix) was added to each pellet. The samples were incubated on a rotator for 
10 minutes at 4°C and any non-soluble material was removed by spinning in a 
microcentrifuge at 12,000 g for 10 minutes.
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2.8.2 Immunoprecipitation of PTEN
Protein-A sepharose beads were prepared as previously described. The cell lysates 
were incubated overnight with a 1:50 dilution of rabbit polyclonal anti-PTEN antibody 
(Cell Signaling Technology, Hertfordshire, UK) on a rotator at 4°C. The 
immunocomplex was then captured by adding 50 >xl of prepared Protein-A 
sepharose to each sample as previously described.
2.8.3 Phosphatase Assay
The immunoprecipitates were washed 3 times in lysis buffer (minus inhibitors). 
Between each wash, the beads were pelleted by pulsing at 12,000 g for 5 seconds 
in a microcentrifuge. The final wash was removed as completely as possible and 
25 pi of assay buffer (500 mM TRIS, pH 7.5; 10 mM MgCI2) was added to each 
sample along with 3 pi of [3H]-Ptdlns-1,3,4,5-P4 (Amersham Pharmacia, 
Buckinghamshire, UK). The reactions were allowed to proceed for 20 minutes at 
37°C and were terminated by the addition of 150 pi of acidified chloroform/methanol 
(1:3) to each sample. The samples were mixed by vortexing and 50 pi of chloroform 
plus 50 pi of 10 mM HCI were added followed by centrifugation at 12,000 g for 5 
minutes. The aqueous phase was removed into clean centrifuge tubes and dried in 
vacuo for 1 hour. After drying each pellet was resuspended in 100 pi of filtered Milli- 
Q water and vortexed.
2.8.4 High Pressure Liquid Chromatography (HPLC) Analysis
The products of the reaction were separated on an HPLC column (12.5cm Whatman 
Partisphere SAX column, Maidstone, Kent, UK). They were eluted from the column
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using a gradient comprising Milli-Q water and phosphate buffer (1.25 M NH4HPO4), 
adjusted to pH 3.8 with H3P04. All solutions used on the HPLC column were filtered 
(0.2 pm Whatman filter paper, Maidstone, Kent, UK) and degassed with helium for 
approximately 10 minutes. The gradient flow rate in the column was 1 ml/minute 
and the total elution time was 90 minutes per sample. As the reaction products 
eluted they were collected in scintillation vials. 3 ml of scintillation fluid was added to 
each vial and the [3H]-labelled lipids were detected via scintillation counting.
2.9 STATISTICAL ANALYSIS
Duplicate determinations were performed in each experiment. The number (n) of 
independent experiments is given in the respective figure legend. Data were 
analysed by two-way analysis of variance (ANOVA) to determine if any statistical 
significance existed within the data groups. ANOVA was followed by Dunnett’s test 
for the comparison of multiple groups to controls. Data were expressed as means ± 
SEM of n independent experiments. A probability value of p<0.05 was taken as the 
criterion for a significant difference.
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3 NITRIC OXIDE PRODUCTION BY AIRWAY EPITHELIAL CELLS
3.1 INTRODUCTION
Initial investigations sought to examine the mechanisms involved in the production and 
regulation of nitric oxide (NO) by CF and non-CF human airway epithelial cells in 
response to proinflammatory cytokine stimulation, using the 9HTEo', ZCFTE29o\ 
9HTEo'/pCEP#2 and 9HTEoYpCEPRF cell lines as models of human airway epithelium. 
The 9HTEo' and SCFTE29o'cell lines are both human tracheal epithelial cells exhibiting 
a non-CF and a CF phenotype respectivley. As discusssed in the preceding chapter, 
the pCEP lines are a genetically matched pair of cell lines. The 9HTEo'/pCEPRF cell 
line was created by transfecting 9HTEo‘ cells with a pCEP4 plasmid containing genes 
that express the regulatory (R) domain of CFTR (Perez etal., 1996). Overexpression of 
the R domain is thought to block the ion channel rendering CFTR non-functional and 
producing a CF phenotype. The 9HTEo'/pCEP#2 cell line was created in a similar 
fashion, but in this case 9HTEo' cells were transfected with an empty pCEP4 plasmid 
producing a matched control line (Perez etal., 1996).
As a prelude to the experiments on the 9HTEo\ ICFTE290', 9HTEo'/pCEP#2 and 
9HTEo'/pCEPRF cell lines, it was necessary to establish the biological activity of the 
proinflammatory cytokines which were to be used in the stimulations. In addition, the 
suitablility of the fluorometric nitrite assay as a means of measuring cytokine-induced 
NO production needed to be assessed. To address these issues stimulations were 
initially carried out on the type II alveolar carcinoma cell line A549. This cell line was 
considered appropriate as it had previously been demonstrated that the combination of
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TNFa, IL-1 (3 and IFNy lead to a significant increase in the levels of iNOS generated 
nitrite in A549 cell culture supernatants compared with supernatants from unstimulated 
cells (Asano etal., 1994; Robbins etal., 1994).
For experimental purposes, cells were seeded into 6-well plates at 3-5 x 104 cells/ml in 
a total volume of 2 ml of complete medium and grown until they were approximately 
90% confluent. The cells were then serum starved for 12 hours and subsequently 
stimulated for 24 hours at 37°C with vehicle or increasing concentrations of IFNy 
(0-300 units/ml), IL-1 p (0-10 ng/ml) and TNFa (0-100 ng/ml), either alone or in various 
combinations. Each stimulation also included 1 mM L-arginine to ensure that substrate 
availability was not a limiting factor for nitric oxide synthase activity. Levels of nitrite 
(the stable breakdown product of NO) were determined in cell culture supernatants 
using a fluorescent substrate as described in the previous chapter.
3.2 NITRITE GENERATION BY A549 CELLS
A549 cells produced a constitutive amount of nitrite in the absence of cytokine 
stimulation (0.73 ± 0.01 pmoles/106 cells) (Fig. 8). Stimulation of the cells with the three 
cytokines combined had the effect of significantly increasing the amount of nitrite 
generated compared with constiutive levels (Fig. 8) (p<0.01). In fact, the highest 
concentration of cytokines resulted in an approximate 5 fold enhancement of nitrite 
levels (3.62 ± 0.5 pmoles/106 cells). The data from these experiments verified that the 
cytokines were active and validated the use of the fluorometric nitrite assay for 
measurement of cytokine-induced NO production.
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Figure 8 Nitrite production by A549 cells after 24 h incubation at 37°C with IFNy 
(100 units/ml), IL-1 p (1-10 ng/ml) and TNFa (10-100 ng/ml) added in combination.
The cells were serum starved for 12 hours prior to treatment. 1 mM L-arginine was 
added to each stimulation. Basal is the amount of nitrite produced in the presence of 
vehicle alone. Each bar is the mean ± SEM of three experiments (** p<0.01 compared 
with basal).
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3.3 NITRITE GENERATION BY 9HTEo‘ and ZCFTE29o' CELLS
Both 9HTEo' and £CFTE29o' cells produced a constitutive amount of nitrite in the 
absence of cytokine stimulation (316.23 ±36.12 nmoles/106 cells for 9HTEo' cells and 
778.51 ± 36.43 nmoles/106 cells for ZCFTE290' cells), with the SCFTE290' cell line 
producing significantly more nitrite than the 9HTEo' cell line (p<0.01) (Fig 9a). 
Increasing concentrations of the proinflammatory cytokines IFNy, IL-1 p and TNFa, 
added alone to either cell line, had no effect on nitrite generation compared to the 
constitutive nitrite production in vehicle treated cells (Figs 9 & 10). Similarly, 
combinations of IFNy/IL-1p and IFNy/TNFahad no effect on the amount of nitrite 
produced by either cell line (Figs 11 & 12). Stimulation of the cells with high 
concentrations of the three proinflammatory cytokines combined also had no effect on 
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Figure 9 Nitrite production by 9HTEo and ECFTE29o cells after 24 h treatment at 
37°C with (a) increasing concentrations of IFNy (50-300 units/ml) and (b) 
increasing concentrations of IL-1 p (0.3-10 ng/ml). The cells were serum starved for 
12 hours prior to treatment. 1 mM L-arginine was added to each stimulation. Basal is 
the amount of nitrite produced in the presence of vehicle alone. Each point is the mean 
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Figure 10 Nitrite production by 9HTEo and ZCFTE29o cells after 24 h treatment 
at 37°C with increasing concentrations of TNFa (3-100 ng/ml). The cells were 
serum starved for 12 hours prior to treatment. 1 mM L-arginine was added to each 
stimulation. Basal is the amount of nitrite produced in the presence of vehicle alone. 
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Figure 11 Nitrite production by 9HTEo and SCFTE29o cells after 24 h treatment 
at 37°C with (a) increasing concentrations of IL-1 p (0-10 ng/ml) and (b) increasing 
concentrations of TNFa (0-100 ng/ml), in the presence of IFNy 100 units/ml. The
cells were serum starved for 12 hours prior to treatment. 1 mM L-arginine was added to 
each stimulation. Basal is the amount of nitrite produced in the presence of vehicle 
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Figure 12 Nitrite production by 9HTEo and XCFTE29o cells after 24 h treatment 
at 37°C with increasing concentrations of IFNy (0-300units/ml) in the presence of
(a) IL-1 p (3 ng/ml) and (b) TNFa (30 ng/ml). The cells were serum starved for 12 
hours prior to treatment. 1 mM L-arginine was added to each stimulation. Basal is the 
amount of nitrite produced in the presence of vehicle alone. Each point is the mean ± 




Figure 13 Nitrite production by 9HTEo' and SCFTE29o cells after 24 h incubation 
at 37°C with IFNy (100 units/ml), IL-lp (1-10 ng/ml) and TNFa (10-100 ng/ml) added 
in combination. The cells were serum starved for 12 hours prior to treatment. 1 mM 
L-arginine was added to each stimulation. Basal is the amount of nitrite produced in the 
presence of vehicle alone. Each bar is the mean ± SEM of three experiments.
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Time course studies were carried out to investigate if stimulation of the airway epithelial 
cells with IFNy 100 units/ml, IL-1J3 3 ng/ml and TNFa 30 ng/ml (cytomix) resulted in 
induction of nitric oxide at timepoints other than 24 hours. These studies revealed a 
time-dependent increase in constitutive nitrite levels of 78.49 ± 24.05, 181.05 ± 26.21, 
204.26 ± 27.51, 328.43 ± 49.61 and 2733.55 ± 226.05 nmoles/106 cells at 6 h, 12 h, 18 
h, 24 h and 48 h respectively for the 9HTEo' cell line and 101.80 ± 16.24, 330.00 ± 
38.43, 526.88 ± 38.32, 841.73 ±45.10 and 3243.44 ± 198.61 nmoles/106 cells at 6 h, 12 
h, 18 h, 24 h and 48 h respectively for the ECFTE29o‘ cell line (Fig 14). At each 
timepoint other than 48 h, the level of nitrite produced by the XCFTE29o' cell line was 
significantly greater than that produced by the 9HTEo' cell line (p<0.01). Stimulation of 
either cell line with cytomix did not significanlty increase the levels of nitrite produced at 
any time point. Interestingly, at 48 h the amount of nitrite in the cell culture supernatant 
from both cell lines was significantly larger than that produced at other time points 
(p<0.01) in both basal and stimulated conditions. Microscopic examination of cells from 
this timepoint showed a decrease in cell number and an increase in cell debris in each 
case. Cell viability at 48 h was examined by trypan blue exclusion and was found to be 
55% for 9HTEo' cells and 46% for £CFTE29o' cells. At all other time points cell viability 
was always greater than 85%. In view of these data, all subsequent experiments were 
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Figure 14 Time course of nitrite production by 9HTEo' and ZCFTE29o' cells after 
incubation at 37°C with vehicle or cytomix (IFNy 100 units/ml, IL-1(3 3 ng/ml and 
TNFa 30 ng/ml). The cells were serum starved for 12 hours prior to treatment. 1 mM 
L-arginine was added to each stimulation. Each bar is the mean ± SEM of three 
experiments. (** p<0.01, compared with other time points).
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To examine the possibility of substrate competition as a limiting factor for iNOS activity, 
the effect of cytomix on nitrite generation by confluent monolayers of airway epithelial 
cells was examined after 30 minutes pre-treatment with 20 mM of the arginase inhibitor 
L-norvaline. Arginase has been shown to have a high activity in activated in 
macrophages, where it metabolises L-arginine to form ornithine and urea (Granger et 
al., 1990; Hrabak et al., 1994). As arginase and NOS both use L-arginine as a 
substrate, it is possible that NO production by iNOS in airway epithelial cells may be 
regulated by arginase through competition for intracellular L-arginine. However, 
arginase inhibition had no significant effect on the levels of nitrite produced by 9HTEo' 
and ZCFTE29o' cells after cytomix stimulation compared to the constitutive nitrite 
produced by vehicle treated cells (Fig 15).
Recently, it has been shown that iNOS gene expression in human airway epithelial cells 
occurs in response to cytokines in combination with double-stranded RNA (dsRNA) 
(Uetani et al., 2001). In light of these findings, dsRNA was included in a series of 
24-hour cytokine stimulations with the 9HTEo' and ZCFTE29o' cell lines. Fig 16 reveals 
that stimulation of either cell line with dsRNA alone (10-100 pg/ml) did not affect nitrite 
generation compared with basal levels. In contrast to Uetani et al. (2001) the 
combination of cytomix and dsRNA (10-100 pg/ml) also had no significant effect on the 
levels of nitrite produced. This was the case for both cell types.
To investigate further the production and regulation of nitric oxide by airway epithelial 
cells, 24-hour cytokine stimulations were carried out in the presence and absence of a 
range of inhibitors. Fig 17 shows the effect of the specific iNOS inhibitor 1400W 
(3-30 pM) on nitrite generation by 9HTEo' and 2CFTE29o' cells. The inhibitor was
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added to the cells at the same time as the cytokines. 1400W did not have any 
significant effect, at any concentration, on nitrite levels in either basal or cytokine 
stimulated conditions. However, the use of the more general NOS inhibitor, 
aminoguanidine (0.5-1 mM) did have an effect on the levels of nitrite produced by the 
airway epithelial cells. As with 1400W, this inhibitor was added to the stimulations at 
the same time as the cytokines. Aminoguanidine (0.5 mM) significantly reduced basal 
nitrite production by the 9HTEo' cell line from 332.68 ± 38.32 nmoles/106 cells to 153.95 
± 22.29 nmoles/106 cells (p<0.01) and had a similar effect on nitrite production by the 
2CFTE29o' cell line (807.77 ± 38.64 nmoles/106 cells to 504.00 ± 47.90 nmoles/106 
cells, p<0.01) (Fig 18). Aminoguanidine (1 mM) also significantly reduced basal nitrite 
production by both cell lines (p<0.01). In the cytokine stimulated conditions both 
concentrations of aminoguanidine significantly reduced nitrite generation in both cell 
types (p<0.05). Finally, pre-treatment of the airway epithelial cells with the protein 
synthesis inhibitor cycloheximide (10-100 pM) for 30 minutes prior to stimulation with 
cytomix had no significant effect on nitrite production by either cell line. In addition, 
treatment of unstimulated cells with this inhibitor had no effect on basal nitrite 
production (Fig 19).
To examine the possible modulatory effect of the phosphatidylinositol 3-kinase inhibitor 
LY294002 and the T helper 2 (Th2) cytokine IL-13 on nitrite generation, confluent 
monolayers of airway epithelial cells were incubated with various concentrations of 
LY294002 (3-30 jliM) and IL-13 (3-30 ng/ml) 30 minutes prior to stimulation with 
cytomix. LY294002 had no significant effect on nitrite production by either cell line. 
This was also the case when unstimulated cells were treated with this inhibitor (Fig 20).
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Fig 21 shows that treatment of the 9HTEo' and £CFTE29o' cell lines with IL-13 also had 
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Figure 15 The effect of the arginase inhibitor L-norvaline (20 mM) on nitrite 
production by 9HTEo and £CFTE29o cells after 24 h incubation at 37°C with 
vehicle or cytomix (IFNy 100 units/ml, IL-1 p 3 ng/ml and TNFa 30 ng/ml). The cells 
were serum starved for 12 hours prior to treatment. L-norvaline was added 30 minutes 
before the cytokines. 1 mM L-arginine was added to each stimulation. Each bar is the 
mean ± SEM of three experiments.
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Figure 16 Nitrite production by 9HTEo and £CFTE29o cells after 24 h incubation 
at 37°C with vehicle, cytomix and double stranded RNA (10-100 pg/ml) added 
alone or in combination. The cells were serum starved for 12 hours prior to 
treatment. 1 mM L-arginine was added to each stimulation. Each bar is the mean ± 
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Figure 17 The effect of the iNOS inhibitor 1400W (3-30 fiM) on nitrite production 
by 9HTEo and LCFTE29o cells after 24 h incubation at 37°C with vehicle or 
cytomix (IFNy 100 units/ml, IL-ip 3 ng/ml, TNFa 30 ng/ml). The cells were serum 
starved for 12 hours prior to treatment. 1400W was added at the same time as the 
cytokines. 1 mM L-arginine was added to each stimulation. Each bar is the mean ± 
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Figure 18 The effect of the general NOS inhibitor aminoguanidine (0.5-1 mM) on 
nitrite production by 9HTEo' and ZCFTE29o cells after 24 h incubation at 37°C 
with vehicle or cytomix (IFNy 100 units/ml, IL-ip 3 ng/ml, TNFa 30 ng/ml). The
cells were serum starved for 12 hours prior to treatment. Aminoguanidine was added at 
the same time as the cytokines. 1 mM L-arginine was added to each stimulation. Each 





Figure 19 The effect of the protein synthesis inhibitor cycloheximide (10-100 pM) 
on nitrite production by 9HTEo and ECFTE29o cells after 24 h incubation at 37°C 
with vehicle or cytomix (IFNy 100 units/ml, IL-1p 3 ng/ml, TNFa 30 ng/ml). The
cells were serum starved for 12 hours prior to treatment. Cycloheximide was added 30 
minutes before the cytokines. 1 mM L-arginine was added to each stimulation. Each 
bar is the mean ± SEM of three experiments.
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Figure 20 The effect of the phosphatidylinositol 3-kinase inhibitor LY294002 (3-30 
fiM) on nitrite production by 9HTEo and XCFTE29o cells after 24 h incubation at 
37°C with vehicle or cytomix (IFNy 100 units/ml, IL-1p 3 ng/ml, TNFa 30 ng/ml).
The cells were serum starved for 12 hours prior to treatment. LY294002 was added 30 
minutes before the cytokines. 1 mM L-arginine was added to each stimulation. Each 
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Figure 21 The effect of IL-13 (3-30 ng/ml) on nitrite production by 9HTEo' and 
SCFTE29o cells after 24 h incubation at 37°C with vehicle or cytomix (IFNy 
100 units/ml, IL-1p 3 ng/ml, TNFa 30 ng/ml). The cells were serum starved for 12 
hours prior to treatment. IL-13 was added 30 minutes before the cytokines. 1 mM 
L-arginine was added to each stimulation. Each bar is the mean ± SEM of three 
experiments.
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3.4 NITRITE GENERATION BY pCEP9HTEo7#2 AND pCEP9HTEo7RF CELLS
As with the 9HTEo‘ and £CFTE29o' cell lines both pCEP lines produced a constitutive 
amount of nitrite in the absence of cytokine stimulation (351.87 ± 43.32 nmoles/106 cells 
for pCEP9HTEo/#2 cells and 606.80 ± 45.93 nmoles/106 cells for pCEP9HTEo7RF 
cells). Although the constitutive level of nitrite produced by the pCEP9HTEo/RF cell 
line was less than that produced by the £CFTE29o' cell line, it was still significantly 
higher than that produced by the pCEP9HTEo /#2 cells (p<0.05) (Fig 22a). Again, as 
with the 9HTEo‘ and £CFTE29o' cell lines, increasing concentrations of the 
proinflammatory cytokines IFNy, IL-1(3 and TNFa, added alone to either cell line, had no 
effect on nitrite generation compared to the constitutive nitrite production by vehicle 
treated cells (Figs 22 & 23). Similarly, combinations of IFNy/IL-1p and IFNy/TNFa had 
no effect on the amount of nitrite produced (Figs 24 & 25). Stimulation of the cells with 
high concentrations of the three proinflammatory cytokines combined also had no effect 
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Figure 22 Nitrite production by 9HTEo /pCEP#2 and 9HTEo /pCEPRF cells after 24 
h treatment at 37°C with (a) increasing concentrations of IFNy (50-300 units/ml) 
and (b) increasing concentrations of IL-1 p (0.3-10 ng/ml). The cells were serum 
starved for 12 hours prior to treatment. 1 mM L-arginine was added to each stimulation. 
Basal is the amount of nitrite produced in the presence of vehicle alone. Each point is 
the mean ± SEM of three experiments.
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Figure 23 Nitrite production by 9HTEo /pCEP#2 and 9HTEo /pCEPRF cells after 24 
h treatment at 37°C with increasing concentrations of TNFa (3-100 ng/ml). The
cells were serum starved for 12 hours prior to treatment. 1 mM L-arginine was added to 
each stimulation. Basal is the amount of nitrite produced in the presence of vehicle 



































Figure 24 Nitrite production by 9HTEo /pCEP#2 and 9HTEo /pCEPRF cells after 24 
h treatment at 37°C with (a) increasing concentrations of IL-1 (3 (0-10 ng/ml) and (b) 
increasing concentrations of TNFa (0-100 ng/ml) in the presence of IFNy 100 
units/ml. The cells were serum starved for 12 hours prior to treatment. 1 mM 
L-arginine was added to each stimulation. Basal is the amount of nitrite produced in the 
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Figure 25 Nitrite production by 9HTEo/pCEP#2 and 9HTEo/pCEPRF cells after 
24 h treatment at 37°C with increasing concentrations of IFNy (0-300 units/ml) in 
the presence of (a) IL-lp (3 ng/ml) and (b) TNFa (30 ng/ml). The cells were serum 
starved for 12 hours prior to treatment. 1 mM L-arginine was added to each stimulation. 
Basal is the amount of nitrite produced in the presence of vehicle alone. Each point is 



















Figure 26 Nitrite production by 9HTEo/pCEP#2 and 9HTEo/pCEPRF cells after 
24 h incubation at 37°C with IFNy (100 units/ml), IL-1 p (1 -10 ng/ml) and TNFa 
(10-100 ng/ml) added in combination. The cells were serum starved for 12 hours 
prior to treatment. 1 mM L-arginine was added to each stimulation. Basal is the 
amount of nitrite produced in the presence of vehicle alone. Each bar is the mean ± 
SEM of three experiments.
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As previously, time course studies were carried out to investigate if stimulation of the 
airway epithelial cells with cytomix (IFNy 100 units/ml, IL-1(3 3 ng/ml and TNFa 30 
ng/ml) resulted in nitric oxide induction at timepoints other than 24 hours. Once again a 
time-dependent increase in constitutive nitrite levels was revealed for both cell lines (Fig 
27). At each timepoint other than 48 h, the level of nitrite produced by the 9HTEo‘ 
/pCEPRF cell line was significantly greater than that produced by the 9HTEo'/pCEP#2 
cell line (p<0.05). Stimulation of either cell line with cytomix did not significantly 
increase the levels of nitrite produced at any time point. As observed with the 9HTEo' 
and ECFTE29o' cell lines, the amount of nitrite in the cell culture supernatant of both 
pCEP lines at 48 h was significantly larger than that produced at other time points 
(p<0.01) in both basal and stimulated conditions. Cell viability at this time point, 
examined by trypan blue exclusion, was found to be 62% for 9HTEo'/pCEP#2 cells and 
58% for 9HTEo/pCEPRF cells. At all other time points cell viability was always greater 
than 90%.
Table 1 summarises the production of nitrite by 9HTEo'/pCEP#2 and 9HTEo'/pCEPRF 
cells after 24h treatment at 37°C with a variety of cytokine and inhibitor combinations. 
Pre-treatment of the pCEP cell lines for 30 minutes with 20 mM of the arginase inhibitor 
L-norvaline had no significant effect on the levels of nitrite produced by the cells after 
cytomix stimulation compared to the levels of nitrite produced in the absence of the 
inhibitor. In addition, the combination of cytomix and dsRNA (100 pg/ml) had no 
significant effect on the levels of nitrite produced by the pCEP cells. The inclusion of 
the specific iNOS inhibitor 1400W (10 n-M) with cytomix had no significant effect on 














Figure 27 Time course of nitrite production by 9HTEo/pCEP#2 and 9HTEo' 
/pCEPRF cells after incubation at 37°C with vehicle or cytomix (IFNy 100 units/ml, 
IL-ip 3 ng/ml and TNFa 30 ng/ml). The cells were serum starved for 12 hours prior to 
treatment. 1 mM L-arginine was added to each stimulation. Each bar is the mean ± 
SEM of three experiments (** p<0.01 compared with other time points).
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aminoguanidine (0.5 mM) did have an effect on nitrite generation, significantly reducing 
nitrite production in cytokine stimulated pCEP cells from 367.53 ± 35.93 nmoles/106 
cells to 199.49 ± 34.46 nmoles/106 cells for the 9HTEo'/pCEP#2 cell line and from
611.05 ± 56.77 nmoles/106 cells to 356.84 ± 22.44 nmoles/106 cells for the 9HTEo' 
/pCEPRF cell line (p<0.05). Pre-incubation of the airway epithelial cells with 
cycloheximide (10 p,M) for 30 minutes prior to stimulation with cytomix had no significant 
effect on nitrite production by either cell line. Finally, neither 30-minute pre-treatment 
with LY294002 (10 p,M) nor IL-13 (30 ng/ml) had any significant effect on nitrite 
production by either pCEP cell line.
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9HTEo7pCEP#2
T reatment Mean nmoles nitrite/106 cells
basal 352.43 ± 32.20
cytomix 367.53 ± 35.93
cytomix + 20 mM L-norvaline 346.55 ± 35.64
IL-1|3 3 ng/ml + TNFa 30 ng/ml + dsRNA 
100 ng/ml
342.94 ± 29.79
cytomix + 10 juM 1400W 360.69 ± 60.53
cytomix + 0.5 mM aminoguanidine 199.49 ±34.46 *
cytomix +10 nM cycloheximide 382.84 ± 37.30
cytomix + 10 pM LY294002 334.81 ±21.95
cytomix + 30 ng/ml IL-13 348.05 ± 36.01
9HTEo7pCEPRF
T reatment Mean nmoles nitrite/106 cells
basal 629.64 ± 42.04
cytomix 611.05 ± 56.77
cytomix + 20 mM L-norvaline 624.04 ± 44.60
IL-ip 3 ng/ml + TNFa 30 ng/ml + dsRNA 
100 pg/rnl
613.04 ±46.16
cytomix + 10 nM 1400W 590.35 ± 47.75
cytomix + 0.5 mM aminoguanidine 356.84 ±22.44 *
cytomix + 10 nM cycloheximide 649.49 ± 32.27
cytomix + 10 nM LY294002 613.47 ± 19.97
cytomix + 30 ng/ml IL-13 638.02 ± 44.41
Table 1 Summary of nitrite production by 9HTEo/pCEP#2 and 9HTEo/pCEPRF 
cells after 24 h treatment at 37°C with a variety of cytokine and inhibitor 
combinations. The cells were serum starved for 12 hours prior to treatment. 1 mM L- 
arginine was added to each stimulation. Cytomix: IFNy 100 units/ml, IL-1p 3 ng/ml, 
TNFa 30 ng/ml. Each value is the mean ± SEM of three experiments (* p<0.05 
compared with control group).
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3.5 DISCUSSION
Pulmonary disease in CF is characterised by long-lasting bacterial infection and chronic 
inflammation. Since high levels of NO have been shown to correlate with inflamed 
airways (Kharitonov et al., 1994; Lundberg et a l, 1996), it might be expected that 
exhaled air from the lungs of CF patients should contain high levels of NO. However, it 
has been suggested that exhaled NO levels are reduced in CF patients compared with 
normal subjects and patients with other inflammatory airway diseases (Light et 
al., 1989; Grasemann et al., 1997). The observation by Kelley & Drumm (1998) that 
iNOS expression is reduced in airway epithelium from CF mice provides support for 
these findings and offers an explanation for the persistence of bacterial infections in the 
CF lung. However, other studies examining iNOS expression in human airway 
epithelial cells have conflicted with these findings. For example, the discovery that 
primary airway epithelial cells from humans rapidly lose their ability to synthesise iNOS 
mRNA ex vivo (Guo et al., 1995) and the fact that some immortalised human airway 
epithelial cells show increased iNOS expression in response to proinflammatory 
cytokine stimulation (Asano et al., 1994; Robbins et al., 1994; Guo et al., 1997; Watkins 
et al., 1997) whereas others are unresponsive (Guo et al., 1997), have made it difficult 
to accurately study NO biology in human airway epithelium. In the light of these 
findings, it seemed reasonable to investigate the production and regulation of NO by 
human airway epithelial cells and to identify potential differences in CF versus normal 
cells.
Each cell line studied produced a constitutive amount of nitrite in the absence of 
cytokine stimulation. The 9HTEo' and 9HTEo'/pCEP#2 cell lines produced basal levels 
of nitrite similar to those produced by unstimulated BEAS-2B cells (an SV-40
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immortalised human bronchial epithelial cell line) (Watkins et al., 1997). Interestingly, 
the ECFTE29o' and 9HTEoVpCEPRF cell lines produced significantly more basal nitrite 
than their normal phenotype counterparts (p<0.01 for 9HTEo‘ / ECFTE29o' cells and 
p<0.05 for 9HTEoVpCEP#2 / 9HTEo'/pCEPRF cells). At first glance these data would 
seem to refute the findings of Kelley & Drumm (1998) and those of Meng et al. (1998), 
who stated that iNOS expression (and therefore presumably NO production) is reduced 
in the human CF bronchial epithelial cell line CFBE41o\ However, these nitrite levels 
are on a par with those produced by unstimulated A549 cells (a non-CF, type II alveolar 
carcinoma cell line) (Asano et al., 1994; Robbins et al., 1994) and are much less than 
the levels of nitrite produced by unstimulated primary airway epithelial cells from normal 
patients (Donnelly & Barnes, 2002). It is therefore difficult to ascertain whether or not 
the differences in basal nitrite between the CF and non-CF cell lines have any 
relevance. This is particularly true for the 9HTEo' and ZCFTE29o' cells, as they are not 
a genetically matched pair of cell lines. However, the 9HTEoVpCEP#2 and 9HTEo' 
/pCEPRF cell lines are genetically matched and any differences observed between 
them are potentially more valid. It is possible that the higher levels of basal nitrite 
produced by the 9HTEo'/pCEPRF cell line are a consequence of the cells having 
repressed function, although variability between clones cannot be excluded.
Stimulation of the cell lines over 24 hours with IFNy, IL-1(3 or TNFa alone had no effect 
on basal nitrite generation. This was to be expected, as although IFNy alone has been 
shown to induce a high level of iNOS expression in primary cultured human airway 
epithelial cells (Guo et al., 1997), no single cytokine has been found to increase iNOS 
expression in human airway epithelial cell lines. In fact, the proinflammatory cytokine 
requirement for the induction of iNOS in immortalised airway epithelial cells appears to
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vary depending upon the cell line being studied. For example, the combination of IFNy, 
IL-1 p and TNFa leads to iNOS induction in A549 cells (Asano et al., 1994; Robbins et 
al., 1994; Guo et al., 1997), whereas IFNy, TNFa and LPS are required for iNOS 
induction in the BEAS-2B bronchial cell line (Watkins et al., 1997). In contrast, the 
bronchial epithelial cell line BET-1 A does not show any iNOS induction in response to 
proinflammatory cytokine combinations (Guo et al., 1997). In this series of experiments, 
a variety of combinations of IFNy, IL-1 p and TNFa were tested on the 9HTEo', 
ZCFTE29o', 9HTEo7pCEP#2 and 9HTEoYpCEPRF cell lines, but were found to have 
no effect on the amount of nitrite produced over a 24 hour period. Furthermore, the 
data from the time course studies revealed that these cytokines did not have any effect 
on nitrite generation by these cell lines at any time point from 6-48 hours.
The lack of response of the 9HTEo' / XCFTE290" and 9HTEo'/pCEP#2 / 9HTEo' 
/pCEPRF cell lines to cytokine stimulation was unlikely to be due to substrate limitation, 
as all the experiments were carried out in the presence of 1 mM L-arginine. This 
concentration of L-arginine has been shown to significantly increase nitrite output from 
cytokine stimulated BEAS-2B cells, without having any effect on unstimulated cells 
(Watkins et al., 1997). In addition, the use of the specific arginase inhibitor L-norvaline 
removed the possibility of any competition for intracellular L-arginine between iNOS and 
arginase in these cell lines. L-norvaline has been shown to significantly increase NO 
production from LPS activated mouse macrophages (Chang et al., 1998), with the effect 
being dose dependent up to 10 mM L-norvaline. Concentrations greater than 10 mM 
had no further effect on NO production. This suggests that the concentration of 
L-norvaline chosen for this series of experiments (20 mM) should have successfully 
inhibited any arginase present in the cells. The fact that L-norvaline had no effect on
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cytokine stimulated nitrite generation in this study does not necessarily mean that 
arginase is absent from these airway epithelial cell lines. It is equally probable that 
some other factor or combination of factors were responsible for the lack of nitrite 
generation by the 9HTEo', 2CFTE29o\ 9HTEoVpCEP#2 and 9HTEo'/pCEPRF cells in 
response to cytokine stimulation. If this were the case, it would conceal the effect of 
any arginase inhibition.
It is interesting to note from the time course data the magnitude of the nitrite levels 
produced by the cells upon 48-hour incubation with vehicle or cytomix. In the case of 
the 9HTEo' and 9HTEo‘/pCEP#2 cell lines, the levels of nitrite produced by unstimulated 
cells at 48 hours were 8 fold higher than the levels produced at 24 hours. For 
unstimulated XCFTE29o' cells the nitrite levels were 4 fold higher at 48 hours than at 24 
hours and for unstimulated 9HTEo'/pCEPRF cells the levels were 5 fold higher. A 
similar pattern was observed when the cells were stimulated with cytokines. These high 
nitrite levels correlated with an increase in cell debris and a decrease in cell number in 
each case. The most likely explanation for these findings is that the cells were cultured 
for too long in the absence of serum (they were serum starved for 12 hours prior to the 
experiment and then stimulated by vehicle or cytomix for 48 hours also in the absence 
of serum) and had started to die. It is possible that the dying cells released a large 
amount of NO, giving rise to the highly elevated nitrite readings.
The fact that different human airway epithelial cell lines show different cytokine 
requirements for the induction of iNOS suggests that the mechanisms regulating iNOS 
expression in human airway epithelial cells are complex and involve the activation of 
multiple signal transduction pathways. Recently, Uetani et al. (2001), have shown that
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iNOS gene expression in BEAS-2B cells occurs in response to double-stranded RNA 
(dsRNA), through the rapid activation of dsRNA-activated protein kinase (PKR) and 
subsequent activation of signalling proteins including NF-kB and IRF-1. They have also 
verified a central role for dsRNA-activated pathways in generalised iNOS signalling, by 
demonstrating a loss of iNOS induction in response to a wide variety of cytokines and 
mediators in PKR-null cells (Uetani et al., 2000). Uetani and colleagues (2001) did not 
show any iNOS induction in BEAS-2B cells in response to stimulation with IFNy, 
TNFa and IL-ip combined. Nor did they show any change in iNOS expression when 
cells were incubated with dsRNA alone. It was only when dsRNA and proinflammatory 
cytokines were used together that iNOS mRNA could be detected in BEAS-2B cell 
lysates. This data appears to be in conflict with that of Watkins et al. (1997), who claim 
that iNOS mRNA is expressed in response to IFNy, TNFa and LPS in BEAS-2B cells. 
However, Watkins and colleagues (1997) also state that the expression of iNOS mRNA 
in response to cytokine stimulation diminished rapidly with successive passages. It may 
well be that the BEAS-2B cells used by Uetani et al. (2001), were of a later passage 
than those used by Watkins et al. (1997). Uetani and colleagues (2001) claim that 
dsRNA is a physiologically relevant activator of gene expression in airway epithelial 
cells. The airway is frequently the first site of contact for viral infections and most 
viruses induce the synthesis of dsRNA at some time during their replication cycles 
(Jacobs & Langland, 1996; Maggi et al., 2000). The involvement of dsRNA in the 
generation of NO by the airway epithelium may therefore be important in antiviral host 
defence.
In addition to their work with the BEAS-2B cell line, Uetani et al. (2001) also examined 
iNOS expression in BET-1A cells. Firstly, they established that these cells did not
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express iNOS in response to proinflammatory cytokine stimulation. This finding 
supports the earlier work of Guo et al. (1997), who also examined iNOS expression in 
this cell line. As with the BEAS-2B cells, stimulation of BET-1 A cells with dsRNA alone 
had no effect on iNOS induction. However, in contrast to the results obtained with the 
BEAS-2B cell line, incubation of BET-1 A cells with a combination of cytokines and 
dsRNA also had no effect on iNOS expression. In conclusion, it appears that although 
both BEAS-2B and BET-1 A cells are derived from normal bronchial epithelial cells 
(Reddel et al., 1988), the conditions required for iNOS expression are different in the 
two cell lines. This may well be a result of how the cell lines were created. BEAS-2B 
cells were formed by transformation of primary human bronchial epithelial cells with 
adenovirus-12 SV40 hybrid virus defective in the SV40 origin of replication, whereas 
BET-1 A cells were derived from primary human bronchial epithelial cells transformed 
using a retrovirus vector containing the SV40 large T antigen (Reddel et al., 1988).
Stimulation of the 9HTEo' / SCFTE29o‘ and 9HTEo7pCEP#2 / 9HTEo'/pCEPRF cell 
lines with proinflammatory cytokines combined with dsRNA had no effect on nitrite 
generation compared to basal levels. These cell lines are derived from tracheal 
epithelial cells and this could explain why they behave differently to the bronchial BEAS- 
2B cell line. However, there are also differences in the way these cell lines were 
created compared to both the BEAS-2B and BET-1 A cell lines. Both the 9HTEo' and 
ZCFTE29o' cell lines were created from primary human tracheal epithelial cells 
transformed using a plasmid containing an SV40 genome defective in the origin of 
replication (Gruenert et al., 1988; Kunzelmann et al., 1993). As discussed earlier, the 
pCEP cell lines are derived from 9HTEo' cells (Perez et al., 1996) and have therefore 
undergone similar transformation procedures to this cell line. It is possible that
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differences in transformation between cell lines and/or subsequent differences in 
genetic mutations are responsible for the observed variation in iNOS activity and 
subsequent nitrite production between the cell lines used in this study and those used 
elsewhere.
The cell lines used in this study did not produce nitrite above basal levels in response to 
any cytokine combination and it can therefore be assumed that no induction of iNOS 
occurred. In contrast, the combination of IFNy, IL-1(3 and TNFa did lead to nitrite 
generation by the A549 alveolar cell line. This finding rules out the possibility that the 
cytokines were non-viable and provides support for the use of the fluorometric nitrite 
assay as a way of assessing iNOS induced NO production. Attempts were also made 
to examine iNOS induction by immunoblot and Northern blot analysis. However, no 
iNOS protein or iNOS message could be detected in any of the cell lysates (data not 
included). The inability to induce iNOS in these airway epithelial cell lines explains why 
the protein synthesis inhibitor, cycloheximide had little effect on the levels of nitrite 
generated. The basal levels of nitrite produced by these cell lines must have been due 
to the result of constitutive enzyme activity, which did not require do novo protein 
synthesis. The lack of iNOS induction also explains why the specific iNOS inhibitor, 
1400W had no effect on cytokine stimulated nitrite levels. This inhibitor also failed to 
have any effect on unstimulated cells, making it very unlikely that the basal levels of 
nitrite produced by the cell lines were the result of constitutive iNOS activity. The more 
general NOS inhibitor, aminoguanidine did significantly decrease the levels of nitrite 
produced by the airway epithelial cells. This finding suggests that a large proportion of 
the nitrite generated in the absence of cytokine stimulation was the result of some kind 
of constitutive NOS activity. Constitutive NOS produce small amounts of NO (nM 
range) and this fits with the observed data.
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The T helper 2 (Th2) cytokine interleukin-13 has been reported to inhibit NO production 
by activated murine peritoneal macrophages (Doyle et al., 1994) and mouse bone 
marrow-derived macrophages (Doherty et al., 1993). More recently Wright et al. (1997) 
demonstrated that IL-13 inhibits iNOS expression in the human colonic epithelial cell 
line HT-29 and the mechanism of this inhibition was linked to activation of the signalling 
enzyme phosphatidylinositol 3-kinase (PI3K). In support of this, IL-13 has been shown 
to inhibit NF-kB activation in some cell models (Manna & Aggarwai, 1998). To examine 
a possible link between PI3K and NO production in human airway epithelial cells, IL-13 
and the PI3K inhibitor LY294002 were included in a series of 24-hour cytokine 
stimulations using the 4 cell lines under investigation. Unfortunately, it was not possible 
to demonstrate any links between IL-13, PI3K and NO production in these cells due to 
the inability to induce nitrite generation above basal levels.
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3.6 SUMMARY OF RESULTS
• The 9HTEo', ZCFTE29o', 9HTEoVpCEP#2 and 9HTEoVpCEPRF cell lines all 
produced nitrite in the absence of cytokine stimulation with the CF phenotype cells 
producing significantly more nitrite than the non-CF phenotype cells.
• Stimulation of the 9HTEo\ LCFTE29o', 9HTEo‘/pCEP#2 and 9HTEo/pCEPRF cell 
lines with proinflammatory cytokines did not result in production of nitrite above 
basal levels at any time point from 6-48 hours.
• After 48 hours in the absence of serum, cell viability was considerably reduced for 
all four cell lines and this correlated with a high level of basal nitrite release.
• The use of the arginase inhibitor L-norvaline had no effect on the levels of nitrite 
produced in response to cytokine stimulation by the 9HTEo', £CFTE29o', 9HTEo' 
/pCEP#2 and 9HTEoVpCEPRF cell lines.
• The inclusion of dsRNA in the cytokine stimulations had no effect on the levels of 
nitrite produced by any of the four cell lines.
• Neither the specific iNOS inhibitor 1400W, nor the protein synthesis inhibitor 
cycloheximide, had any effect on the basal or cytokine stimulated nitrite levels 
produced by the four cell lines.
• The general NOS inhibitor aminoguanidine significantly reduced the basal levels of 
nitrite produced by all four cell lines.
• Neither LY294002 nor IL-13 had any effect on the levels of nitrite produced by the 
four cell lines.
• Stimulation of the type II alveolar carcinoma cell line A549 with IFNy, IL-ip and 
TNFa resulted in a significant increase in nitrite production compared with basal 
levels.
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4 INTERLEUKIN-8 PRODUCTION BY AIRWAY EPITHELIAL
CELLS
4.1 INTRODUCTION
The aim of this work was to examine the mechanisms involved in the production and 
regulation of IL-8 by CF and non-CF human airway epithelial cells, using the 9HTEo' 
(non-CF), ZCFTE29o' (CF), 9HTEoYpCEP#2 (empty vector transfected) and 
9HTEo'/pCEPRF (R domain overexpressing) cell lines as models of human airway 
epithelium. The supernatants assayed for IL-8 were from the same cell cultures as 
those assayed for nitrite levels, where confluent monolayers of cells were serum 
starved for 12 hours and subsequently stimulated for 24 hours at 37°C with vehicle or 
increasing concentrations of IFNy (0-300 units/ml), IL-1(3 (0-10 ng/ml) and TNFa (0-100 
ng/ml), either alone or in various combinations. IL-8 levels were determined in cell 
culture supernatants using an IL-8 enzyme-linked immunosorbant assay as described in 
the materials and methods section.
4.2 INTERLEUKIN-8 GENERATION BY 9HTEo‘ and ECFTE29o' CELLS
Both 9HTEo' and ECFTE29o‘ cells produced a small amount of IL-8 in the absence of 
cytokine stimulation (5.29 ± 0.91 ng/106 cells for 9HTEo' cells and 7.09 ± 0.90 ng/106 
cells for 2CFTE29o‘ cells) (Fig 28a). The differences between these levels was not 
found to be significant. Increasing concentrations of the proinflammatory cytokine 
IFNy had no effect on basal IL-8 levels in either cell line (Fig 28a), whereas increasing 
concentrations of IL-1 (3 and TNFa added alone did affect IL-8 generation (Figs 28b &
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29). IL-8 production by the 9HTEo‘ cell line was significantly increased upon incubation 
with IL-ip 0.3 ng/ml from 5.41 ± 0.49 ng/106 cells under basal conditions to 15.14 ± 1.11 
ng/106 cells after stimulation (p<0.01). Incubation of these cells with IL-1(31 ng/ml 
further increased IL-8 generation to 24.08 ± 1.18 ng/106 cells. Higher concentrations of 
IL-1(3 (3 & 10 ng/ml) had no additional effects on IL-8 levels. In comparison, IL-8 
production by the £CFTE29o" cell line significantly increased from 6.13 ± 0.36 ng/106 
cells under basal conditions to 12.05 ± 1.01 ng/106 cells in the presence of IL-1(3 3 
ng/ml (p<0.01). Stimulation with IL-1p 10 ng/ml had no additional effect (Fig 28b). At 
all concentrations of IL-1(3 (0.3-10 ng/ml) 9HTEo' cells produced significantly more IL-8 
than XCFTE29o' cells (p<0.01). In both cell lines, stimulation with low concentrations of 
TNFa (3 & 10 ng/ml) lead to reduced IL-8 production compared with vehicle treated 
cells (Fig 29). Stimulations involving higher concentrations of TNFa (30 & 100 ng/ml) 
significantly augmented IL-8 production by both cell lines (p<0.01). IL-8 generation 
increased to 17.00 ± 1.14 ng/106 cells for 9HTEo‘ cells stimulated with TNFa 100 ng/ml 
and to 10.85 ± 1.23 ng/106 cells for ICFTE290' cells stimulated with this highest 
concentration of TNFa. In addition, at higher concentrations of TNFa (30 & 100 ng/ml) 
the 9HTEo' cell line produced significantly more IL-8 than the 2CFTE29o' cell line
(p<0.01).
The combination of IFNy 100 units/ml and IL-1(3 (0-10 ng/ml) or TNFa (0-100 ng/ml) 
produced the same pattern of IL-8 generation as IL-ip or TNFa alone in both cell lines 
(Fig 30). Similarly, the combination of IL-1 (3 (1-10 ng/ml) and TNFa (10-100 ng/ml) 
produced no significant differences in either cell line when compared with IL-1 (3 alone 
(Fig 31). Stimulation of the cells with increasing concentrations of the three
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proinflammatory cytokines combined did show an additive effect on IL-8 generation (Fig
32). Incubation of 9HTEo' cells with IFNy 100 units/ml, IL-1 (3 1 ng/ml and TNFa 10 
ng/ml produced significantly more IL-8 (34.21 ± 1.51 ng/106 cells) than stimulation with 
IL-1|3 1 ng/ml and TNFa 10 ng/ml (26.92 ±1.14 ng/106 cells) (p<0.05). Stimulation of 
this cell line with higher concentrations of the three cytokines combined also resulted in 
significantly increased IL-8 production compared to corresponding concentrations of IL- 
1|3 and TNFa in combination (p<0.05). A similar pattern was observed with the 
ZCFTE29o' cell line. Incubation of 2CFTE29o' cells with IFNy 100 units/ml, IL-1 (3 1 
ng/ml and TNFa 10 ng/ml lead to significantly increased IL-8 production (20.92 ± 1.46 
ng/106 cells) compared to stimulation with IL-1 (3 1 ng/ml and TNFa 10 ng/ml (10.24 ± 
0.91 ng/106 cells) (p<0.05). As with the 9HTEo' cell line, stimulation of 2CFTE29o‘ cells 
with higher concentrations of the three cytokines combined also resulted in significantly 
increased IL-8 production compared to corresponding concentrations of IL-1 (3 and 
TNFa in combination (p<0.01).
Time course studies were carried out to investigate if stimulation of the airway epithelial 
cells with IFNy 100 units/ml, IL-113 3 ng/ml and TNFa 30 ng/ml (cytomix) resulted in 
induction of IL-8 at any other timepoints. These studies revealed very little increase in 
basal IL-8 generation over time. However, a time-dependent increase in cytomix 
stimulated IL-8 production was observed for both cell lines over a 48 hour period (Fig.
33). At each timepoint the amount of cytokine stimulated IL-8 produced by both 
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Figure 28 IL-8 production by 9HTEo and £CFTE29o cells after 24 h treatment at 
37°C with (a) increasing concentrations of IFNy (50-300 units/ml) and (b) 
increasing concentrations of IL-1 (3 (0.3-10 ng/ml). The cells were serum starved for 
12 hours prior to treatment. Basal is the amount of IL-8 produced in the presence of 
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Figure 29 IL-8 production by 9HTEo and ECFTE29o cells after 24 h treatment at 
37°C with increasing concentrations of TNFa (3-100 ng/ml). The cells were serum 
starved for 12 hours prior to treatment. Basal is the amount of IL-8 produced in the 
presence of vehicle alone. Each point is the mean ± SEM of three experiments 
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Figure 30 IL-8 production by 9HTEo and £CFTE29o cells after 24 h treatment at 
37°C with (a) increasing concentrations of IL-1 p (0-10 ng/ml) and (b) increasing 
concentrations of TNFa (0-100 ng/ml), in the presence of IFNy 100 units/ml. The
cells were serum starved for 12 hours prior to treatment. Basal is the amount of IL-8 
produced in the presence of vehicle alone. Each point is the mean ± SEM of three 
experiments (** p<0.01 compared with basal).
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Figure 31 IL-8 production by 9HTEo and £CFTE29o cells after 24 h treatment at 
37°C with IL-1 p (1-10 ng/ml) and TNFa (10-100 ng/ml) added in combination. The
cells were serum starved for 12 hours prior to treatment. Basal is the amount of IL-8 
produced in the presence of vehicle alone. Each point is the mean ± SEM of three 
experiments (* p<0.05, ** p<0.01 compared with basal).
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Figure 32 IL-8 production by 9HTEo and £CFTE29o cells after 24 h incubation at 
37°C with IFNy (100 units/ml), IL-1 p (1-10 ng/ml) and TNFa (10-100 ng/ml) added in 
combination. The cells were serum starved for 12 hours prior to treatment. Basal is 
the amount of IL-8 produced in the presence of vehicle alone. Each bar is the mean ± 
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Figure 33 Time course of IL-8 production by 9HTEo and £CFTE29o cells after 
incubation at 37°C with vehicle or cytomix (IFNy 100 units/ml, IL-10 3 ng/ml and 
TNFa 30 ng/ml). The cells were serum starved for 12 hours prior to treatment. Each 
bar is the mean ± SEM of three experiments (* p<0.05, ** p<0.01 compared with basal).
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conditions (p<0.05 for 6h and p<0.01 for 12-48h). To allow for valid comparisons 
between the IL-8 and the nitrite data obtained from these cell lines, all further 
stimulations were carried out over a 24-hour time period.
Figure 34 shows the effects of the protein synthesis inhibitor cycloheximide (10-100 p,M) 
on IL-8 production by airway epithelial cells. This inhibitor had no effect on basal IL-8 
levels, but it significantly reduced cytokine stimulated IL-8 generation in both cell lines. 
30-minutes pre-treatment of 9HTEo' cells with 10 pM cycloheximide decreased cytokine 
stimulated IL-8 production from 35.97 ±1.10 ng/106 cells to 8.60 ± 0.57 ng/106 cells 
(p<0.01). The use of 100 pM cycloheximide on this cell line further reduced cytokine 
stimulated IL-8 generation (p<0.01). This pattern was repeated for the ZCFTE29o' cell 
line, with cytokine stimulated IL-8 production significantly reduced from 21.33 ± 1.81 
ng/106 cells to 4.14 ± 0.29 ng/106 cells after pre-treatment with 100 p,M cycloheximide
(p<0.01).
To examine the possible modulatory effect of the phosphatidylinositol 3-kinase inhibitor 
LY294002 and IL-13 on IL-8 generation, airway epithelial cells were incubated with 
various concentrations of LY294002 (3-30 |liM) and IL-13 (3-30 ng/ml) 30 minutes prior 
to stimulation with cytomix. LY294002 had no significant effect on IL-8 production by 
either cell line. This was also the case when unstimulated cells were treated with this 
inhibitor (Fig 35). Fig 36 shows that treatment of the 9HTEo' and ZCFTE29o' cell lines 


























Figure 34 The effect of the protein synthesis inhibitor cycloheximide (10-100 pM) 
on IL-8 production by 9HTEo and £CFTE29o cells after 24 h incubation at 37°C 
with vehicle or cytomix (IFNy 100 units/ml, IL-1 p 3 ng/ml, TNFa 30 ng/ml). The
cells were serum starved for 12 hours prior to treatment. Cycloheximide was added 30 
minutes before the cytokines. Each bar is the mean ± SEM of three experiments 
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Figure 35 The effect of the phosphatidylinositol 3-kinase inhibitor LY294002 (3-30 
jiM) on IL-8 production by 9HTEo and SCFTE29o cells after 24 h incubation at 
37°C with vehicle or cytomix (IFNy 100 units/ml, IL-1 (3 3 ng/ml, TNFa 30 ng/ml).
The cells were serum starved for 12 hours prior to treatment. LY294002 was added 30 
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Figure 36 The effect of IL-13 (3-30 ng/ml) on IL-8 production by 9HTEo and 
SCFTE29o cells after 24 h incubation at 37°C with vehicle or cytomix (IFNy 100 
units/ml, IL-1 (3 3 ng/ml, TNFa 30 ng/ml). The cells were serum starved for 12 hours 
prior to treatment. IL-13 was added 30 minutes before the cytokines. Each bar is the 
mean ± SEM of three experiments.
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4.3 INTERLEUKIN-8 GENERATION BY pCEP9HTEo7#2 AND pCEP9HTEo7RF 
CELLS
As with the 9HTEo" and ZCFTE29o' cell lines both pCEP lines produced a small amount 
of IL-8 in the absence of cytokine stimulation (2.37 ± 0.25 ng/106 cells for pCEP9HTEo‘ 
/#2 cells and 3.47 ± 0.22 ng/106 cells for pCEP9HTEo7RF cells) (Fig 37a), with the 
pCEP9HTEo/RF cell line producing significantly more IL-8 than the pCEP9HTEo/#2 
cell line (p<0.05). Again, as with the 9HTEo' and XCFTE29o' cell lines, increasing 
concentrations of IFNy had no effect on IL-8 generation compared with the basal levels 
of IL-8 produced by vehicle treated cells (Fig 37a), whereas increasing concentrations 
of IL-1 (3 and TNFa added alone did affect IL-8 generation (Figs 37b & 38). IL-8 
production by the 9HTEo /pCEP#2 cell line was significantly increased upon incubation 
with IL-13 1 ng/ml (p<0.01). Incubation of these cells with IL-1 p 3 ng/ml further 
increased IL-8 generation, whereas incubation with IL-1 p 10 ng/ml had no additional 
effects on IL-8 levels. Similarly, IL-8 production by the 9HTEo/pCEPRF cell line 
significantly increased in the presence of IL-1 p 1 ng/ml (p<0.01). Stimulation with 
IL-1 p 3 ng/ml further increased IL-8 production and these levels were not significantly 
increased by stimulation of 9HTEo7pCEPRF cells with IL-1 p 10 ng/ml (Fig 37b). It is 
worth noting that at the higher concentrations of IL-1 p (3 & 10 ng/ml) 9HTEo/pCEPRF 
cells produced significantly more IL-8 than 9HTEo7pCEP#2 cells (p<0.05). Stimulation 
of both cell lines with low concentrations of TNFa (3 & 10 ng/ml) produced a similar 
pattern of IL-8 production to that seen with the 9HTEo' and ECFTE29o' cells (Fig 38). 
Stimulations involving higher concentrations of TNFa (30 & 100 ng/ml) significantly 
increased IL-8 production by both cell lines (p<0.01), with levels rising to 10.11 ± 1.79 
ng/106 cells for 9HTEo/pCEP#2 cells stimulated with TNFa 100 ng/ml and to 11.68 ±
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1.32 ng/106 cells for 9HTEoVpCEPRF cells stimulated with this concentration of TNFa. 
At these higher concentrations of TNFa no significant differences were found between 
the IL-8 levels produced by the two cell lines.
Stimulation of 9HTEo'/pCEP#2 cells and 9HTEo'/pCEPRF cells with combinations of 
IFNy 100 units/ml and IL-1 (3 (0-10 ng/ml) or TNFa (0-100 ng/ml) produced the same 
pattern of IL-8 generation as IL-1 j3 or TNFa alone (Fig 39). Similarly, the combination of 
IL-1 p (1-10 ng/ml) and TNFa (10-100 ng/ml) produced no significant differences in 
either cell line when compared to IL-1 p alone (Fig 40). However, as with the 9HTEo‘ 
and 2CFTE29o' cell lines, stimulation of the pCEP cells with increasing concentrations 
of the three proinflammatory cytokines combined did show an additive effect on IL-8 
generation (Fig 41). Incubation of 9HTEo'/pCEP#2 cells with IFNy 100 units/ml, IL-1 p 1 
ng/ml and TNFa 10 ng/ml produced significantly more IL-8 (16.24 ± 1.22 ng/106 cells) 
than stimulation with IL-1 p 1 ng/ml and TNFa 10 ng/ml (10.85 ±1.16 ng/106 cells) 
(p<0.05). Stimulation of this cell line with higher concentrations of the three cytokines 
combined also resulted in significantly increased IL-8 production compared to 
corresponding concentrations of IL-1 p and TNFa in combination (p<0.05). A similar 
pattern was observed with the 9HTEo'/pCEPRF cell line; incubation with IFNy 100 
units/ml, IL-1 p 1 ng/ml and TNFa 10 ng/ml lead to significantly increased IL-8 
production (25.97 ± 1.27 ng/106 cells) compared to stimulation with IL-1 p 1 ng/ml and 
TNFa 10 ng/ml (12.31 ±1.18 ng/106 cells) (p<0.01). As with the 9HTEo'/pCEP#2 cell 
line, stimulation of 9HTEo'/pCEPRF cells with higher concentrations of the three 
cytokines combined also resulted in significantly increased IL-8 production compared to 
corresponding concentrations of IL-1 p and TNFa in combination (p<0.01).
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As previously, time course studies were carried out to investigate if stimulation of the 
airway epithelial cells with cytomix (IFNy 100 units/ml, IL-103 ng/ml and TNFa 30 
ng/ml) resulted in induction of IL-8 at timepoints other than 24 hours. Once again a 
time-dependent increase in cytomix stimulated IL-8 production was observed for both 
cell lines. At each timepoint the amount of IL-8 produced by both cell lines upon 
cytokine stimulation was signifcantly greater than the amount produced under basal 
conditions (p<0.05 for 6h and p<0.01 for 12-48h). There was very little increase in 
basal IL-8 generation overtime (Fig 42).
Table 2 summarises the production of cytokine stimulated IL-8 by 9HTEo7pCEP#2 and 
9HTEoVpCEPRF cells after 30-minutes pre-treatment with cycloheximide, LY294002 or 
IL-13. Cycloheximide (10 pM) significantly decreased cytokine stimulated IL-8 
production in 9HTEo'/pCEP#2 cells from 16.70 ± 1.80ng/106 cells to 6.61 ± 0.43ng/106 
cells (p<0.01). This pattern was repeated for the 9HTEo'/pCEPRF cell line, with 
cytokine stimulated IL-8 production significantly reduced from 28.83 ± 2.02ng/106 cells 
to 10.56 ± 1.22ng/106 cells after pre-treatment with 10pM cycloheximide (p<0.01). 
Finally, neither the phosphatidylinositol 3-kinase inhibitor LY294002 nor IL-13 had any 















Figure 37 IL-8 production by 9HTEo /pCEP#2 and 9HTEo /pCEPRF cells after 24 h 
treatment at 37°C with (a) increasing concentrations of IFNy (50-300 units/ml) and 
(b) increasing concentrations of IL-1 p (0.3-10 ng/ml). The cells were serum starved 
for 12 hours prior to treatment. Basal is the amount of IL-8 produced in the presence of 
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Figure 38 IL-8 production by 9HTEo /pCEP#2 and 9HTEo /pCEPRF cells after 24 h 
treatment at 37°C with increasing concentrations of TNFa (3-100 ng/ml). The cells 
were serum starved for 12 hours prior to treatment. Basal is the amount of IL-8 
produced in the presence of vehicle alone. Each point is the mean ± SEM of three 
experiments (** p<0.01 compared with basal).
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Figure 39 IL-8 production by 9HTEo /pCEP#2 and 9HTEo /pCEPRF cells after 24 h 
treatment at 37°C with (a) increasing concentrations of IL-1 p (0-10 ng/ml) and (b) 
increasing concentrations of TNFa (0-100 ng/ml), in the presence of IFNy 100 
units/ml. The cells were serum starved for 12 hours prior to treatment. Basal is the 
amount of IL-8 produced in the presence of vehicle alone. Each point is the mean ± 












Figure 40 IL-8 production by 9HTEo /pCEP#2 and 9HTEo'/pCEPRF cells after 24 h 
treatment at 37°C with IL-1 p (1-10 ng/ml) and TNFa (10-100 ng/ml) added i 
combination. The cells were serum starved for 12 hours prior to treatment. Basal i 
the amount of IL-8 produced in the presence of vehicle alone. Each point is the mean 






Figure 41 IL-8 production by 9HTEo/pCEP#2 and 9HTEo /pCEP#2 cells after 24 h 
incubation at 37°C with IFNy (100 units/ml), IL-1 p (1-10 ng/ml) and TNFa 
(10-100 ng/ml) added in combination. The cells were serum starved for 12 hours 
prior to treatment. Basal is the amount of IL-8 produced in the presence of vehicle 
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Figure 42 Time course of IL-8 production by 9HTEo /pCEP#2 and 9HTEo"/pCEPRF 
cells after incubation at 37°C with vehicle or cytomix (IFNy 100 units/ml, IL- 
1(3 3 ng/ml and TNFa 30 ng/ml). The cells were serum starved for 12 hours prior to 




T reatment Mean ng IL-8/106 cells
basal 2.233 ±0 .17
cytomix 16.70 ±1 .80  **
cytomix + 1 0  jliM cycloheximide 6.61 ± 0.43 **
cytomix + 10 jliM LY294002 15.09 ±0 .95
cytomix + 30 ng/ml IL-13 17.05 ± 1.71
9HTEoYpCEPRF
T reatment Mean ng IL-8/106 cells
basal 3.95 ± 0.46
cytomix 28.83 ±2.02 **
cytomix + 10 jlaM cycloheximide 10.56 ±1.22 **
cytomix + 10 jliM LY294002 27.26 ± 1.64
cytomix + 30 ng/ml IL-13 26.30 ± 1.94
Table 2 Summary of IL-8 production by 9HTEo'/pCEP#2 and 9HTEo/pCEPRF 
cells after 24h treatment at 37°C with a variety of cytokine and inhibitor 
combinations. The cells were serum starved for 12 hours prior to treatment. 
Cytomix: IFNy 100 units/ml, IL-1 (3 3 ng/ml, TNFa 30 ng/ml. Each value is the mean ± 
SEM of three experiments (** p<0.01 compared with control group).
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4.4 DISCUSSION
Airway inflammation in CF is characterised by an excessive influx of neutrophils into the 
lung. Neutrophil chemotaxis is mediated primarily by the proinflammatory chemokine 
IL-8 (Baggiolini et al., 1989) and elevated IL-8 levels have been detected in the 
bronchoalveolar lavage (BAL) fluid from CF patients (Richman-Eisenstat et al., 1993). 
A potentially major source of IL-8 in the airways is the epithelium (Marini et al., 1992; 
Becker et al., 1993). Since the airway epithelium also manifests the most important 
phenotypic abnormalities of CF, many researchers have hypothesised that CF airway 
epithelial cells overproduce IL-8 and that this is linked to abnormal function of the cystic 
fibrosis transmembrane conductance regulator (CFTR). Several groups have 
demonstrated that stimulation of airway epithelial cell lines with Pseudomonas 
aeruginosa, leads to increased expression of IL-8 in cells with CFTR dysfunction 
compared to matched control lines (DiMango et al., 1995; Bryan et al., 1998; Tabary et 
al., 1999). However, other studies examining the effects of cytokine stimulation on 
airway epithelial cells have produced conflicting data (Ruef et al., 1993; Stecenko et 
al., 1997; Black et al., 1998; Schwiebert et al., 1999; Massengale et al., 1999). In order 
to successfully manage the excessive inflammation present in the CF lung, it will be 
important to accurately determine the source of increased IL-8 levels in CF airways and 
to discover the mechanisms controlling production of IL-8 by normal and CF airway 
cells. To attempt to clarify the role of airway epithelial cells in lung inflammation, part of 
this study was involved in examining the production and regulation of IL-8 in CF and 
non-CF airway epithelial cell lines.
The finding that all the cell lines used in this study produced a small amount of IL-8 in 
the absence of cytokine stimulation is consistent with other reports (Ruef et al., 1993;
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Stecenko et al., 1997; Black et al., 1998; Schwiebert et al., 1999; Massengale et 
al., 1999; Venkatakrishnan et al., 2000). The ECFTE29o' and 9HTEoVpCEPRF cells 
produced more IL-8 than their non-CF counterparts, but this difference was only 
significant for the pCEP lines. As discussed previously, the pCEP cell lines are a 
genetically matched pair of cell lines and therefore any differences observed between 
them are potentially more valid. The fact that the 9HTEoVpCEPRF cell line produced 
more basal IL-8 than the 9HTEo'/pCEP#2 cell line seems to suggest that CF airway 
epithelial cells are intrinsically more proinflammatory than non-CF airway epithelial cells 
and that this characteristic is linked to the absence of functional CFTR. However, 
although the differences in basal IL-8 levels between the pCEP lines are significant, 
they are still very small and the physiological relevance of such differences is 
questionable.
The significant increase in IL-8 levels observed when the cell lines were incubated with 
IL-1 p or a high concentration of TNFa provides confirmation that airway epithelial cells 
are a possible source of IL-8 in the inflamed airway. The fact that IFNy alone had no 
effect on basal IL-8 levels supports the findings of Schwiebert et al. (1999), who found 
either no effect or an inhibitory effect of IFNy on IL-8 production with a variety of airway 
epithelial cell lines. Using gastric epithelial cell lines Yasumoto et al. (1992) 
demonstrated that although IFNy had no effect on IL-8 production when used alone, co 
incubation of gastric cells with IFNy and TNFa synergistically increased IL-8 production. 
Combining IFNy and TNFa in this study resulted in no such synergism in any of the cell 
lines. However, a synergistic effect was observed when IFNy, IL-1 p and TNFa were 
used in combination as an inflammatory stimulus. IL-8 production has been 
investigated in many different experimental systems and its regulation occurs at a
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variety of levels. Yasumoto and colleagues (1992) established that the cooperative 
effect of TNFaand IFNy on IL-8 production in their gastric epithelial cell lines occurred 
at the level of transcription, through activation of the transcription factors NF-kB and 
AP-1. In 1994 Mukaida et al. stated that, depending on the cell line, cooperation 
between NF-kB and either NF-IL-6 or AP-1 is sufficient for IL-8 gene activation. In 
contrast, Smith et al. (2001) showed that when the airway epithelial cell line 16HBE14o' 
was stimulated with a combination of IL-ip and TNFa, IL-8 production occurred via the 
activation of NF-kB only. It is highly probable that the increased IL-8 levels produced by 
the 9HTEo', £CFTE29o', 9HTEo'/pCEP#2 and 9HTEoVpCEPRF cell lines in response 
to IL-ip and TNFa stimulation involved activation of NF-kB. However, from the data 
gathered in this chapter, it is difficult to speculate on the exact mechanisms behind the 
synergistic effects of IFNy, IL-ip and TNFa in these cell lines.
The response to cytokine stimulation over 48 hours showed similar patterns for the four 
cell lines studied. As reported in the previous chapter, at the 48 hour time point 
microscopic examination of the cells revealed a decrease in cell number and an 
increase in cell debris, with cell viability being 55% for the 9HTEo' cell line, 46% for the 
ZCFTE29C cell line, 62% for the 9HTEo'/pCEP#2 cell line and 58% for the 9HTEo‘ 
/pCEPRF cell line. At all other time points cell viability was much higher and the 
amount of debris present was much less. In view of this, cytokine stimulations were 
routinely carried out over 24 hours. In contrast to the nitrite data, the cells did not 
appear to release large amounts of IL-8 after 48 hours. However, considering the state 
of the cell cultures at this time point, these IL-8 levels cannot be considered reliable. 
The fact that the protein synthesis inhibitor cycloheximide significantly reduced IL-8 
production by all cell lines after a 24 hour cytokine stimulation, suggests that IL-8
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generation is dependent on de novo protein synthesis and verifies the induction of IL-8 
gene expression in response to proinflammatory cytokines. The inhibitor had no effect 
on basal IL-8 levels, confirming that there is always some constitutive IL-8 gene 
expression even in the absence of an inflammatory stimulus.
It has been demonstrated that the Th2 cytokine IL-13 modulates chemokine expression 
in a variety of cell types, including monocytes, endothelial cells and gut epithelial cells 
(Herbert etal., 1993; Sironi et al., 1994; Zurawski & De Vries, 1994; Kolios etal., 1996). 
In the light of these findings and in view of the fact that IL-13 has been shown to inhibit 
NF-kB activation in some cell models (Manna & Aggarwai, 1998), it seemed reasonable 
to investigate a possible link between IL-13 and IL-8 production in airway epithelial 
cells. However, no effect of IL-13 on cytokine stimulated IL-8 expression was observed, 
suggesting there is no connection between IL-13, NF-kB and IL-8 gene expression in 
the 9HTEo' / ZCFTE29o‘ and 9HTEo'/pCEP#2 / 9HTEo7pCEPRF cell lines. The 
enzyme PI3K has also been implicated in NF-kB regulation in a range of cell lines 
(Ozes et al., 1999; Romashkova & Makarov, 1999; Kane et al., 1999; Madrid et 
al., 2000) and the potential role of this enzyme in IL-8 production was investigated using 
the PI3K inhibitor LY294002. The finding that LY294002 had no effect on cytokine 
stimulated IL-8 levels appears to imply no link between PI3K and IL-8 production in 
these particular cell lines.
It is notable that the 9HTEo' cell line produced significantly more IL-8 than XCFTE290' 
cell line in response to cytokine stimulation, whereas with the pCEP cell lines this 
pattern was reversed. There is evidence to support both these sets of findings. 
Venkatakrishnan et al. (2000) studied three different types of transformed human
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bronchial epithelial cell lines. One type expressed mutant CFTR (IB3), one type 
expressed wild-type CFTR (BEAS-2B) and the third was a corrected CF cell line that 
was derived from IB3 cells stably transfected with wild-type CFTR (C38). They found 
that TNFa-stimulated production of IL-8 by IB3 cells was significantly increased 
compared with either BEAS-2B or C38 cells. These data attest to the hypothesis that 
cells with CFTR mutations over express IL-8 in response to proinflammatory signals 
and seem to support the results obtained with the pCEP cell lines. However, it is worth 
remembering that although the 9HTEo'/pCEPRF cells produced more IL-8 than the 
9HTEoVpCEP#2 cells after IL-1 (3 and cytomix stimulation, when these lines were 
stimulated with TNFa alone, no significant differences in IL-8 production were observed. 
Ruef and co-workers (1993) demonstrated that the CF airway epithelial cell line 
JME/CF15 secreted IL-8 in the absence of stimuli and that this expression was further 
enhanced in the presence of IL-ip. In addition, Stecenko and colleagues (1997) 
reported that the CF airway epithelial cells IB3 and 2CF expressed significantly more IL- 
8 protein than the BEAS-2B cell line or normal primary bronchial epithelial cells in the 
presence of TNFa or IL-1|3. These findings support the IL-p and cytomix results found 
with the pCEP cell lines. In contrast, other studies have shown no differences in the 
IL-8 response of CF and non-CF immortalised airway epithelial cell lines to cytokine 
stimulation (Black et al., 1998; Schwiebert et al., 1999; Massengale et al., 1999). In 
fact, two of these studies actually demonstrated a trend towards lower IL-8 production in 
the cell lines with CFTR dysfunction (Black et al., 1998; Massengale et al., 1999). It is 
worth noting that both of these studies used isogenic cell lines and the authors claim 
this eliminates the possibility that the observed differences are due to inter-cell line 
variation. These findings refute the hypothesis that CF airway epithelial cells are 
primed to over express IL-8 and support the pattern of cytokine stimulated IL-8
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production observed with the 9HTEo' and XCFTE29o' cell lines. Massengale and 
colleagues (1999) suggest their observations provide preliminary evidence that IL-8 
secretion by CF respiratory epithelium is actually defective and propose this provides a 
potential mechanism for early airway colonisation with bacteria, particularly P. 
aeruginosa.
As the pCEP airway epithelial cell lines used in this particular study are a genetically 
matched pair of lines, the cytokine response profiles obtained from these cells may be 
more compelling than those obtained from the 9HTEo‘ and XCFTE29o' cell lines. 
However, in light of the studies discussed above it is hard to comment with any certainty 
on the relationship between non-functional CFTR and IL-8 production. It is difficult to 
explain the contradictory results obtained from all the studies on cytokine stimulated 
IL-8 production by airway epithelial cells. It should be noted that much of the work 
showing increased IL-8 production by CF airway epithelia did not report IL-8 secretion in 
a vector control line and those that used isogenic cells, did not demonstrate their 
corrected lines exhibited wild-type CFTR activity. On the other hand, many of the 
studies showing reduced IL-8 production by CF phenotype cells had inconsistencies in 
cell culture conditions. For example Massengale et al. (1999) cultured their CF cell 
lines in medium containing hydrocortisone and this glucocorticoid was not included in 
the normal cell line cultures. Hydrocortisone inhibits the transcription of inflammatory 
genes and this may well explain the differences seen.
Although the studies discussed here indicate that CF and non-CF airway epithelial cells 
express inconsistent differences in the levels of IL-8 produced in the presence and 
absence of cytokine stimulation, the mere expression of this chemokine implicates CF
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epithelia at some level in the leukocyte migration observed in CF associated airway 
inflammation. Elevated levels of TNFa have been detected in the sputum of CF 
patients who were not infected with Pseudomonas aeruginosa (Schuster et al, 1995) 
and it may be that these increased TNFa levels contribute to the increased IL-8 levels 
detected in uninfected CF patient BAL fluid. However, at this stage it is impossible to 
claim with confidence that airway epithelial cells are the source of these increased IL-8 
levels and that cytokine-induced epithelial IL-8 expression is dependent on functional 
CFTR.
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4.5 SUMMARY OF RESULTS
• All cell lines produced a small amount of IL-8 in the absence of cytokine stimulation, 
with the 9HTEo'/pCEPRF cell line producing significantly more IL-8 than the 9HTEo' 
/pCEP#2 cell line.
• IFNy had no effect on basal IL-8 production, but IL-1p (3-10 ng/ml) or TNFa (30-100 
ng/ml) alone significantly increased basal IL-8 levels in all cell lines.
• IL-1 p and TNFa combined did not produce an additive effect on IL-8 production with 
any cell line.
• Although the addition of IFNy to IL-1 (3 or TNFa stimulations did not alter IL -8 
generation, the combination of all 3 cytokines did have a synergistic effect on IL-8 
levels produced by all cell lines.
• Upon cytokine stimulation (IL-1p alone, TNFa alone or cytomix), 9HTEo' cells 
produced significantly more IL-8 than £CFTE29o' cells.
• 9HTEoVpCEPRF cells produced significantly more IL-8 than 9HTEo'/pCEP#2 cells 
after stimulation with IL-1 p or cytomix.
• Differences in cytokine stimulated IL-8 levels between 9HTEo' and £CFTE29o' cells 
were significant at all time points (6-48 hours), but for the pCEP cell lines the 
differences were only significant at 18, 24 and 48 hours.
• Cycloheximide significantly reduced the cytokine stimulated IL-8 levels produced by 
all cell lines.
• Neither LY294002 nor IL-13 had any effect on the basal or cytokine stimulated IL-8 
levels produced by any cell line.
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5 PHOSPHATIDYLINOSITOL 3-KINASE SIGNALLING IN AIRWAY
EPITHELIAL CELLS
5.1 INTRODUCTION
The aim of this work was to examine the mechanisms involved in the regulation of the 
phosphatidylinositol 3-kinase signal transduction pathway in CF and non-CF human 
airway epithelial cells, using the 9HTEo' (non-CF) and ECFTE29o' (CF) cell lines as 
models of human airway epithelium. PI3K activity was determined indirectly by 
measuring the levels of phosphorylated PKB and GSK3 (downstream effectors of PI3K) 
in stimulated and unstimulated cell lysates. The activity of PI3K was also examined 
directly by means of in vitro lipid kinase assays and finally the activity of the lipid 
phosphatase PTEN (an antagonist of PI3K signalling) was investigated using in vitro 
lipid phosphatase assays.
5.2 THE REGULATION OF PROTEIN KINASE B (PKB) AND GLYCOGEN 
SYNTHASE KINASE-3 (GSK3) PHOSPHORYLATION IN 9HTEo' AND ZCFTE29o‘ 
CELLS
For experimental purposes, cells were seeded into petri dishes at 3-5 x 104 cells/ml in a 
total volume of 4 ml of complete medium and grown until they were approximately 90% 
confluent. The cells were then serum starved for 4 hours and subsequently stimulated 
at 37°C with vehicle or IL-13 (30 ng/ml) with or without 1 hour pretreatment with the 
PI3K inhibitor LY294002 (10 jliM), the ERK1/2 inhibitor PD098059 (10 jliM), the p38
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inhibitor SB203580 (10 pM), the JNK inhibitor SP600125 (10 pM) and the protein kinase 
C (PKC) inhibitor Ro320432 (10 pM), either alone or in various combinations. Levels of 
phosphorylated PKB and GSK3 in cell lysates were determined via immunoblot analysis 
as described in the materials and methods section. Basal phosphorylated PKB levels 
were found to be low in both cell lines (Fig 43). Stimulation with the cytokine IL-13 
(30 ng/ml) for 1-5 minutes had no detectable effect on phosphorylated PKB levels in 
either cell line. However by 15 minutes the levels of phosphorylated PKB had 
increased considerably to high levels in both cell lines (Fig 43). Pretreatment of the 
cells with the PI3K inhibitor LY294002 (10 pM) completely abrogated this response in 
both 9HTEo‘ and ZCFTE29o' cells (Fig 43). Some phosphorylated GSK3 was 
detectable in the absence of cytokine stimulation in both cell lines (approximately 29% 
of maximum in 9HTEo' cells and 75% of maximum in ZCFTE290' cells) (Fig 44). As 
with phosphorylated PKB, these levels were increased to maximum levels after 15 
minutes stimution with IL-13 (30 ng/ml). However, in this instance pretreatment of both 
cell lines with the PI3K inhibitor LY294002 (10 jliM ) only partially reduced the amount of 
phosphorylated GSK3 present (to approximately 60% and 42% of maximum after 20 
minutes IL-13 stimulation for 9HTEo' cells and ECFTE29o' cells respectively) (Fig 44). 
It should be pointed out that the immunoblots show two bands for GSK3, which 
correspond to a and (3 isoforms of the protein. The (3 isoform has been studied much 
more intensively than the a isoform and therefore the lower band (GSK3|3) was used 
when carrying out densitometry analysis and comparing phosphorylated GSK3 levels.
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Figure 43 Phosphorylation of PKB in 9HTEo and ZCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PI3K inhibitor LY294002 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) PKB (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 44 Phosphorylation of GSK3 in 9HTEo and XCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PI3K inhibitor LY294002 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) GSK3 (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 45 shows the results of a time course study carried out to investigate the effects 
of IL-13 stimulation on phosphorylated PKB levels over a 90 minute period. This study 
supported the previous findings which showed low levels of phosphorylated PKB in both 
cell lines in the absence of cytokine stimulation (approximately 10% of maximum in 
9HTEo' cells and 16% of maximum in SCFTE29o‘ cells) and demonstrated that PKB 
becomes phosphorylated within 10 minutes of IL-13 stimulation (to maximum levels in 
both cell lines). The levels of phosphorylated PKB remained consistently high 
throughout the 90 minute period and there were no observable differences between the 
two cell lines.
None of the inhibitors of the mitogen activated protein kinase (MAPK) pathway or the 
PKC inhibitor had any effect on IL-13 stimulated phosphorylated PKB levels in either 
cell line (Figs 46-49). However, some of these inhibitors did have effects on 
phosphorylated GSK3 levels (Figs 50-53). For example, the ERK1/2 inhibitor 
PD098959 (10 juM) did not appear to reduce basally phosphorylated GSK3 levels in 
9HTEo' cells but did reduce basal phosphorylated GSK3 levels in £CFTE29o' cells from 
50% of maximum to 33% (Fig 50). When considering the 20-minute time point, the 
levels of phosphorylated GSK3 in 9HTEo' cells were reduced to 82% of maximum and 
in ECFTE29o' cells to 21% of maximum (Fig. 50). In contrast, the use of the p38 
inhibitor SB203580 (10 jliM ) had no effect on phosphorylated GSK3 levels in either cell 
line (Fig 51). The JNK inhibitor SP600125 (10 p,M) appeared to have little effect on the 
levels of phosphorylated GSK3 in 9HTEo' cells, but did have an effect on 
phosphorylated GSK3 levels in the ZCFTE29o' cell line (Fig 52). In the absence of 
cytokine stimulation SP600125 reduced phosphorylated GSK3 levels in these cells from 
approximately 30% of maximum to 15% and at the 15 minute time point it decreased
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Figure 45 Phosphorylation of PKB in 9HTEo and ECFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 90 minute time period at 37°C. The cells 
were serum starved for 4 hours prior to treatment. The top panel is the immunoblot 
probed with a specific antibody against phospho-(p) PKB (each blot is representative of 
3 experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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the levels of phosphorylated GSK3 from approximately 96% of maximum to 32%. 
Finally the use of the PKC inhibitor Ro320432 (10 pM) also had differing effects on 
phosphorylated GSK3 levels in the two cell lines (Fig 53). In the 9HTEo' cell line 
Ro320432 decreased basally phosphorylated GSK3 levels from approximately 54% of 
maximum to 20% and at the 15-minute time point it had the effect of reducing the 
amount of IL-13 stimulated phosphorylated GSK3 from maximum levels to 24% of 
maximum. By contrast, in the ICFTE290' cell line the PKC inhibitor reduced basally 
phosphorylated GSK3 levels from approximately 67% of maximum to 2% and reduced 
IL-13 stimulated levels from approximately 100% to 6% (15-minute time point). It is also 
interesting to note that the ERK1/2 inhibitor (PD098059), the JNK inhibitor (SP600125) 
and the PKC inhibitor (Ro320432) all substantially decreased the levels of 
phosphorylated GSK3a in the SCFTE29o‘ cell line whilst having little effect on GSK3a 
levels in the 9HTEo' cell line (Figs 50, 52 & 53).
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Figure 46 Phosphorylation of PKB in 9HTEo and £CFTE29o' cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the ERK1/2 inhibitor PD098059 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) PKB (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 47 Phosphorylation of PKB in 9HTEo and £CFTE29o cells after 
stimulation with IL13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the p38 inhibitor SB203580 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) PKB (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 48 Phosphorylation of PKB in 9HTEo and XCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the JNK inhibitor SP600125 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) PKB (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 49 Phosphorylation of PKB in 9HTEo and ECFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 15 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PKC inhibitor Ro320432 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) PKB (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 50 Phosphorylation of GSK3 in 9HTEo and ZCFTE29o' cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the ERK1/2 inhibitor PD098059 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) GSK3 (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
Results 148
9HTEo' 2CFTE29o‘
Time(mins) 0 1 5  15 20 0 1 5 1 5  20
pGSK3 a/p
0 1 5 15 20 0 1 5 15 20
55kDa
••KO m m - saw*8-
, 9|Ir







E ?  60
O c








0 1 5 15 20 0 1 5 15 20
Time (minutes)
PKB
Figure 51 Phosphorylation of GSK3 in 9HTEo and £CFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the p38 inhibitor SB203580 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) GSK3 (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 52 Phosphorylation of GSK3 in 9HTEo and ECFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the JNK inhibitor SP600125 (10 \M). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) GSK3 (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
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Figure 53 Phosphorylation of GSK3 in 9HTEo and ZCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 15 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PKC inhibitor Ro320432 (10 jiM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) GSK3 (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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The pattern of phosphorylated GSK3 inhibition observed when using the MAPK and 
PKC inhibitors alone was repeated when these inhibitors were used in combination 
(Figs 54-56). When the PI3K inhibitor LY294002 (10 pM) was used in conjunction with 
the ERK1/2 inhibitor PD098059 (10 pM), the resulting pattern of GSK3 phosphorylation 
in the 9HTEo' cell line (Fig 54) was very similar to that obtained with the use of 
LY294002 alone. In contrast when these two inhibitors were used with the ICFTE290" 
cell line (Fig 54), PD098059 appeared to have an additive effect on phosphorylated 
GSK3 inhibition compared with LY294002 alone. In fact the combination of these two 
inhibitors reduced basally phosphorylated GSK3 levels in £CFTE29o' cells from 
approximately 16% of maximum to 7% and reduced IL-13 stimulated levels from 
approximately 100% to 1% (15-minute time point). The combination of LY294002 (10 
pM) and the JNK inhibitor SP600125 (10 pM) also had a greater inhibitory effect on 
phosphorylated GSK3 in the SCFTE29o‘ cell line compared with the 9HTEo' cell line 
(Fig 55). Levels of phosphorylated GSK3 after 15 minutes IL-13 stimulation were 
reduced from maximal levels to approximately 52% of maximum in 9HTEo' cells and 
from approximately 99% to 6 % in ECFTE290' cells. When LY294002 (10 pM) and the 
PKC inhibitor Ro320432 (10 pM) were used in combination, phosphorylation of GSK3 
was almost completely inhibited in both cell lines (Fig 56). In the 9HTEo' cell line levels 
of basally phosphorylated GSK3 were reduced from approximately 63% of maximum to 
5% and in the ECFTE29o‘ cell line these levels were reduced from approximately 44% 
of maximum to 1%. At the 15-minute time point, phosphorylated GSK3 levels were 
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Figure 54 Phosphorylation of GSK3 in 9HTEo and XCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PI3K inhibitor LY294002 (10 pM) and the ERK1/2 inhibitor 
PD098059 (10 fiM). The cells were serum starved for 4 hours prior to treatment. The 
top panel is the immunoblot probed with a specific antibody against phospho-(p) GSK3 
(each blot is representative of 3 experiments), the middle panel is the densitometry 
analysis of the immunoblot (each bar is the mean ± SEM of 3 experiments) and the 
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Figure 55 Phosphorylation of GSK3 in 9HTEo and £CFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 20 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PI3K inhibitor LY294002 (10 pM) and the JNK inhibitor 
SP600125 (10 pM). The cells were serum starved for 4 hours prior to treatment. The 
top panel is the immunoblot probed with a specific antibody against phospho-(p) GSK3 
(each blot is representative of 3 experiments), the middle panel is the densitometry 
analysis of the immunoblot (each bar is the mean ± SEM of 3 experiments) and the 
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Figure 56 Phosphorylation of GSK3 in 9HTEo and ZCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 15 minute time period at 37°C, +/- 1 hour 
pre-treatment with the PI3K inhibitor LY294002 (10 pM) and the PKC inhibitor 
Ro320432 (10 pM). The cells were serum starved for 4 hours prior to treatment. The 
top panel is the immunoblot probed with a specific antibody against phospho-(p) GSK3 
(each blot is representative of 3 experiments), the middle panel is the densitometry 
analysis of the immunoblot (each bar is the mean ± SEM of 3 experiments) and the 
lower panel shows membranes probed with an antibody against pan PKB to check for 
equal loading.
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As expected, when PD098059 (10 pM), SP600125 (10 pM) and Ro320432 (10 pM) 
were all used in combination, the levels of phosphorylated GSK3 were considerably 
reduced in both cell lines (Fig. 57). At the 20 minute time point, IL-13 induced 
phosphorylated GSK3 levels were reduced to 10% of maximum in the 9HTEo' cell line 
and to 1% of maximum in the ECFTE29o' cell line. It was probable that the combination 
of two or more inhibitors was having wide spread effects on the cells and the observed 
reduction in phosphorylated GSK3 levels was not solely due to the inhibition of 
particular GSK3 phosphorylating pathways. In order to eliminate this possibility, the 
combined effect of PD098059 (10 pM), SP600125 (10 pM) and Ro320432 (10 pM) on 
PKB phosphorylation was examined. When used alone none of these inhibitors had 
any effect on IL-13 induced phosphorylated PKB levels. Figure 58 demonstrates that 
this was also the case when these inhibitors were used together.
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Figure 57 Phosphorylation of GSK3 in 9HTEo and £CFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 15 minute time period at 37°C, +/- 1 hour 
pre-treatment with the ERK1/2 inhibitor PD098059 (10 pM), the JNK inhibitor 
SP600125 (10 pM) and the PKC inhibitor Ro320432 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) GSK3 (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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Figure 58 Phosphorylation of PKB in 9HTEo and ZCFTE29o cells after 
stimulation with IL-13 (30 ng/ml) over a 15 minute time period at 37°C, +/- 1 hour 
pre-treatment with the ERK1/2 inhibitor PD098059 (10 j iM ), the JNK inhibitor 
SP600125 (10 pM) and the PKC inhibitor Ro320432 (10 pM). The cells were serum 
starved for 4 hours prior to treatment. The top panel is the immunoblot probed with a 
specific antibody against phospho-(p) PKB (each blot is representative of 3 
experiments), the middle panel is the densitometry analysis of the immunoblot (each 
bar is the mean ± SEM of 3 experiments) and the lower panel shows membranes 
probed with an antibody against pan PKB to check for equal loading.
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During the course of the experiments some interesting differences in the ratio of 
GSK3a/p were noted between the two cell lines. These ratios are summarised in table 
3. In the absence of any inhibitors, GSK3a/p ratios of 0.6 ± 0.04 and 0.4 ± 0.02 were 
observed for unstimulated 9HTEo' and £CFTE29o' cells respectively. After 20 minutes 
stimulation with IL-13 (30 ng/ml) these ratios increased to 0.8 ± 0.02 and 0.6 ± 0.05 
respectively. The change in these ratios was due to a greater increase in the levels of 
phosphorylated GSK3a compared to GSK3P in each case. The inclusion of certain 
inhibitors in the stimulations lead to larger differences in these ratios. For example, 
pre-treatment of 9HTEo' cells with the PI3K inhibitor LY294002 (10 |nM) resulted in a 
GSK3a/p ratio of 1.0 ± 0.08 under basal conditions compared to 0.2 ± 0.06 for similarly 
treated 2CFTE29o‘ cells. After 20 minutes stimulation with IL-13 (30 ng/ml) these ratios 
changed to 0.8 ± 0.02 for 9HTEo' cells and 0.3 ± 0.03 for ZCFTE290' cells. With the 
9HTEo' cell line LY294002 seemed to inhibit both GSK3a and p to a similar degree, 
whereas with XCFTE29o' cells, the PI3K inhibitor appeared to have a greater effect on 
the a isoform than the p isoform. This differing action of LY294002 on GSK3a/p levels 
lead to the observed differences in oc/p ratios between the cell lines. The JNK inhibitor 
SP600125 (10 nM) had a similar effect on GSK3ct/p levels and also produced a large 
difference in GSK3a/p ratios, with values of 0.9 ± 0.01 for IL-13 stimulated 9HTEo' cells 
and 0.1 ±0.04 for IL-13 stimulated £CFTE29o' cells. A similar pattern was observed 
when cells were pre-treated with the PKC inhibitor Ro320432 (10 nM) (ratios of 1.7 ± 
0.15 for IL-13 stimulated 9HTEo' cells and 1.1 ±0.20 for IL-13 stimulated ICFTE290" 
cells). However, it was the combination of inhibitors that produced the greatest 
differences in GSK3a/p ratios. For instance, pre-treatment with LY294002 (10 pM) and 
the ERK1/2 inhibitor PD098059 (10 |iM) resulted in a ratio of 0.8 ± 0.05 for IL-13
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stimulated 9HTEo' cells and 4.3 ± 1.86 for IL-13 stimulated £CFTE29o' cells. In this 
case the high GSK3a/p ratio observed with the XCFTE29o' cell line seemed to result 
from the almost total abrogation of GSK3(3 by this particular inhibitor combination. 
Finally, when PD098059 (10 pM), SP600125 (10 ^M) and Ro320432 (10 i^M) were all 
used in combination GSK3a/p ratios of 7.6 ± 1.55 and 2.7 ± 1.02 were obtained for 
IL-13 stimulated 9HTEo' cells and £CFTE29o' cells respectively. The use of these 
three inhibitors resulted in a high level of GSK30 inhibition in both cell lines, whereas 
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Table 3 Summary of GSK3 a/p ratios in 9HTEo' and SCFTE29o‘ cells under basal 
conditions and after 20 minutes stimulation with IL-13 (30ng/ml) +/- 1 hour 
pre-treatment with various combinations of the PI3K inhibitor LY294002 (10 pM), 
the ERK1/2 inhibitor PD098059 (10 pM), the JNK inhibitor SP600125 (10 pM) and 
the PKC inhibitor Ro320432 (10 pM). Each value is the mean ± SEM of three 
experiments.
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5.3 PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY IN 9HTEo‘ AND ECFTE290' 
CELLS
Confluent monolayers of 9HTEo' and ECFTE29o‘ cells were serum starved for 4 hours, 
resuspended in FCS-free medium and then pre-incubated with wortmannin (100 nM) or 
vehicle control for 15 minutes at 37°C. The cells were subsequently stimulated at 37°C 
with vehicle or IL-13 (30 ng/ml) for 1-15 minutes. PI3K was immunoprecipitated from 
cell lysates and a lipid kinase assay was carried out as described in the materials and 
methods section. Figure 59 shows the result of one such lipid kinase assay. Basal 
levels of Ptdlns-3-P appeared to be low in both the unstimulated 9HTEo' and 
ECFTE29o' cell samples (7% of maximum and 8% of maximum respectively), 
suggesting relatively low basal levels of PI3K activity (or possibly high basal phospatase 
activity). After 1 minute IL-13 stimulation the levels of Ptdlns-3-P had begun to increase 
and had peaked by 5 minutes in both cell lines (70% of maximum for the 9HTEo' cell 
line and 100% for the ECFTE29o' cell line). After 15 minutes IL-13 stimulation, 
Ptdlns-3-P levels were still higher than basal but had started to decrease in both cell 
lines (down to 25% of maximum in 9HTEo' cells and 85% of maximum in ECFTE29o- 
cells). Pretreatment of the cells with the PI3K inhibitor wortmannin (100 nM) reduced 
maximum Ptdlns-3-P levels almost to basal in both the 9HTEo' and ECFTE29o' cell 
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Figure 59 In vitro lipid kinase activity of immunoprecipitated PI3K from 9HTEo 
and XCFTE29o cell lysates after stimulation with IL-13 (30 ng/ml) over a 15 minute 
time period at 37°C, +/- 15 minutes pre-treatment with the PI3K inhibitor 
wortmannin (100 nM). The immunoprecipitates were washed and analysed for PI3K 
activity using Ptdlns as a substrate. Extraction and TLC separation of the lipid products 
were performed as described in the materials and methods section. Lipids were 
detected by exposure to film at -70°C. The cells were serum starved for 4 hours prior 
to treatment. The top panel is the autoradiograph and the lower panel is the 
densitometry analysis of the autoradiograph. The data are representative of 2 
experiments.
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5.4 ACTIVITY OF THE LIPID PHOSPHATASE PTEN IN 9HTEo‘ AND ZCFTE29o‘ 
CELLS
Confluent monolayers of 9HTEo' and 2CFTE29o' cells were serum starved for 4 hours 
and the levels of PTEN in unstimulated cell lysates were determined via immunoblot 
analysis as described in the materials and methods section. PTEN was found to be 
present in both 9HTEo' and £CFTE29o' cell lines (Fig 60). However, immunoblot 
analysis of PTEN did not provide any indication of the activity of this lipid phosphatase. 
In order to establish basal phsophatase activity in the two cell lines, confluent 
monolayers of 9HTEo‘ and £CFTE29o' cells were serum starved for 4 hours and PTEN 
was immunoprecipitated from cell lysates. A lipid phosphatase assay was then carried 
out as described in the materials and methods section. The lipids generated during the 
assay were separated by high-pressure liquid chromatography (HPLC) and detected via 
scintillation counting. Figure 61 shows the result of one such phosphatase assay. The 
substrate for PTEN, [3H]-Ptdlns-1,3,4,5-P4 eluted from the HPLC column after the 
reaction product, [3H]-Ptdlns-1,4,5-P3. By calculating the substrate : product ratio for 
each cell line, it was possible to make comparisons of basal PTEN activity.




ZCFTE29o: substrate : product ([3H]-Ptdlns-1,3-4,5-P4 : [3H]-Ptdlns-1,4,5-P3)
183.64 : 97.77 
1.8 1
The difference in substrate : product ratio between the two cell lines was very small and 
suggests that there was no major difference in basal PTEN activity between the 9HTEo' 




Figure 60 Immunoblot analysis of unstimulated 9HTEo and SCFTE29o cell 
lysates probed with a specific antibody against the lipid phosphatase PTEN. The
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Figure 61 In vitro lipid phosphatase activity of immunoprecipitated PTEN from 
unstimulated 9HTEo and £CFTE29o cell lysates. The immunoprecipitates were 
washed and analysed for PTEN phosphatase activity using [3H]-Ptdlns-1,3,4,5-P4 as a 
substrate. Extraction and HPLC separation of the lipid products were performed as 
described in the materials and methods section. Lipids were detected via scintillation 
counting. The cells were serum starved for 4 hours prior to lysis. The data are 
representative of 2 experiments.
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5.5 DISCUSSION
The D-3 phosphoinositide lipids have been linked to the triggering of a diverse array of 
cellular responses including cell survival, mitogenesis, membrane trafficking, glucose 
transport, neurite outgrowth, membrane ruffling, superoxide production, actin 
polymerisation and chemotaxis (Wright & Ward, 2001). Recently, a number of proteins 
have been identified that bind directly to these D-3 phosphoinositide lipids, including 
protein kinase B (PKB) and phosphoinositide-dependent kinase-1 (PDK1) (Rameh & 
Cantley, 1999; Stephens et al., 1998). Activated PKB has been implicated in the 
activation of the transcription factor NF-kB in human leucocytes and a variety of human 
cancer cell lines (Ozes et al., 1999; Romashkova & Makarov, 1999; Kane et al., 1999; 
Madrid et al., 2000). Furthermore, glycogen synthase kinase-3 (GSK3), a major 
downstream target of PKB, has been linked to the regulation of a range of transcription 
factors including c-Jun (part of the AP-1 transcription factor complex), cyclic-AMP 
response element binding protein (CREB) and c-Myc (Woodgett, 1991; DeGroot et 
al., 1992; Plyte et al., 1992; Fiol et al., 1994). The regulation of inflammatory genes, for 
instance those for iNOS and IL-8, have been linked to the activation of transcription 
factors such as NF-kB and AP-1 (Lowenstein et al., 1993; Mukaida et al., 1990; Kunsch 
& Rosen, 1993; Matsusaka et al., 1993; Oliveira et al., 1994) and PI3K/PKB/GSK3 
signalling may well be involved in these regulatory processes. Recently PKB and GSK3 
have also been shown to play an important role in the regulation of cell survival 
mechanisms (Coffer et al., 1998; Pap & Cooper, 1998). There is a large body of 
evidence suggesting that iNOS and IL-8 production are dysregulated in OF airway 
epithelia (Light et al., 1989; Grasemann et al., 1997; Kelley & Drumm, 1998; Ruef et 
al., 1993; Stecenko et al., 1997; Black et al., 1998; Schwiebert et al., 1999; Massengale
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et al., 1999) and it has also been suggested that cell survival mechanisms may be 
altered in CF (Maiuri, 1997). In the light of these findings it seemed reasonable to 
examine PI3K/PKB/GSK3 signalling in airway epithelium and to see if any differences 
existed in this signalling pathway between CF and non-CF cells.
In the gut epithelial cell line HT-29, the Th2 cytokine IL-13 has been shown to induce a 
concentration and time-dependent increase in the formation of the lipid products of PI3K 
activity, namely Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3 and this has been linked to the 
inhibition of cytokine-induced iNOS expression (Wright et al., 1997). Stimulation of 
9HTEo" and SCFTE29o‘ cells with IL-13 (30 ng/ml) resulted in phosphorylation of both 
PKB and GSK3a/p within a 15 minute time period and these levels were comparable 
between the two cell lines. The phosphorylation of PKB was shown to be dependent on 
PI3K activity. PI3K inhibition also partially reduced GSK3 phosphorylation. This link 
between growth factor stimulation, PI3K activation and PKB/GSK3 phosphorylation had 
previously been demonstrated in a range of other systems (Coffer et al., 1998; Frame & 
Cohen, 2001) but until now had not been confirmed in airway epithelium. Interestingly, 
no consistent differences in basal PKB and GSK3 phosphorylation levels were 
observed between the 9HTEo' and ECFTE29o' cells and therefore it appears that both 
basal and IL-13 stimulated PI3K activity (as measured by PKB and GSK3 
phosphorylation) were similar in these cell lines.
PKB is the most extensively studied target of Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3 and its 
phosphorylation is thought to be regulated exclusively by phosphoinositide-dependent 
kinases like PDK1 (Franke et al., 1997; Downward et al., 1998). The results of this 
study support such a proposal, as PKB phosphorylation in the 9HTEo' and ECFTE29o'
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airway epithelial cell lines was shown to be independent of any MAPK activity (ERK1/2, 
p38 and JNK independent) and PKC independent. On the other hand, it has been 
demonstrated in vitro that MAPK pathways can phosphorylate GSK3 on the same 
N-terminal serine residues that are phosphorylated in vivo by PKB (Sutherland et 
al., 1993). It has also been established that the mammalian target of rapamycin 
(mTOR) signalling pathway can lead to GSK3 phosphorylation and inactivation in some 
systems (Frame & Cohen, 2001). The results from this study have established that 
certain MAPK pathways and the PKC signalling pathway are involved in GSK3 
phosphorylation in airway epithelial cells. As phosphorylation by GSK3 appears to 
inhibit the activities of proteins involved in a range of biosynthetic processes, it makes 
sense that GSK3 should be inactivated through a variety of means. Such regulation 
may provide a coordinated mechanism for activating a spectrum of anabolic pathways 
in response to particular stimuli. It is also possible that individual growth factors inhibit 
GSK3 via more than one pathway. IL-13 may have acted in such a way in the airway 
epithelial cells used in this study, as PI3K, MAPK and PKC inhibitors all attenuated 
IL-13 stimulated GSK3 phosphorylation.
Although the MAPK and PKC signalling pathways were shown to be involved in 
phosphorylating GSK3 in both the 9HTEo' and ZCFTE29o' cell lines, some interesting 
differences were observed in the relative contributions of these pathways to GSK3 
inactivation. Both the ERK1/2 and JNK MAPK pathways appeared to have a greater 
role in GSK3 phosphorylation in ECFTE29o' cells than in 9HTEo' cells. However, the 
p38 branch of the MAPK pathway was not found to be involved in GSK3 
phosphorylation in either cell line. Finally, the PKC signalling pathway was also shown 
to play a larger role in GSK3 inactivation in the ICFTE290' cell line compared to the
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9HTEo' cell line. These data suggest that GSK3 phosphorylation is subject to different 
regulatory mechanisms in 9HTEo' and £CFTE29o' cells. This finding could have 
implications for the control of the many cellular processes that are regulated by GSK3, 
such as transcription factor activation and the regulation of cell survival pathways.
It is important to note that it was the (3 isoform of GSK3 that was analysed when 
comparing phosphorylated GSK3 levels between the 9HTEo" and ZCFTE29o' cell lines. 
This isoform has been implicated in the regulation of gene transcription and cell survival 
(Woodgett, 1991; DeGroot etal., 1992; Plyte eta!., 1992; Fiol et al., 1994), while little is 
known about the signalling properties of GSK3a. Interestingly, inhibition of ERK1/2, 
JNK and PKC all substantially decreased the levels of phosphorylated GSK3a in the 
2CFTE29o' cell line whilst having little effect on GSK3a levels in the 9HTEo' cell line. In 
addition, some interesting differences in certain GSK3a/|3 ratios were observed between 
the two cell lines. However, until the role of GSK3a in the regulation of cellular activities 
is elucidated further, the relevance of these particular findings will remain unclear.
The results from the in vitro lipid kinase assays gave some support to the data from the 
immunoblot experiments. In these assays, the levels of Ptdlns-3-P visualised on the 
autoradiograph corresponded directly to PI3K activity. No differences were observed in 
the basal levels of PI3K activity in the two cell lines. This corresponded with the levels 
of phosphorylated PKB and GSK3 found in these cells in the absence of cytokine 
stimulation. Treatment of both cell lines with IL-13 (30 ng/ml) resulted in PI3K 
activation, which peaked after 5 minutes and was attenuated by the PI3K inhibitor 
wortmannin (100 nM). It is interesting to note that after 15 minutes IL-13 stimulation, 
PI3K activity began to decrease in the 9HTEo' and ECFTE29o' cells whereas
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phosphorylated PKB levels showed no signs of decreasing 90 minutes after IL-13 
stimulation. It could be argued that phosphorylated PKB levels remained high after this 
length of time due to the constant presence of IL-13 in the cell culture medium. 
However, IL-13 was also constantly present in the cell culture medium of cells used for 
the in vitro lipid kinase assays. It would seem therefore that a short burst of PI3K 
activity is associated with prolonged PKB phosphorylation. On the other hand, although 
PI3K activity started to decrease 15 minutes after IL-13 stimulation in both cell lines, it 
had not returned to basal levels. Perhaps this level of PI3K activity was sufficient to 
maintain the long-lasting phosphorylation of PKB. It is apparent that IL-13 stimulations 
need to be carried out over longer time periods in order to establish the true relationship 
between PI3K activity and phosphorylated PKB levels in these airway epithelial cells.
Wortmannin was used instead of LY294002 to inhibit PI3K activity during the in vitro 
lipid kinase assays. Both these compounds are effective inhibitors of PI3K but differ in 
their modes of action. Wortmannin is classified as a non-competitive inhibitor of PI3K 
and is effective at nanomolar concentrations (Wymann et al., 1996), while LY294002 is 
classed as a competitive inhibitor of PI3K and is effective at micromolar concentrations 
(Vlahos et al., 1994). Wortmannin is also extremely light sensitive and degrades 
rapidly, whereas LY294002 is much more stable (Wymann et al., 1996). Due to the 
inherent instability of wortmannin, LY294002 was used in all the immunoblot 
stimulations. However, the fact that LY294002 is a competitive inhibitor of PI3K meant 
that it was unsuitable for use with the in vitro lipid kinase assays. It is highly unlikely 
that this inhibitor would have remained in association with PI3K during the assay 
procedure due to the high levels of Ptdlns present in the assay reaction mixture.
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The in vitro lipid kinase assays also helped to shed some light on the nature of the PI3K 
isoforms present in the 9HTEo' and ICFTE290' cell lines. Unstimulated and IL-13 
stimulated cell lysates were incubated overnight with mouse monoclonal anti-PI3K p85 
antibody. This antibody only recognises PI3K isoforms that consist of a p85 regulatory 
subunit. Only class 1A PI3Ks have this particular type of regulatory subunit, which is 
complexed to a p110 catalytic subunit (Vanhaesebroeck et al., 1997). The fact that 
PI3K activity was readily demonstrated after p85 immunoprecipitation suggests that 
9HTEo‘ and ZCFTE29o' airway epithelial cells contain at least one class 1A PI3K 
isoform. Of course, other PI3K isoforms could also be present in these cells. It may be 
that the prolonged phosphorylation of PKB in response to IL-13 stimulation was the 
result of the activity of PI3K isoforms other than the immunoprecipitated p85/p110 class 
1A isoform. Further work will need to be carried out in order to identify these isoforms 
and establish their relative activities.
It is well established that phosphoinositide second messengers are essential 
components of signalling pathways that control critical cellular functions. Consequently, 
it is not surprising that the regulation of cellular phosphoinositide levels is a complex 
process involving the interplay of various phosphoinositide kinases as well as 
phosphatases and lipases. Together these enzymes control the biosynthesis and 
degradation of inositol lipids. The phosphatase PTEN (phosphatase and tensin 
homologue deleted on chromosome 10), also known as MMAC1 (mutated in multiple 
advanced cancers 1) and TEP1 (transforming growth factor p-regulated and 
epitheiial-cell-enriched phosphatase), has both protein and lipid phosphatase activity 
and is a regulator of the phosphoinositide second messenger Ptdlns-3,4,5-P3 in many 
cell types (Krystal, 2000). The PTEN gene was originally identified as a human tumour
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suppressor gene located on chromosome 10q23.3, a region associated with high grade 
glioblastomas, prostate cancer and breast cancer (Li et al., 1997; Li & Sun, 1997; Steck 
et al., 1997). However, more recently PTEN has been shown to downregulate 
signalling through PKB by dephosphorylating Ptdlns-3,4,5-P3 at the 3’-OH position. 
This action prevents the activation of PDK1 and PKB and therefore inhibits cell 
proliferation and anti-apoptotic signalling (Stambolic et al., 1998; Cantley & Neel, 1999; 
Maehama & Dixon, 1999; DiCristofano et al., 1999).
This study hypothesises that aberrant PI3K signalling may be responsible for some of 
the lung manifestations observed in CF. If this is the case it could be related to a 
deficient PTEN regulatory system. The fact that basal levels of PI3K activity and 
phosphorylated PKB were low in both cell lines and were similar in IL-13 stimulated 
cells suggested that this was not the case. The PTEN immunoblot analysis verified that 
this particular lipid phosphatase was present in the 9HTEo' and ZCFTE29o' cell lines 
and the results from the in vitro lipid phosphatase assays suggested that there was little 
difference in PTEN activity between these two cell lines in the absence of cytokine 
stimulation. It will be necessary to establish the activity of PTEN in IL-13 stimulated 
cells in order to say with any certainty whether or not there are deficiencies in PTEN 
regulation between the 9HTEo' and XCFTE290' cell lines.
In summary it can be said that there are no differences in PI3K activity between 9HTEo' 
and ZCFTE29o' cells and no differences in basal PTEN activity. However, there are
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some interesting differences in the regulation of the PI3K downstream effector 
GSK3a/(3, which may impact on a range of cellular processes.
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5.6 SUMMARY OF RESULTS
• Basal levels of phosphorylated PKB were low in both 9HTEo' and £CFTE29o' cell 
lines, but increased considerably after 15 minutes stimulation with IL-13 (30 ng/ml)
• The PI3K inhibitor LY294002 (10 pM) completely inhibited IL-13 stimulated PKB 
phosphorylation in both cell lines.
• Levels of phosphorylated PKB were still high 90 minutes after IL-13 stimulation in 
both cell lines.
• The MAPK inhibitors (PD098059, 10 pM; SB203580, 10 pM; SP600125, 10 pM) and 
the PKC inhibitor (Ro320432, 10 pM) either alone or in combiniation had no effect 
on IL-13 stimulated PKB phosphorylation in either cell line.
• The ERK1/2 inhibitor PD098959 (10 pM), the JNK inhibitor SB203580 (10 pM) and 
the PKC inhibitor Ro320432 (10 pM) all had a greater inhibitory effect on IL-13 
stimulated phosphorylated GSK3 levels in ICFTE290' cells compared with 9HTEo' 
cells when used alone or in combination with LY294002 (10 pM).
• The p38 inhibitor SB203580 (10 pM) had no effect on phosphorylated GSK3 levels 
in either cell line.
• Differences in GSK3a/p ratios were observed between the cell lines after inhibitor 
treatment and IL-13 stimulation.
• Basal levels of Ptdlns-3-P were low in both cell lines and peaked after 5 minutes IL- 
13 stimulation.
• IL-13 stimulated Ptdlns-3-P accumulation was inhibited by wortmannin (100 nM) in 
both cell lines.
• Basal PTEN activity was low in both cell lines.
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6 DISCUSSION
The distinguishing feature of CF lung disease is the inability of the host to clear the 
initial colonisation and subsequent infection of the airways by Staphyloccocus aureus, 
Pseudomonas aeruginosa and sometimes, Burkholderia cepacia. This is despite an 
intense inflammatory response that is characterised by an influx of neutrophils and 
macrophages and the secretion of proinflammatory cytokines such as IL-ip, TNFa and 
IFNy. Activated inflammatory cells also release proteases, oxidants and defensins, 
which exacerbate the inflammatory response. The overall result is obstructive lung 
disease and eventual tissue destruction. It has been proposed that a tendency towards 
excessive inflammation is intrinsic in CF (Cantin, 1995) and this has been linked to the 
finding that CF airway epithelial cell lines produce higher levels of the neutrophil 
attracting chemokine IL-8, in response to Pseudomonas stimulation, than non-CF 
airway epithelial cell lines (DiMango et al., 1995; Bryan et al., 1998; Tabary et 
al., 1999). NO levels have also been shown to be aberrant in CF airways. It has been 
demonstrated that NO levels in the exhaled air from CF patients are reduced compared 
with normal controls (Light et al., 1989; Grasemann et al., 1997) and this has been 
correlated with the observation that iNOS expression is reduced in murine CF airway 
epithelium and the human CF epithelial cell line CFBE41o' (Kelley & Drumm, 1998; 
Meng et al., 1998). The induction of NO in many animal models is directly associated 
with the ability of the host to contain microbial proliferation (Stenger et al., 1996; 
MacMicking et al., 1997). Therefore, if iNOS expression is reduced in human airway 
epithelium it might help to explain why the human CF lung is so susceptible to bacterial 
colonisation. In view of these findings, this study set out to examine the role of well 
characterised human airway epithelial cell lines in the production of IL-8 and NO, in the
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context of an inflammatory situation, and to define which agents might affect their 
regulation.
The airway epithelial cell lines 9HTEo\ 2CFTE29o', 9HTEo7pCEP#2 and 9HTEo' 
/pCEPRF all produced a small amount of NO (as determined by nitrite release) in the 
absence of cytokine stimulation, but this was not found to be the result of constitutive 
iNOS activity. Curiously, the CF phenotype cells produced significantly more nitrite than 
their non-CF counterparts and none of the cell lines produced increased nitrite in 
response to stimulation with proinflammatory cytokines. These cell lines also produced 
small amounts of IL-8 in the absence of cytokine stimulation and these levels were 
significantly increased by stimulation of the cells with IL-1(3 alone, TNFa alone or IFNy, 
IL-1|3 and TNFa in combination. It was interesting to note that while the cytokine 
stimulated IL-8 levels produced by the 9HTEo' cell line were significantly higher than 
those produced by the ECFTE29o‘ cell line, the converse was true for the control and 
CF-phenotype pCEP cell lines.
It appears that the proinflammatory cytokine requirement for the induction of iNOS in 
immortalised airway epithelial cells varies depending upon the cell line being studied 
(Asano et al., 1994; Robbins et al., 1994; Guo et al., 1997; Watkins et al., 1997; Uetani 
et al., 2001) and may even be a consequence of how the cell lines were created. In a 
number of airway epithelial cell lines iNOS expression cannot be induced in response to 
proinflammatory cytokine stimulation (Guo et al., 1997; Uetani et al., 2001). This also 
appears to be the case with the 9HTEo', SCFTE29o‘, 9HTEo'/pCEP#2 and 9HTEo' 
/pCEPRF cell lines used in this study. The induction of iNOS, in response to cytokine 
stimulation, has been demonstrated in the type II alveolar carcinoma cell line, A549
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(Asano et al., 1994; Robbins et al., 1994) and by some researchers in the bronchial 
epithelial cell line, BEAS-2B (Watkins et al., 1997). However, it should be noted that in 
the latter study the authors observed that cytokine stimulated iNOS mRNA expression 
diminished rapidly with successive cell passages. Interestingly, a recent study by 
Donnelly & Barnes (2002) reported that the A549 and BEAS-2B cell lines produced very 
little nitrite, under both basal and stimulated conditions, compared with primary cells.
The induction of iNOS gene expression seems to be regulated differently between 
various human cell lines (Charles et al., 1993; Geller et al., 1993; Linn et al., 1997) and 
such differences in regulation may explain the inconsistencies observed in the 
production of NO between different human airway epithelial cell lines. Although 
numerous intracellular signal transduction pathways have been implicated in iNOS gene 
expression, including those leading to NF-kB and AP-1 activation (DeVera et al., 1996; 
Marks-Konczalik et al., 1998), IFNy activation of STAT-1 and IRF-1 is also likely to be 
essential for iNOS induction in human cells (Guo et al., 2000; Uetani et al., 2000). It 
has been demonstrated that infection of cells with adenovirus may impair STAT-1 
activation (Look et al., 1998) and this could explain why cell lines created by the 
transformation of airway epithelial cells with adenovirus-12 SV40 hybrid virus, such as 
the BEAS-2B cell line, show low levels of iNOS expression in response to cytokine 
stimulation. However, the IFNy signalling pathway and subsequent IFNy-inducible gene 
transcription are reportedly intact in BEAS-2B cells (Uetani et al., 2001). Taken 
together with the knowledge that IFNy potentiated IL-1(3 and TNFa induced IL-8 
production in the 9HTEo‘, £CFTE29o', 9HTEo'/pCEP#2 and 9HTEo'/pCEPRF cells, at 
least some of the IFNy signalling pathway is also intact in these cell lines. It is 
interesting to note that Uetani and colleagues (2001), were unable to show iNOS
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expression in response to cytokine stimulation in BEAS-2B and BET-1 A cells, although 
they did demonstrate that TNFa strongly induced NF-kB activation in these cell lines. 
Once again, the fact that cytokine stimulation of the 9HTEo', XCFTE29o', 9HTEo' 
/pCEP#2 and 9HTEo'/pCEPRF cell lines resulted in high levels of IL-8 production, 
confirms that the NF-kB activation pathway must also be intact in these particular cells. 
Uetani etal. (2001), were able to induce iNOS expression in BEAS-2B cells in response 
to stimulation with proinflammatory cytokines and double-stranded RNA (dsRNA). 
However, this combination had no effect on iNOS expression in the BET-1 A cell line. 
Similarly in this study, the stimulation of 9HTEo', ECFTE29o', 9HTEo'/pCEP#2 and 
9HTEo'/pCEPRF cells with cytokines and dsRNA did not lead to nitrite induction. It 
therefore appears that although the expression of iNOS in transformed human airway 
epithelial cells may well be dependent on the activation of STAT-1, IRF-1 and NF-kB, 
other pathways must also be involved and these may vary depending on the cell line in 
question. Taking all these studies and variations into consideration, it seems that 
immortalised airway epithelial cell lines may be poor models for the study of human 
airway epithelial iNOS expression.
As well as the reported inconsistencies in iNOS expression between various airway 
epithelial cell lines, it has also been demonstrated that primary cells that have been 
passaged once show considerably reduced levels of nitrite release, under both basal 
and cytokine stimulated conditions, compared with freshly isolated cells (Donnelly & 
Barnes, 2002). This finding is supported by the work of Guo and colleagues (1995) who 
demonstrated that freshly isolated human bronchial epithelial cells lose their ability to 
synthesise iNOS mRNA within 72 hours. These findings suggest that the control of 
iNOS expression in human airway epithelium is dependent on a combination of in vivo
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factors or exposures, to which airway epithelial cells are uniquely responsive and 
support the premise that multiple signal transduction pathways are involved in the 
regulation of iNOS expression in human airway epithelium.
The lack of a suitable model for the study of NO regulation in human airway epithelium 
makes it very difficult to comment on the relevance of the observations that iNOS 
expression is reduced in the human CF epithelial cell line CFBE41o' and in murine CF 
airway epithelium (Kelley & Drumm, 1998; Meng et al., 1998). In the study by Meng 
and colleagues (1998) the expression of iNOS mRNA in cytokine stimulated and 
unstimulated human CF (CFBE41o ) and non-CF (16HBE14o ) bronchial epithelial cell 
lines was detected by reverse transcriptase-polymerase chain reaction (RT-PCR). The 
authors demonstrated the induction of iNOS mRNA in cytokine stimulated 16HBE14o' 
cells, but in contrast no specific target mRNA band was detected in either cytokine 
stimulated or unstimulated CFBE41o' cells amplified for the same number of cycles. 
Meng et al. (1998) concluded that the absence of iNOS mRNA in the CFBE41o- cell line 
was due to a lack of iNOS gene expression, most likely resulting from abnormalities in 
the signalling system that normally causes induction. However, the authors only looked 
at RT-PCR amplified iNOS message and did not look directly at iNOS mRNA induction, 
iNOS protein expression or NO production. In the manner used RT-PCR is not a 
quantitative procedure and in the absence of any direct measurements of NO 
production or iNOS expression, it is difficult to establish the true magnitude or 
significance of the differences found. It is also unwise to extrapolate data regarding the 
regulation of murine iNOS to human tissue. Much of the work regarding the regulation 
of iNOS expression has been performed in murine models (Robbins et al., 1994; Walker 
et al., 1997; Jeon et al., 1998). In these systems iNOS is readily induced and produces 
large quantities of NO. However, as demonstrated, studies of human iNOS have
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proved to be less successful. There are differences in the promoters of human and 
murine iNOS that are thought to account for the hyporesponsiveness of human iNOS 
(DeVera et al., 1996; Taylor et al., 1998; Ganster et al., 2001; Mellott et al., 2001). In 
particular it is thought that NF-kB is more important in the regulation of murine iNOS 
(Chu et al., 1998) whilst the IFNy signalling pathway is more important in the regulation 
of the human gene (Bories et al., 1999; Guo et al., 1997). It would seem that human 
iNOS expression and hence NO production is more tightly regulated than murine 
models. This may be linked to the suggestion that in human tissue NO has a role to 
control the regulation of gene expression rather than just directing cytotoxicity (Kroncke 
et al., 1998). In summary, it appears that until the conditions for iNOS expression are 
better characterised in both human primary airway epithelial cells and human airway 
epithelial cell lines, there will continue to be a need for a reliable model system to 
further investigate the complex mechanisms leading to iNOS gene expression in human 
airway epithelium.
The transcriptional control of IL-8 expression has been linked to the activation of a 
range of transcription factors, including IRF-1, AP-1, AP-2, C/EBP and NF-IL-6 
(Mukaida et al., 1990; Kunsch & Rosen, 1993; Matsusaka et al., 1993; Oliveira et 
al., 1994). However, activation of NF-kB is thought to be the most crucial step for the 
initiation of IL-8 gene transcription in the majority of cell types (Mukaida et al., 1994). 
As mentioned earlier, the fact that the 9HTEo', XCFTE29o', 9HTEo'/pCEP#2 and 
9HTEo'/pCEPRF cell lines used in this study all produced high levels of IL-8 in 
response to cytokine stimulation suggests that they contain intact NF-kB activation 
pathways. In addition, the synergistic affect of IFNy on IL-1(3 and TNFa stimulated IL-8 
production indicates that, in these particular cells, NF-kB may be cooperating with
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elements of the IRF-1/STAT-1/IFNy signalling pathway in order to achieve maximum 
IL-8 generation. It is possible that other transcription factors, such as AP-1, are also 
involved in the regulation of IL-8 production in these cell lines in response to 
proinflammatory cytokine stimulation.
The molecular mechanism involved in IL-8 gene transcription is thought to differ, even 
within the same cell, depending upon the stimulus used. For example AP-1 has been 
shown to be the preferred transcription factor (over NF-IL-6) for cooperative interaction 
with NF-kB for IL-8 gene expression in respiratory syncytial virus-infected A549 cells 
(Mastronarde et al., 1998). However, when this same cell line is stimulated with 
Pseudomonas nitrite reductase (PNR), activation of NF-kB alone is sufficient for 
maximal IL-8 gene transcription (Mori et al., 1999). Such differences in IL-8 regulation 
may help to explain some of the inconsistencies observed in studies examining IL-8 
production by airway epithelial cell lines in response to particular stimuli. It has been 
demonstrated on many occasions that stimulation of airway epithelial cells with 
Pseudomonas aeruginosa or certain Pseudomonas products, such as PNR or 
N-3-oxododecanoyl homoserine lactone (3-0-C12-HSL), results in increased 
expression of IL-8 in cells with CFTR dysfunction compared with matched controls 
(DiMango et al., 1995; Bryan et al., 1998; Tabary et al., 1999). However, studies 
looking at the effects of proinflammatory cytokines on airway epithelial IL-8 production 
have produced conflicting data (Ruef et al., 1993; Stecenko et al., 1997; Black et al., 
1998; Schwiebert et al., 1999; Massengale et al., 1999; Venkatakrishnan et al., 2000). 
Even in this study, the IL-8 profiles generated by cytokine stimulated 9HTEo' and 
lCFTE29o' cell lines contrasted with those produced by the cytokine stimulated pCEP 
cell lines. Kube et al. (2000) examined IL-8 production in matched pairs of airway
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epithelial cell lines and confirmed that CF phenotype cells generated significantly more 
IL-8 than control lines in response to Pseudomonas stimulation. They also 
demonstrated prolonged IL-8 production by the CF phenotype cells compared with the 
control cells. When the same cells were stimulated with a mixture of IL-ip and TNFa 
the CF phenotype cells again produced more IL-8 than the non-CF cells. However, in 
this instance, the difference in IL-8 levels between the two cell types was considerably 
less than the difference observed after Pseudomonas stimulation. In addition, no 
disparity in the time course of IL-8 production was reported between cytokine stimulated 
CF and non-CF cell lines. The results of this study lend credence to the hypothesis that 
different signal transduction pathways and ultimately different transcription factors, are 
activated in response to the stimulation of airway epithelial cells with bacteria compared 
with stimulation by proinflammatory cytokines. It may even be the case that similar 
signal transduction pathways are activated in response to IL-10 and TNFa stimulation in 
normal and CF phenotype cells, whereas the mix of pathways may be different in 
normal and CF lines in response to Pseudomonas stimulation. It has also been 
suggested that CFTR function has a significant effect on signal transduction pathways 
activated by Pseudomonas stimulation, whilst having little effect on more general IL-8 
induction pathways, such as those activated by proinflammatory cytokines (Black et al.,
1998). The difference in cytokine stimulated IL-8 levels between CF and non-CF cells 
may vary depending upon the cell line used and this may shed some light on why some 
researchers report increased IL-8 production by CF airway epithelial cells in response to 
cytokine stimulation, whereas others do not.
The fact that the pCEP airway epithelial cell lines used in this study showed increased 
IL-8 production by the CF phenotype cells compared with the normal phenotype cells,
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suggests that the presence of functional CFTR may influence cytokine stimulated IL-8 
production at some level in these particular cell lines. The CF phenotype 9HTEo' 
/pCEPRF cells also produced significantly more IL-8 in the absence of cytokine 
stimulation than the non-CF 9HTEoYpCEP#2 cells. This finding seems to lend support 
to the theory that NF-kB is constitutively active in CF airway epithelial cells compared 
with normal cells (DiMango et al., 1998; Tabary et al., 1999). However, the use of the 
pCEP cell lines argues against the ER overload hypothesis. This hypothesis states that 
aberrant trafficking of mutant CFTR and its accumulation in the endoplasmic reticulum 
(ER) overwhelms normal cell degradation pathways, provoking stress activation of 
NF-kB (DiMango et al., 1998). Mutant CFTR is not present in either of the two pCEP 
cell lines. In these cells CFTR is processed normally and is present at the apical 
membrane (Perez et al., 1996). Thus, the data generated in this study suggests that 
the excess cytokine responses are a consequence of impaired cAMP-dependent 
chloride transport. Venkatakrishnan et al. (2000) also refute the ER overload 
hypothesis and demonstrated that alterations in NF-kB activity in CF airway epithelial 
cells were associated with changes in IkBP regulation. After cell stimulation members 
of the IkB family are phosphorylated, polyubiquitinated and degraded by the 26S 
proteosome, enabling NF-kB to translocate to the nucleus (reviewed by Barnes & Karin, 
1997). Activated nuclear NF-kB causes an upregulation of IkBoc mRNA levels by 
binding to kB motifs in the IkBcc promoter (Arenzana-Seisdedos et al., 1995). The 
newly synthesised IkBoc helps terminate the NF-kB response by resequestering NF-kB 
in the cytoplasm. In quiescent cells IkB(3 exists as a basal phosphorylated form that, 
like IkBoc, masks the nuclear localisation signals on NF-kB. After proteosome 
degradation it is resynthesised as an unphosphorylated (hypophosphorylated) form 
(Suyang et al., 1996). Unlike IkBcc and the basally phosphorylated form of IkBP,
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hypophosphorylated kBp is unable to mask the nuclear localisation signal and the DNA 
binding domain of NF-kB (Suyang et al., 1996). Therefore, NF-kB bound to 
hypophosphorylated kBp is protected from inactivation by IkBoc and can enter or 
remain in the nucleus and mediate persistent transcriptional activation of 
proinflammatory genes. Venkatakrishnan and colleagues (2000) showed that 
stimulation of airway epithelial cells with TNFa resulted in kBp degradation and 
accumulation of hypophosphorylated kBp, which was associated with prolonged NF-kB 
activation. However, CF epithelial cells had augmented production of 
hypophosphorylated kBp and increased nuclear NF-kB after TNFa treatment 
compared with normal and corrected epithelial cell lines. These increased levels of 
hypophosphorylated kBp in the CF epithelial cells correlated with increased IL-8 
production. It is possible that the increased production of IL-8 by 9HTEo'/pCEPRF cells 
after cytokine stimulation was associated with changes in kBp regulation and these 
changes may somehow have been related to impaired cAMP-dependent chloride ion 
transport. However, it should be noted that this theory does not account for the higher 
IL-8 levels observed in the absence of cytokine stimulation, when kBp would have 
been present in its phosphorylated form.
Large numbers of macrophages and neutrophils are present in the inflamed CF lung. 
However, despite this invading bacteria are not eradicated. High concentrations of 
elastase and reactive oxygen species, such as superoxide (02*) and hydrogen peroxide 
(H20 2), are released as a result of the inefficient phagocytosis and lysis of microbes. 
This creates a highly oxidative environment in the CF airway (Tummler & Kiewitz,
1999). In many systems oxidative stress has been shown to increase cytokine- 
mediated iNOS expression (Kuo et al., 1997). It has also been demonstrated that
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reactive oxygen intermediates induce the activation of NF-kB (Hoare et al., 1999). 
However, some oxidants, including H20 2, have been found to activate the PI3K pathway 
(Shaw et al., 1998; Sonoda et al., 1999) and inhibition of PI3K has been shown to be 
necessary for the expression of iNOS in a variety of systems (Donaldson et al., 1996; 
Park et al., 1997; Wright et al., 1997). It is therefore possible that the highly oxidative 
environment of the CF lung may lead to activation of PI3K in the airway epithelium, 
which in turn down regulates iNOS expression. Unfortunately this study was unable to 
establish any such link between iNOS expression and PI3K activation in the 9HTEo', 
ZCFTE29o\ 9HTEo"/pCEP#2 and 9HTEo'/pCEPRF cell lines due to the lack of nitrite 
production by these cells in response to proinflammatory cytokine stimulation. Despite 
this, some interesting differences in the regulation of PI3K/PKB/GSK3 signalling were 
observed between the 9HTEo' and 2CFTE29o' cell lines. Phosphorylation of GSK3a/p 
in 9HTEo' cells was found to be largely dependent on the PI3K pathway, with a small 
contribution in regulation from the ERK1/2, JNK and PKC signalling pathways. 
However, in contrast GSK3a/(3 phosphorylation in ECFTE29o' cells appeared to show a 
greater dependence on the ERK1/2, JNK and PKC pathways. These findings are 
summarised in figure 62 (a & b) and may have an impact on a range of cellular 
processes, including the regulation of inflammatory genes such as iNOS and the 
regulation of cell survival pathways.
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It is interesting to note that although the general consensus is that PI3K is required for 
the activation of NF-kB in most settings, Wright and colleagues (1997) demonstrated 
that PI3K activation attenuated iNOS expression in HT-29 gut epithelial cells rather than 
leading to gene induction. No mechanism was proposed to explain the regulation of 
iNOS expression via PI3K in this study. However, a recent report by Wang and 
colleagues (2000) has shed some light on these findings. They have demonstrated that 
inhibition of PI3K in colonic epithelial cells induced NF-kB binding activity and 
transactivation independently of any effects on IkBoc. It may be the case that in some 
systems PI3K activation affects the phosphorylation status and activity of another 
protein, which in turn interferes with the iNOS transcriptional machinery. It is also 
possible that PI3K regulates the transcription of this unknown protein. Such regulatory 
mechanisms may also operate in other tissues. However, in the absence of a reliable 
model system for the study of iNOS gene expression in human airway epithelial cells, 
potential links between PI3K signalling, NF-kB activation and iNOS induction in the 
context of lung inflammation cannot be fully examined
The role of the lipid phosphatase PTEN in PI3K signalling is very interesting and is 
worthy of further examination, in that its activity could possibly be linked to the presence 
of functional CFTR. Although the role of PTEN as a tumour suppressor is well 
established, the mechanisms by which its lipid phosphatase activity is regulated have 
only recently begun to be elucidated. PTEN is comprised of an N-terminal phosphatase 
domain, a C2 domain that binds lipid vesicles and a C-terminal tail that contains a PDZ 
binding domain (Lee et al., 1999). Several PDZ domain containing proteins have been 
shown to interact with PTEN, including members of the membrane-associated 
guanylate kinase (MAGUK) family (Wu et al., 2000). It has been proposed that
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MAGUKs function as scaffold proteins to assemble multiprotein signalling complexes 
and enhance their stability, thereby increasing the efficiency of signal transduction 
(Pawson & Scott, 1997). In particular, membrane-associated guanylate kinase 
inverted-2 (MAGI-2) and MAGI-3 have been shown to enhance the activity of PTEN as 
measured by inhibition of PKB phosphorylation (Wu et al., 2000). Conversely Vazquez 
& Sellers (2000), have demonstrated that phosphorylation of the PTEN tail by a 
constitutively active kinase negatively regulates its function as an antagonist of PI3K 
signalling. More recently Vazquez et al. (2001) have shown that unphosphorylated 
PTEN is found as part of a high molecular weight complex associated with the PDZ 
domain containing proteins MAGI-2 and MAGI-3. They named this complex the PTEN- 
associated complex (PAC). Vazquez and colleagues (2001) suggest that recruitment 
into the PAC is important for localisation of PTEN to the plasma membrane where its 
substrate lies. They also propose that phosphorylated PTEN exists in a closed 
conformation and is unable to interact with PDZ domain containing proteins. 
Phosphorylated PTEN is therefore unable to locate to the plasma membrane. Vazquez 
et al. (2001) hypothesise that as phosphorylation of the PTEN tail is regulated by a 
constitutively active kinase, the rate-limiting step in switching between phosphorylated 
and unphosphorylated PTEN is governed by a phosphatase. This phosphatase, upon 
activation, presumably dephosphorylates the PTEN tail changing its conformation and 
thus increasing the amount of PTEN available for the PAC (Fig 63). However, in order 
to confirm this model of PTEN regulation this putative phosphatase as well as its 
cellular location will need to be identified and its relationship to activated PI3K 
investigated.
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Figure 63 A model for phosphorylation-dependent regulation of PTEN activity (adapted 






PAC PDZ C2dT pHd)
PPase?
C2D PHD PTEN
Abbreviations: ( ? )  phosphate; PIP3, Ptdlns-3,4,5-P3; PIP2, Ptdlns-4,5-P2; PI3K,
phosphatidylinositol 3-kinase; PKB, protein kinase B; PTEN, phosphatase and tensin 
homologue deleted on chromosome ten; C2D, C2 domain; PHD, phosphatase domain; 
PDZ, PSD-95, DLG, ZO-1 domain; PAC, PTEN associated complex; CAK, constitutively 
active kinase; PPase?, putative phosphatase
PTEN and CFTR both contain PDZ binding domains (Lee et al., 1999; Moyer et al., 
1999; Moyer et al., 2000; Milewski et al., 2001) and are therefore both capable of 
interacting with PDZ domain containing proteins such as members of the MAGUK 
family. MAGUK proteins are believed to play a major role in signal transduction through
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the clustering of protein complexes at critical structures in the membrane such as the 
cytoplasmic tails of transmembrane receptors and ion channels (Kornau et al., 1995; 
Niethammer et al., 1996). It is therefore possible that the PAC into which
unphosphorylated PTEN is recruited is linked in some way to membrane-associated 
CFTR. An absence of functional CFTR in the apical membrane of CF airway epithelial 
cells could consequently result in a lack of PTEN recruitment to the plasma membrane 
and a failure to regulate PI3K signalling efficiently. The results of this study confirm that 
PTEN is present in 9HTEo' and 2CFTE29o' cells and preliminary data suggest that 
basal PTEN activity is similar between these two cell lines. However, further
investigation into the activity of PTEN and its relationship to CFTR in airway epithelial
cells may help to provide a broader picture of PI3K signalling and may help to identify 




In this study, human airway epithelial cells were found to produce high levels of the 
chemokine IL-8 in response to stimulation with a combination of the proinflammatory 
cytokines IFNy, IL-1 (3 and TNFa. These findings provide support for the suggestion that 
the epithelium is a potentially major source of IL-8 in the airways and implicate CF 
epithelia at some level in the neutrophil migration observed in CF associated airway 
inflammation. The Th2 derived cytokine, IL-13 did not affect airway epithelial IL-8 
generation and the regulation of IL-8 production was found to be independent of PI3K 
activity. Cytokine-induced IL-8 production by the CF phenotype cell line 
9HTEo'/pCEPRF was found to be significantly increased compared with the genetically 
matched non-CF control cell line 9HTEo'/pCEP#2. These results lend credence to the 
theory that CF airway epithelium is proinflammatory compared with normal airway 
epithelium and suggest that this may be a consequence of impaired cAMP-dependent 
chloride ion transport.
Human airway epithelial cells were found to produce basal levels of nitrite that were not 
increased by inflammatory stimuli. These findings suggest that iNOS cannot be 
induced by proinflammatory cytokines in the particular airway epithelial cell lines used in 
this study. The lack of response was not a consequence of substrate limitation or 
substrate competition and may well be a result of immortalisation procedures. It was 
not possible to demonstrate any links between IL-13, PI3K and NO production in these 
cells due to the inability to induce nitrite generation above basal levels. It therefore 
appears that immortalised airway epithelial cell lines may be poor models for the study 
of human airway epithelial iNOS expression.
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IL-13 was shown to activate PI3K and lead to the phosphorylation of PKB and GSK3 in 
human airway epithelial cells. This has been demonstrated in a range of other systems, 
but until now had not been confirmed in human airway epithelium. No differences in 
PI3K activity or levels of PKB and GSK3 phosphorylation were observed between CF 
and non-CF airway epithelial cell lines. However, some discrepancies in GSK3 
regulation were revealed. The ERK1/2, JNK and PKC pathways were shown to play a 
larger role in GSK3 phosphorylation in a CF airway epithelial cell line than a non-CF 
airway epithelial cell line. These findings could have implications for the control of the 
many cellular processes that are regulated by GSK3, such as transcription factor 
activation and the regulation of cell survival pathways.
In order to investigate fully the possible links between PI3K signalling and the regulation 
of iNOS, it will be necessary to develop a reliable model system in which the conditions 
for iNOS expression in human airway epithelial cells are fully characterised. A putative 
link between PI3K signalling, PTEN and CFTR is also of interest and should be 
explored further. Once the connections between signal transduction pathways, 
transcription factor activation and the production of inflammatory mediators such as 
iNOS and IL-8 are established, it may be possible to manipulate these pathways in 
order to restore an inflammatory balance in the CF airway. It may also be useful to 
examine the relationship between GSK3 inactivation and the triggering of cell survival 
pathways in airway epithelial cells, in the light of suggestions that cell survival 
mechanisms may be altered in CF.
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8 APPENDIX
8.1 SOLUTIONS FOR IMMUNOBLOT ANALYSIS
Lysis Buffer
50 mM TRIS-HCI, pH 7.5 
150 mM NaCI 
5 mM EDTA, pH 8.0 
1 % Nonidet P40 
10% glycerol 
1 mM Na3V04 
1 mM NaMo04
5X Sample Buffer




0.01 g Bromophenol blue (Bio-Rad) (just enough to give a dark blue colour)
7.5% w/v Acrylamide Running Gel (10ml)
3.75ml Protogel {30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide} (National 
Diagnostics, Hull, UK)
1 M TRIS-HCI, pH 8.8
10 mM NaF
40 jug/ml PMSF
0.7 ^ig/ml pepstatin A
10 jmg/ml aprotinin
10 |ug/ml leupeptin
10 jxg/ml soyabean trypsin inhibitor
Appendix 195
0.1% SDS
0.1% ammonium persulphate 
5.6 ml Milli-Q water
20 jul N,N,N’,N\tetramethylene-diamine (TEMED)
5% w/v Acrylamide Stacking Gel (8ml)
1.33 ml Protogel {30% (w/v) acrylamide, 0.8% (w/v) bisacrylamide} (National 
Diagnostics, Hull, UK)
1 M TRIS-HCI, pH 6.8 
0.1% SDS
0.1% ammonium persulphate 
6.36 ml Milli-Q water
20 p.l N,N,N’,N’,tetramethylene-diamine (TEMED)
8.2 SOLUTIONS FOR IN VITRO LIPID KINASE ASSAY
Lysis Buffer
20 mM TRIS 100 pM Na3V04
137 mM NaCI 1 mM PMSF
1 mM MgCI2 2 pi/ml aprotinin
1 mM CaCI2 2 pl/ml leupeptin
10% glycerol 0.4 pl/ml pepstatin A
1% NP-40
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8.3 SOLUTIONS FOR IN VITRO LIPID PHOSPHATASE ASSAY
Lysis Buffer
20 mM TRIS 1% NP-40
137 mM NaCI 1 mM PMSF
1 mM MgCI2 2 pl/ml aprotinin
1 mM CaCI2 2 pl/ml leupeptin
10% glycerol 0.4 pl/ml pepstatin A
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